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Bipolar affective disorder (BPAD) and schizophrenia are severe psychiatric
diseases with a strong genetic basis. Analysis of putative susceptibility genes
requires the identification of polymorphisms, such as microsatellites and Single
Nucleotide Polymorphisms (SNPs), in coding and non-coding sequences. The aim of
this thesis was to develop and use bioinformatic tools to direct laboratory work on a
candidate region for BPAD and schizophrenia on the short arm of human
chromosome 4. Specifically, the research aimed to facilitate the management and
analysis of data generated by allelic association studies, and identify putative
functional sequences as targets for SNP selection.
This thesis first reports the creation of an extension of the ACeDB database
used by the laboratory to manage the sequence of the candidate region, and a front-
end to manage and analyse raw data generated by allelic association studies based on
individual genotypes and pooled DNA. It then describes various strategies to define
putative non-coding functional sequences benchmarked against a set of genes with
experimentally verified regulatory regions. Initially, methods for detecting known
transcription factor binding sites and novel motifs were combined with tests of
sequence conservation between human and mouse. This approach showed modest
sensitivity and generated a high rate of false positives. Next, a purely comparative
genomics approach was explored using publicly available genome sequences from
human, mouse, rat, chicken, zebrafish and pufferfish. Several scoring systems for
multiple alignments of genomic sequences were tested. The most successful scoring
scheme detected regulatory sequences in 78% of the control genes using human,
mouse and rat sequences. The inclusion of the chicken and fish sequences in the
analysis reduced the number of genes that could be considered and the accuracy of
all scoring systems. Predictions of the functional potential of non-coding DNA were
sufficiently sensitive and specific to suggest a limited number of putative functional
regions for experimental verification. This approach was therefore applied to genes
in the 4p region linked to psychosis.
IV
The work presented in this thesis fulfilled three goals towards the
characterisation of candidates genes in the 4p region linked to psychosis: i) the
development of a computational tool to assist ongoing laboratory work by facilitating
association data management and analysis, ii) the in silico identification of non-
coding sequences with a functional potential using fast developing comparative
genomics and iii) the selection of SNPs located in these regions as candidate markers
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1.1 Identification of genes involved in complex diseases
A Mendelian trait is controlled by the genotype at a locus that is necessary
and sufficient for the expression of that character. Genes causing human Mendelian
traits and diseases have been discovered by positional cloning whereby a gene is
identified solely on the basis that the phenotype is inherited (Morton, 1955). The
chromosomal region that co-segregates with the disease in families with affected
members is determined by linkage analysis (Botstein et al., 1980). A candidate gene
in this region is then identified and causal variants are found in patients. Diseases for
which genes have been identified using positional cloning include: Duchenne
muscular dystrophy (Koenig et al., 1987), cystic fibrosis (Kerem et al., 1989), breast
cancer (Miki et al., 1994; Wooster et al., 1995) and Huntington disease (Gusella et
al., 1983).
Many complex diseases do not segregate in families as Mendelian traits, but
are instead influenced by multiple genetic and environmental factors (Lander and
Schork, 1994; Botstein and Risch, 2003). The major cause for diseases known to date
is mutation in coding regions of genes which affect protein quantity and/or quality
(Cargill et al., 1999). There is increasing evidence that polymorphisms in regulatory
regions may increase risk of diseases (Risch and Merikangas, 1996; Collins et al.,
1997; Wray et al., 2003; Knight, 2005). Some diseases have also been shown to
implicate epigenetic changes.
The term epigenetics refers to the transmission of information from a cell or
multicellular organism to its descendants without that information being encoded in
the nucleotide sequence of genes (Grunstein, 1998; Davis and Brackmann, 2003;
Sollars et al., 2003). Transmission of epigenetic factors from one generation to the
next is partially stable. Epigenetic marking is mediated by DNA methylation and
core histones methylation and acetylation, and creates molecular landmarks that
differentiate between active and inactive chromatin. Epigenetic modifications play an
important role during development and adult life via the inactivation of the X
chromosome, genomic imprinting and gene silencing. At an imprinted locus, one
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allele is typically transcriptionally silent but epigenetic heterogeneity is recognised
between individuals (Pastinen et al., 2004). The environment may also affect
epigenetic factors (Petronis and Petroniene, 2000; Wong et ah, 2005). Epigenetic
factors may also be involved in several complex diseases (Petronis, 2001; Wong et
ah, 2005) such as inflammatory bowel disease (Petronis and Petroniene, 2000) and
neuropsychiatric diseases (Petronis et ah, 2000; Aranyi et ah, 2002; Kim et ah, 2003;
Petronis, 2003; Petronis et ah, 2003; van Overveld et ah, 2003; Abdolmaleky et ah,
2004; Kan et ah, 2004; Caballero and Hendrich, 2005). For example, abnormal
epigenetic marking may be implicated in facioscapulohumeral muscular distrophy
(FSHD; OMIM 158900) and the Rett syndrome (OM1M 158900). Most patients with
FSHD carry deletions of a number of 3.3 Kb tandem repeats, termed D4Z4, located
on 4q35. The repeats are linked to hypomethylation of a silencer which correlates
with upregulation of nearby genes (van Overveld et ah, 2003). Rett syndrome is a
neurodevelopmental disorder involving impaired speech and motor skills, as well as
seizures and autistic behaviour. It is caused by mutations in the gene encoding the
methyl-CpG-binding repressor protein (MECP2). The consequent imperfect
repression of brain-derived neurotrophic factor (BDNF) may be involved in altered
synaptic plasticity causing the Rett syndrome (Caballero and Hendrich, 2005).
The genetic bases of complex traits, including human behavioural traits and
psychiatric disorders, are poorly understood. Many genes implicated in complex
disorders have nonetheless been identified using positional cloning (Botstein and
Risch, 2003). Approaches which have revealed genes of interest include the
identification of chromosomal abnormalities via cytogenetics, the study of families
where disorders segregate in a Mendelian manner, linkage disequilibrium mapping
(Lander and Schork, 1994; Jorde, 2000) and the use of endophenotypes, biological
traits that are associated with target behavioural phenotypes, such as brain activity in
response to stimuli measured by functional Magnetic Resonance Imaging (MRI) (van
Rijn et al., 2005).
Cytogenetic abnormalities have proven to be valuable in the understanding of
complex diseases. Several disorders in human are caused by chromosomal
translocation, insertion or deletion that altered gene expression resulting in similar or
identical phenotypes as those due to point mutations (Collins, 1995; Mclntyre et al.,
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2004; Pickard et al., 2005). Several neuro-psychiatric disorders have been reported to
involve chromosomal abnormalities in or near genes, such as dyslexia susceptibility 1
candidate 1 (DYX1C1) in developmental dyslexia (Taipale et al., 2003), forkhead
box P2 (FOXP2) in speech and language development (Lai et al., 2001; Newbury et
al., 2002; Lai et al., 2003), suppression of tumerogenicity 7 (ST7) and autism
susceptibility candidate 2 (AUTS2) in autism (Vincent et al., 2000a; Sultana et al.,
2002; Vincent et al., 2002), disrupted in schizophrenia 1 and 2 (DISCI and DISC2)
in schizophrenia (Millar et al., 2000b), asparagine-linked glycosylation 9 homolog
(ALG9), formerly 'disrupted in bipolar disorder' (DIBD1) (Baysal et al., 2002), and
glutamate receptor, ionotrophic, AMPA 3 (GRIA3) in BPAD (Baysal et al., 2002;
Gecz et al., 1999).
Appropriate methods to disentangle the genetics of complex illnesses have
been debated. Two main genetic models suggest two different approaches (Jorde,
2000). The following two sections present these two major approaches, namely
linkage analysis and linkage disequilibrium mapping, and the genetic models that
underlie them.
1.1.1 Linkage analysis
The first model assumes rare variants each with an individual, detectable
effect. Under this model, molecular cytogenetics, family linkage studies and
functional candidate gene analysis would be capable of identifying regions and genes
of interest, as they were successfully applied to single-gene illnesses (Botstein and
Risch, 2003). Linkage is the tendency of DNA sequences at specific loci to be
inherited together as a consequence of their physical proximity on a single
chromosome, that is the recombination fraction between the two loci is less than 0.5.
Linkage analysis attempts to detect linkage between genetic markers and the
phenotype of interest in related individuals. Detection of linkage relies on the
calculation of the overall likelihood of the observed pedigree on the alternative
assumptions that the loci are linked, determined by a given recombination fraction,
or not linked, where the recombination fraction is 0.5. The ratio of these two
likelihoods indicates the odds of linkage, and the logarithm of the odds, the lod score,
is used to determine whether the markers are linked: the higher the lod score, the
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stronger the evidence for linkage (Morton, 1955). For a Mendelian character, with a
5% chance of error, the threshold for significance is 3.0 for a single marker, and 3.3
for a genome-wide analysis (Lander and Schork, 1994). Linkage analysis methods
for complex disorders can be divided in parametric and non-parametric methods
(Jorde, 2000). Parametric methods rely on the specification of the Mendelian mode
of inheritance, the number of genes involved, the frequency of susceptibility alleles
and their penetrance (frequency at which a genotype manifests itself in a given
phenotype). Such methods are appropriate for the detection of genes for Mendelian
disorders or genes of major effect. Study of the segregation of markers along a
chromosome with the phenotype of interest requires large multigenerational families
with several affected members. On the other hand, non-parametric methods do not
rely on a specified model, ignore unaffected individuals and identify alleles or
chromosome segments that are shared by affected people, in nuclear (sib pair) or
extended families (Jorde, 2000).
In genome-wide linkage analysis of complex diseases, thresholds for
significance have been suggested and are now widely used: 3.3-4.0 for an initial
report, depending on the study design, and 1.2 for replication reports (Lander and
Kruglyalc, 1995). Linkage analyses of several hundreds of markers across the
genome have so far generated mixed results due to initial reports of significant
linkage of the illnesses to regions in the genome, but lack of confirmation by
subsequent studies (Altmuller et ah, 2001). Initial reports are likely to overestimate
the size of effect while subsequent replication attempts are more likely to indicate the
true size of effect (Lander and Kruglyak, 1995; Altmuller et ah, 2001; Botstein and
Risch, 2003). Some conflicting findings may reflect the complexity of the diseases
and may be due to the involvement of several genes and environmental factors
(Botstein and Risch, 2003). Two genetic models have been considered to explain the
discrepancy between studies. Firstly, mutations in one gene (allelic heterogeneity) or
in several genes (genetic heterogeneity) can generate very similar phenotypes, such
as in retinitis pimentosa (Kennan et ah, 2005). Extended pedigrees where a single
major gene is segregating are therefore more suited to detection of linkage than
smaller families and affected sib pairs. In the second model, several genes with a
small effect interact to generate the observed phenotypes. To detect mutations
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conferring low risk of disease, linkage analyses would require an unachievable
number of families (Risch and Merikangas, 1996). Lack of replication would
therefore be due to the lack of power of current studies (Blangero, 2004; Lander and
Kruglyak, 1995). Imprecise diagnoses, in particular for psychiatric diseases, are also
liabilities in linkage analysis (McGorry et al., 1995). This can be circumvented by
carrying out analyses with several definitions of the phenotypes, such as in the case
of affective disorders, by distinguishing unipolar depression and bipolar affective
disorder (Blackwood et al., 1996). Failure to replicate can also result from population
heterogeneity and statistical fluctuation (Lander and Kruglyak, 1995). Despite mixed
results (Byerley, 1989; Risch and Botstein, 1996), several studies have reported
highly significant linkage based on extended families and large sets of small families
for several complex disorders, such as schizophrenia (SCZ) (St Clair et al., 1990;
Stefansson et al., 2002), affective disorders (Blackwood et al., 1996), type 1 diabetes
(Nistico et al., 1996) and inflammatory bowel disease (Rioux et al., 2000). Linkage
regions are typically measured in megabases (Mb) and harbour tens or hundreds of
genes. Such regions are usually narrowed further via linkage disequilibrium mapping
(Botstein and Risch, 2003).
1.1.2 Linkage disequilibrium mapping
Linkage disequilibrium (LD) is the non-random association between alleles at
different loci. The second approach to disentangle the genetics of complex diseases,
LD mapping or association studies, builds on theoretical and experimental data that
suggest a polygenic model for the genetic variation in complex traits. Because most
complex diseases are also common, variants involved in their genetic aetiology may
be multiple, common and potentially ancient sequences with small effect, acting in
an additive manner (Risch and Merikangas, 1996). Under this model, genome-wide
linkage analyses with a realistic sample size would fail to detect such small effect
determinants (Risch and Merikangas, 1996). In contrast, association studies, which
compare allele frequencies at a locus, microsatellite or Single Nucleotide
Polymorphism (SNP), in patients and matched controls have the power to detect
variants with modest effect in a sample of achievable size (Cardon and Bell, 2001;
Risch, 2000; Risch and Merikangas, 1996).
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The variant typed is either functional, and potentially disease-causing, or
more likely, in LD with the causative variant. LD mapping is complicated by the
uneven and unpredictable distribution of linkage disequilibrium in the human
genome (Tiret et al., 2002). Some studies have shown that populations of different
ethnic origin share a limited number of common haplotypes (series of alleles found at
linked loci on a single chromosome) (Gabriel et al., 2002), while others have found
that any population can be characterised by a small number of haplotypes and that
haplotypes vary among populations (Kauppi et al., 2003). Population stratification is
another confounding factor and can result in spurious association in case-control
studies where controls do not match cases adequately (Clayton and McKeigue,
2001). Methods avail to test for stratification in the study set, as in family-based
association studies relying on the transmission disequilibrium test for example
(Ewens and Spielman, 1995). To avoid scoring markers at high, prohibitive densities
required for whole-genome studies, a higher priority is given to variants within
coding sequences (Botstein and Risch, 2003) and regulatory sequences (Mitchison,
2001). These markers are also chosen to capture the majority of the haplotypes in the
population under scrutiny (Johnson et al., 2001; Goldstein et al., 2003). As
haplotypes have been shown to be more informative than single markers, difference
in haplotype frequencies between affected and unaffected samples are also tested for
association with disease (Hirschhorn and Daly, 2005).
Association studies of variants in several positional or functional candidate
genes for complex diseases have generated promising results (Lohmueller et al.,
2003): insulin (Bell et al., 1984), human leukocyte antigen (Dorman et al., 1990) and
cytotoxic T lymphocyte associated-4 (CTLA4) (Nistico et al., 1996) for type 1
diabetes; peroxisome proliferator-activated receptor-y (PPARG) for type II diabetes
(Deeb et al., 1998; Altshuler et al., 2000); phosphodiesterase 4D (PDE4D) for stroke
(Gretarsdottir et al., 2003); lymphotoxin-alpha (LTA) for myocardial infarction
(Ozaki et al., 2002); caspase recruitment domain family, member 15 (CARD15), and
cytokines for inflammatory bowel disease (Rioux et al., 2000; Hugot et al., 2001;
Ogura et al., 2001); apolipoprotein E (APOE) for Alzheimer's disease (Strittmatter
and Roses, 1996) and neuregulin (NRG1) for schizophrenia (Stefansson et al., 2002).
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Many genes could potentially be involved in the various symptoms observed
in neuropsychiatric disorders, including psychoses such as affective disorders and
schizophrenia, generating a very long list of candidate genes within linked regions. If
several families from a stable population shared a common founder mutation, then
typing markers across the linked region of each affected family may detect
recombinants that define a common, smaller region. Markers in the shared region can
then be tested for association using cases and controls from the same population to
narrow the region further and identify positional candidate genes (Porteous et al.,
2003).
1.2 Psychiatric disorders
Psychiatric disorders involve abnormal anxiety and obsession, mood, thought,
cognition, personality, gender and sexuality. They include psychosis, schizophrenia,
affective disorders, dementia, autism, attention-deficit hyperactivity disorder,
Parkinson's disease, Huntington's disease and Alzheimer's disease. The lifetime risk
for mental illness is 15%, and one to two thirds of serious cases are not treated (Bijl
et al., 2003; Demyttenaere et al., 2004). Psychosis is characterised by derangement of
personality and loss of contact with reality, causing deterioration of normal social
functioning (American Psychiatry Association, 1994). It is the third cause of
disability world-wide after quadriplegia and dementia and before paraplegia and
blindness (Ustun, 1999). To date, 10% of the total expenditure of the UK National
Health Service is used to treat mental illness, and the medical, social and economic
costs supported by the 50 million strong population are estimated at £32 billion per
annum (Simon, 2003). Research into psychiatric disorders includes four strategies: i)
detection of structural abnormalities in the brain, ii) assessment of the effect of drugs
on target receptors and on physiology of the brain, iii) linkage and association studies
of functional or positional candidates genes, and iv) study of epigenetic factors in
disease causation (Inoue and Lupski, 2003). Recent progress in the understanding of
Alzheimer's disease (AD) aetiology, a neurodegenerative disorder with psychiatric
symptoms, such as depression, illustrates the usefulness of combining cytogenetic,
linkage and association analyses (Munoz and Feldman, 2000). A great proportion of
individuals with Down's syndrome, which is caused by the presence of a third
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chromosome 21, suffer from AD. This observation led to the identification of a
mutation in the amyloid precursor gene (APP) (van Leeuwen et al., 1998). The
presenilin 1 (PS1) gene was identified by linkage analysis of families with AD, while
the presenilin 2 (PS2) gene was identified by homology searches with PS1
(Sandbrink et al., 1996). Association studies identified the apolipoprotein E (ApoE)
gene in a region on chromosome 12 previously detected by linkage analysis (Roses,
1994). Biological studies subsequently showed that APP plays a role in learning and
that its activity is regulated by presenilins (Munoz and Feldman, 2000).
Affective disorders and schizophrenia (SCZ) are common and debilitating
diseases which respectively involve disturbed mood and thought, varying in severity
among patients. Both illnesses often appear in early-adult life and occur throughout
the entire lifespan (Gelder et al., 2000). The lifetime risk from each of BPAD and
SCZ is estimated at 1% (Weissman et al., 1988). Because these psychoses can be
particularly disabling and are frequently chronic and relapsing, caring for patients
represents a considerable load for the patient's family, and for the social and health
services (Gelder et al., 2000). The annual cost of depression and SCZ in the United
States has been estimated at $83 billion and $32.5 billion, respectively (Rice, 1999;
Greenberg et al., 2003). The World Health Organisation has predicted that unipolar
depression alone will become the disease placing the heaviest burden of disability
and mortality on the population of developed countries by 2020 (Murray and Lopez,
1997).
1.2.1 Clinical features of affective disorders and
schizophrenia
1.2.1.1 Affective disorders
The earliest description of depression was found in ancient Egyptian medical
papyri, dating approximately from 2000 BC (Scholl, 2002). The concept of bipolar
manic-depressive illness, now termed bipolar affective disorder (BPAD), was
provided by Arataeus, a Roman physician in 2nd century AD (Adams, 1856). It was
later described as 'folie circulaire', that is 'cyclical insanity', by Falret in 1854 who
realised that cycles of depression and elation were different from simple depression,
and were "generally found in similar form in ascendants and descendants" (Falret,
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1854; Sedler, 1983), and by Baillarger in the same year as 'folie a double forme',
meaning 'insanity of double form' (Baillarger, 1854). Further distinction of BPAD
from other mental illnesses, including schizophrenia, was defined by Emil Kraepelin
in 1899, who believed that depression, then called 'melancholia', and symptoms now
defining BPAD were exogenous and thus treatable, while schizophrenia was caused
by organic changes in the brain, hence endogenous and incurable (Kraepelin, 1899).
At present, psychiatric diagnostics are based on profiles of symptoms, such as
behavioural indices and communication patterns, which were standardised to allow
for reproducibility of diagnoses between psychiatrists (American Psychiatry
Association, 1994). Affective disorders can have a uniquely depressive (unipolar) or
manic-depressive (bipolar) course, or occasionally uniquely manic. A major
depressive episode is defined as a period of at least two weeks during which there is
a onset or worsening of depressed mood or dysphoria, that is characterised by loss of
interest or enjoyment of nearly all activities, together with four of the following
symptoms: changes in appetite, weight, sleep and psychomotor activity; decreased
energy; feelings of worthlessness or guilt; difficulty in thinking, concentrating, or
making decisions; or recurrent thoughts of death or suicidal ideation, plans, or
attempts. These symptoms must cause distress or impairment in social, occupational,
or other important area of functioning (American Psychiatry Association, 1994).
Unipolar disorder (UP) is characterised by one or more episodes of depression
without a history of manic, mixed or hypomanic episodes (described below). UP is
often recurrent and is one of the most common psychosis, as it affects between 10%
and 25% of women and 5.5% to 12% of men (American Psychiatry Association,
1994). Among patients suffering from severe depressive disorder 10-15% eventually
commit suicide, and co-morbid panic disorder is common in women, while co-
morbid substance abuse is more common in men (American Psychiatry Association,
1994; Gelder et al., 2000). The rate of suicide is also elevated in schizophrenics,
10% (Caldwell and Gottesman, 1990), while 30% admit to have attempted suicide at
least once (Leucht et al., 2003). Depression is also observed in 20% to 45% of
patients with Parkinson's disease and is also common in patients with multiple
sclerosis (Rickards, 2005). Mania is characterised by abnormally and persistently
elevated mood and/or irritability accompanied by at least three of the following
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symptoms: over-inflated self-esteem, decreased need for sleep or insomnia, racing
thoughts, physical agitation, increased talkativeness, distractibility, increased goal-
directed activity such as shopping, hypersexuality, and excessive involvement in
risky behaviour or activities. Hypomania is a less severe form of mania (American
Psychiatry Association, 1994).
BPAD is characterised by severe swings of mood to depression or mania, as
well as mixed manic and depressive symptoms. These symptoms may be
accompanied by hallucinations and delusions (described below). Episodes of
depression and mania may be separated by periods of wellness, free of symptoms,
during which the patient is able to function normally both at work and in social
affairs. Rapid cycling BPAD is characterised by one or more episodes of illness
within a 12-month period. Bipolar affective disorders are classified into two
categories. BPAD I is defined by the occurrence over the course of the individual's
life of at least one manic or mixed state episode which is usually accompanied by
episodes of depression. BPAD II is defined by the occurrence over the course of the
individual's life of at least one episode of depression which must be accompanied by
at least one hypomanic episode (American Psychiatry Association, 1994).
In the brain, the prefrontal cortex is involved in regulation of mood and
responses to social stimuli. In patients with UP or BPAD, this region is smaller and
shows decreased activity (Drevets et al., 1997). Treatment of affective disorder uses
mood stabilisers to prevent or mitigate manic or depressive episodes, such as
antidepressants, lithium salts and anticonvulsants such as valproic acid and
carbamazepine (Harwood and Agam, 2003). Lithium is thought to substitute for
magnesium ions in the active site of inositol monophosphatase, which
dephosphorylates inositol monophasphate into inositol and phosphate, thereby
reducing its activity and affecting neurotransmitters abundance (Williams et ah,
2004c). Valproic acid has been prescribed to treat mania and seems to target
intracellular inositol too (Williams et ah, 2002; Harwood and Agam, 2003; Shaltiel et
ah, 2004). The episodic nature of BPAD complicates treatment as patients naturally
experience periods of remission. Furthermore medication doses must be monitored
closely as mood stabilisers often have secondary effects which include dry mouth,
blurred vision, constipation, sedation, weight gain and changes in sexual function,




As for depression, description of symptoms akin to that of SCZ can be found
in the ancient Egyptian medical papyri (Scholl, 2002). It is also found in Hindu text
from 1400 BC, containing hymns and incantations to correct an imbalance of the
eight health-controlling elements thought to result in madness (Max-Muller, 1998).
A Chinese text from 1000 BC also describes insanity (Ti and Suwen, 1966). At that
time, psychotic behaviours were often explained by supernatural possession,
including demons and gods (Max-Muller, 1998). This view was abandoned few
centuries later by the Greeks during the fifth and fourth centuries BC who tempted to
rationalise the relationship between mind and body, especially Plato (Jowett, 1898),
and that between mental disorder and the brain, notably Hippocrates (Blits, 1999), as
well as the Roman Arataeus in 2nd century AD (Adams, 1856). Symptoms of SCZ,
were then better described in the late eighteenth century by Pinel, one of the founders
of modern psychiatry (Pinel, 1798), and later termed 'demence precoce', that is
'early dementia', by Morel, an assistant of Falret who described 'cyclical insanity',
to refer to a mental and emotional deterioration which begins at the time of puberty,
in contrast to senile dementia, ending in mental illness, and which involves heredity
as well as abuse of alcohol and drugs (Morel, 1860). The term 'demence precose'
was translated into 'dementia preacox' by Kraepelin in 1899 to distinguish between
BPAD and SCZ, by noticing that these illnesses were best defined by specific
patterns of symptoms rather than by any particular symptom, and that the course of
BPAD was intermittent with symptom-free periods separating manic or depressive
episodes, while the course of SCZ was progressive and irreversible (Kraepelin,
1899). This early clinical description of SCZ synthesised existing concepts into a
workable model which comprised three classes: i) catatonia, in which motor
activities are disrupted, either excessively active or inhibited, ii) hebephrenia,
characterised by inappropriate emotional reactions and behaviour, and iii) paranoia,
characterised by delusions or grandeur and persecution (Kraepelin, 1899). A couple
of decades later, Bleuler believed that 'dementia praecox' did not fit symptoms of
current patients, some ofwhich did not have dementia nor showed deterioration early
in life, and opposed the view that so called 'dementia praecox' was incurable. In
1911, Bleuler coined the term 'schizophrenia' from the Greek for split, 'schizo', and
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mind, 'phrene', to characterise the disharmonious state of mind, and introduced the
notions of autism, the loss of contact with reality, and ambivalence, the coexistence
ofmutually exclusive contradictions in the mind (Bleuler, 1911).
At present, SCZ is characterised by symptoms such as cognitive dysfunction,
disordered thinking, affective changes, and catatonia, which are classified as
positive, when they are additional to normal experience and behaviour, and negative,
to express the lack or decline in normal experience or behaviour. Positive symptoms
include hallucinations, delusions, and paranoia. Hallucinations are characterised by
hearing, seeing, or sensing the presence of stimuli that do not exist. Delusions are
false personal beliefs that are not subject to reason or contradictory evidence and are
not explained by a person's cultural background. Negative symptoms comprise
disorganised thought and speech, flattened affect, apathy, inability to experience
pleasure, impaired attention and poor social skills including social withdrawal. To be
diagnosed as schizophrenic an individual must display over a significant portion of
time during a 1-month period a combination of two or more characteristic symptoms,
including hallucinations, delusions, frequently derailed or incoherent speech,
disorganised or catatonic behaviour. These signs of disturbance must persist for at
least six months and lead to social or occupational dysfunction in one or more of the
following areas: work, interpersonal relations or self-care (American Psychiatry
Association, 1994). SCZ affects emotions, but is distinguished from mood disorders
where affective symptoms are primary. Similarly, SCZ and dementia are
distinguished on the basis that cognition is most severely impaired in dementia
(American Psychiatry Association, 1994).
Five sub-classifications of SCZ exist: i) catatonic, ii) disorganised, where
thought disorder and flat or inappropriate mood co-occur, iii) paranoid, characterised
by hallucinations and delusions in the absence of disorganised thought, behaviour or
mood, iv) residual, where intensity of positive symptoms is low, and v)
undifferentiated, where psychotic symptoms exist but criteria for catatonic,
disorganised and paranoid classes are not met (American Psychiatry Association,
1994). These symptoms of SCZ are often accompanied, and may be caused by,
specific neurocognitive deficits characterised by impairment or reduction in basic
psychological functions such as memory, attention, problem solving and executive
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function (Gelder et al., 2000). Structural neuroimaging and neuropathological studies
have suggested that SCZ may result from abnormal neurodevelopment, especially in
the second trimester of foetal life (Woods, 1998). Structural abnormalities observed
in brain of SCZ patients, such as decreased volume of overall white matter and
prefrontal cortex, were correlated with severity of negative symptoms (Sanfdipo et
al., 2000; Wible et al., 2001). Functional differences in activity in the brain of
schizophrenics have been reported in the frontal lobes, hippocampus, and temporal
lobes (Green et al., 2001). Many drugs used to treat SCZ are dopamine receptor
antagonists and typically have secondary effects in schizophrenics such as rigidity,
bradykinesia, dyskinesia (Malhotra et al., 2004). Drugs used to treat SCZ are
generally referred to as antipsychotic and may be classified as 'typical', such as
chloropramazine and haloperidol, and 'atypical', such as clozapine, risperidone,
olanzapine, because the latter avoid side effects associated with prolonged treatment
with 'typical' dopamine antagonists. However, atypical antipsychotics appear to have
metabolic side effects, such as weight gain, hyperglycemia and hypertriglyceridemia
(Leucht et al., 2003).
1.2.2 Aetiology of affective disorders and schizophrenia
There is evidence from twin, adoption and family studies for non-genetic as
well as genetic effects in affective disorders and SCZ (Bertelsen et al., 1977; Baron,
1997; Merikangas and Risch, 2003). For example, heavy use to stimulants, such as
methamphetamine, and hallucinogenic drugs, such as LSD, ketamine, or
phencyclidine, so-called 'angel dust', can result in syndromes similar to those
observed in SCZ (Joyce et al., 1993; Goodman, 2002). Moreover, there are structural
similarities between the hallucinogen LSD and medical target serotonin (Johnson et
al., 1991), in keeping with the reduced concentrations of serotonin in the brain of
schizophrenics after treatment by medical drugs, such as typical antipsychotic
reserpine (Stahl and Wets, 1988). Other environmental factors include stressful life
events, latitude, urban birth, household crowding, having older siblings and famine
during pregnancy (Huttunen and Niskanen, 1978; Day et al., 1987; Yolken and
Torrey, 1995; Susser et al., 1996; Sundquist et al., 2004). Some of these correlations
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might be explained by certain infections, perinatal brain damage, stillbirths,
prematurity and nutritional deficiencies (Torrey et al., 1997). For example, an excess
of 5 to 8% of SCZ birth has been observed in the winter-spring months, in particular
in individuals with no SCZ family history, and may involve viral infections during
early pregnancy leading to disruption of neurodevelopmental processes by viral toxic
substances (Torrey et ah, 1997; Davies et al., 2003). Other cases may involve
interactions between environmental influences and genetic predisposition (Risch and
Merikangas, 1996).
Though little is understood about the underlying causes of major affective
disorders and SCZ, strong support for a genetic aetiology has arisen from family,
twin and adoption studies (Bertelsen et al., 1977; Baron, 1997; Merikangas and
Risch, 2003). The estimates of heritability for BPAD and SCZ vary but are as high as
80% (Hoeffer and Pollin, 1970; Owen and Cardno, 1999). The risk to a first-degree
relative of an individual affected by BPAD or SCZ is approximately ten times that to
a member of the general population (Merikangas and Risch, 2003). The age of first
diagnosis in early adulthood suggests a time for expression of symptoms that is
biologically and genetically influenced, and a potential susceptibility to life changes
and exposures that depend on age (Merikangas and Risch, 2003). Genetic analyses of
psychoses are confounded by the current classification based on diagnoses, which are
reported by patients and hence often imprecise, by the lack of reliable biological and
genetic markers, anticipation and parent-of-origin effect (Gelder et al., 2000;
Merikangas and Risch, 2003).
Anticipation is the phenomenon by which the age of onset of the disorder is
reduced and / or the severity of the symptoms increases in subsequent generations. It
can be due to observation bias (Bassett and Husted, 1997; Husted et al., 1998) or
environmental factors, but recent genetic studies of neurodegenerative diseases such
as muscular dystrophy, fragile X syndrome and spinal muscular atrophy have been
shown to be caused by trinucleotide repeat expansion (Teisberg, 1995; Mclnnis,
1996; Bayless et al., 1998; Kenneson et al., 2001). Anticipation has been observed in
several neuropsychiatric diseases, including BPAD and SCZ, and tentatively
associated with trinucleotide expansions (Mclnnis et ah, 1993; Stober et al., 1995;
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O'Donovan et al., 1996; Mendlewicz et al., 1997; Lindblad et al., 1998; Mclnnis et
al., 1999b; O'Donovan et al., 2003a; Swift-Scanlan et al., 2005) but these findings
have not been replicated or specific examples of trinucleotide repeat expansion
demonstrated (O'Donovan et al., 1996; Craddock et al., 1997; Visscher et al., 2001;
Lange and Mclnnis, 2002; O'Donovan et al., 2003a; Tsutsumi et al., 2004).
The 'parent-of-origin' effect refers to the higher number of affected mothers
and maternal relatives than affected fathers, and paternal relatives, or vice-versa, and
has been observed in bipolar patients (Winokur and Reich, 1970). It might reflect
parent-of-origin specific imprinting or mitochondrial inheritance (McMahon et al.,
1995; Stober et al., 1998a). For example, McMahon et al. (1995) reported
significantly higher frequency of affected mothers, increased risk of illness for
maternal relatives and offspring, but no paternal transmission of BPAD was detected.
The authors suggested that these observations may indicate a potential role for
mtDNA and imprinted DNA in affective disorders. Also, linkage to 18p 11 is limited
to families where the disease is transmitted paternally (Stine et al., 1995; Escamilla et
al., 1999; Mclnnes et al., 2001) while maternal effect on 6q 16.3-22.1 is suggested by
affected siblings sharing the maternal chromosome more often than the paternal
chromosome (Schulze et al., 2004). Association of a mtDNA polymorphism and
BPAD has also been suggested and might be a risk factor with small effect (Kato et
al., 2001; Kato and Kato, 2000; McMahon et al., 2000).
Psychosis is currently thought to be the result of a combination of polygenic
inheritance, genetic and allelic heterogeneity, and variable exposures to
environmental factors, including stress (Merikangas and Risch, 2003). The
identification of susceptibility genes is required to unravel interactions among genes,
between genes and environmental factor, and the role of epigenetics factors
(Harrison and Weinberger, 2005). The next sections provide details on the genetic
determinants of affective disorders and schizophrenia.
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1.2.3 Genetic basis of affective disorders
1.2.3.1 Positional candidate genes
Genes implicated in genetic diseases associated with BPAD are putative
candidates genes for affective disorders (Kato, 2001b). Some single-locus diseases
have phenotypes similar to that found in common diseases. Alterations in the genes
for such Mendelian diseases may be implicated in the aetiology of common
disorders. For example, Wolfram syndrome, characterised by diabetes mellitus, optic
atrophy, deafness and depression is an autosomal recessive disease caused by
mutation in the WFS1 gene at 4pl6 (Inoue et al., 1998). Non-affected, heterozygous
carriers of this gene constitute 1% of the population and have a 26-fold increased risk
of psychiatric disorder, suggesting that WFS1 may therefore be implicated in
psychiatric diseases, although this role has yet not been established (Swift and Swift,
2000).
1.2.3.1.1 llq 23 andALG9
Other genes involved in affective disorders have been identified using a
cytogenetic approach. A reciprocal chromosomal translocation t(9;l I)(p24;q23) has
been identified in patients with UP and BPAD, disrupting a gene, then called
disrupted in bipolar disorder (D1BD1) and later renamed asparagine-linked
glycosylation 9 homolog (ALG9) at 11 q23 (Baysal et al., 2002). Regions within
11 q21 to 11 q25 have been linked to SCZ (St Clair et al., 1990), schizoaffective
disorder (Holland and Gosden, 1990) and Tourette syndrome (Simonic et al., 2001),
a neurologic disorder characterised by motor and vocal tics and associated with
behavioural abnormalities (American Psychiatry Association, 1994). The ALG9 gene
encodes a mannosyltransferase which is involved in the N-glycosylation pathway by
adding mannose residues to lipid-linked oligosaccharides (Burda et al., 1996). ALG9
has been implicated in congenital disorder of glycosylation (CDG) (Frank et al.,
2004), which is characterised by failure to thrive, axial hypotonia, cerebellar
dysfunction, seizures, mental retardation and coagulopathy (Krasnewich and Gahl,
1997). The role of ALG9 in BPAD however remains a open question (Baysal et al.,
2002; Frank et al., 2004).
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1.2.3.1.2 lq43 and DISC1/DISC2
Linkage between a t(l; 11)(q43;q21) balanced reciprocal translocation and
major psychiatric illness, including UP, BPAD and SCZ was found in a Scottish
family (St Clair et al., 1990; Muir et ah, 1995; Blackwood et ah, 2001). The
t( 1; 11 )(q43;q21) breakpoint directly disrupts two overlapping genes of unknown
function, DISCI and D1SC2, which are located on chromosome 1 and expressed in
the brain. DISCI is predicted to have a globular head, with no similarity to any
known proteins, and a tail with a putative ability to interact with other proteins (Ma
et ah, 2002; Taylor et ah, 2003). DISCI has been shown to interact with NUDEL, a
cytoskeletal protein expressed in the cortex and involved in neuronal migration
(Ozeki et ah, 2003). Interactions between DISCI and NUDEL may play an important
role in early brain development (Brandon et ah, 2004). Other potential interactors
with known neuronal function have been predicted (Millar et ah, 2003), such as
FEZ1 which is implicated in axon guidance, cell adhesion and neurogenesis
(Miyoshi et ah, 2003). DISCI is predominantly associated with mitochondria, but is
also observed in the cytoskeleton and the nucleus (Ozeki et ah, 2003; James et ah,
2004b). These findings suggest that DISCI may serve as a 'scaffold' protein and be
involved in several neuronal processes, such as signal transduction, cytoskeletal
alteration, neuronal migration and neurite outgrowth (Millar et ah, 2004). DISC2
seems to be a non-coding RNA gene antisense to DISCI and might therefore regulate
DISCI expression (Millar et ah, 2000b). Upstream of DISCI lies the Translin-
associated factor X (TRAX) gene which undergoes intergenic splicing with DISCI
(Millar et ah, 2000a). TRAX binds to and is stabilised by Translin, which migrates to
neuronal dendrites upon neuronal activity (Kobayashi et ah, 1998; Yang and Hecht,
2004). In the brain of mutant mice deficient for Translin, and thus for TRAX,
expression of genes encoding neurotransmitter receptors and ion channels is
decreased (Chennathukuzhi et ah, 2003). The disruption of DISCI and DISC2, and
additional genetic and environmental factors may be sufficient to explain psychosis
observed in carriers of the translocation (Millar et ah, 2003). Recently, SNPs and
haplotypes in the TRAX/DISC1 region have been associated with BPAD,
schizoaffective disorder and SCZ (Hennah et ah, 2003; Hodgkinson et ah, 2004;




Positional candidate genes are generally identified due to their location in
chromosomal regions linked to the disease. Several candidate regions for BPAD
have been identified by two or more linkage studies: lq21-42, 4pl6, 4q, 6p, 10q21 -
26, 1 Ip 15.5, 12q23-24, 13ql 1-32, 15q, 18p 11, 21q and 22ql 1-12 (Potash and
DePaulo, Jr., 2000; Baron, 1997; Owen and Cardno, 1999; Sklar, 2002). Linkage of
the chromosome 4p 15-16 region to UP and BPAD has first been reported by our
laboratory (Blackwood et al., 1996). Subsequent studies have found linkage to this
region for BPAD (Ewald et ah, 1998; Detera-Wadleigh et ah, 1999) and
schizoaffective disorder (Asherson et ah, 1998). Association between markers at
4p 15-16 and BPAD and SCZ, and increased allele sharing in schizophrenics has also
been reported (Als et ah, 2004; Williams et ah, 1999). Positional cloning in this
region is being carried out in the laboratory to uncover putative susceptibility genes
for these diseases. Continuing work aims to assess the roles of these genes in the
aetiology of these illnesses (chapter 6).
1.2.3.2 Functional candidate genes
The anti-depressive effect of monoamine reuptake inhibitors and the anti-
manic effects of monoamine receptor antagonists suggest that alteration of the
monoaminergic neurotransmission is involved in the pathophysiology of affective
disorders. Genes implicated in neurotransmitter pathways, such as the dopaminergic,
serotonergic and glutamatergic systems are therefore potential candidate genes
(Merilcangas and Risch, 2003). These genes either encode the neurotransmitters or
their receptors, or are involved in the uptake, synthesis, transport, reuptake and
degradation of neurotransmitters. Also, response to treatment, in particular with
antidepressant drugs, has been suggested to be partly heritable (Pare and Mack,
1971; O'Reilly et al., 1994; Franchini et al., 1998).
1.2.3.2.1 Serotonergic transmission
Serotonin governs several behavioural aspects such as sleep and mood
(Malhotra et al., 2004). Association of the gene encoding the rate-limiting enzyme
for serotonin synthesis in the brain, tryptophan hydroxylase 2 (TPH2), has been
associated with UP (Zhang et al., 2005). Seven serotonin receptors have been
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identified: 5HT-1 to 5HT-7, with several subtypes for 5HT-2 and 5HT-3 (Barnes and
Sharp, 1999). Variants in three receptors have been reported to be associated with
BPAD: 5HTR2A, 5HTR2C and 5HTR6 (Fanous et al., 2004; Malhotra et al., 2004)
and response to antidepressant (Minov et al., 2001; Cusin et al., 2002b). The
serotonin transporter (SLC6A4) gene mediates serotonergic neurotransmission by
controlling magnitude and duration of the serotonin signal (Lesch and Mossner,
1998) and is an important gene involved in neurodevelopment, as well as functioning
and plasticity of the brain (Catalano, 2001).
Two polymorphisms in SLC6A4 have also been associated with affective
disorders in some but not all studies. First, a 44bp insertion/deletion in the promoter
region (Heils et al., 1996), which regulates the expression of the gene (Heils et al.,
1996; Mortensen et al., 1999) and affects the abundance (Fleinz et al., 2000) and
function (Hariri et al., 2002) of SLC6A4. This variant has also been reported to be
associated with BPAD (Rotondo et al., 2002; Collier et al., 1996) and anxiety- and
depressive-related personality traits of neuroticism (Lesch et al., 1996). Second, a
variable number of tandem repeats (VNTR) in the second intron (Lesch et al., 1994)
upregulates the expression of the SLC6A4 gene (Fiskerstrand et al., 1999; Hoefgen et
al., 2005; Lasky-Su et al., 2005) in a manner dependent on the number and structure
of the VNTR (Lovejoy et al., 2003). This variant has been associated with UP
(Ogilvie et al., 1996) and seems to act in combination with the insertion/deletion
variant in the promoter (Hranilovic et al., 2004). Stronger evidence for the
implication in anxiety of the latter polymorphism was obtained by a study of the
association of an endophenotype for anxiety and fear behaviour: the response of the
amygdala to fearful stimuli, measured by functional MRI. Differences between two
haplotypes in neuronal activity in amygdala were 10-fold stronger than in previous
studies when the endophenotype was not considered (van Rijn et al., 2005). The role
of SLC6A4 in affective disorders is further supported by association of the promoter
variant with response to selective serotonin reuptake inhibitors used to treat major
depression (Smeraldi et al., 1998; Pollock et al., 1998; Zanardi et al., 2000; Kim et
al., 2000; Minov et al., 2001; Yoshida et al., 2002; Serretti et al., 2004).
Polymorphisms in the SLC6A4 gene, including variants in its promoter have also
been associated with Alzheimer's disease (Li et al., 1997a), autism in some studies
(Conroy et al., 2004; Kim et al., 2002), obsessive-compulsive disorder (Ozaki et al.,




Dopamine systems are involved in a wide spectrum of neurological and
psychiatric disorders, such as Parkinson's disease, schizophrenia, drug abuse,
affective disorders, Tourette's syndrome and ADHD (Bannon et al., 2001; Diehl and
Gershon, 1992; Emilien et al., 1999). Tyrosine hydroxylase (TH) is a rate-limiting
enzyme implicated in the metabolism of dopamine, adrenaline and noradrenaline
(Kobayashi et al., 1995; Zhou et al., 1995). The TH gene lies on 1 lpl5, which is
linked to affective disorders (Sklar, 2002). Association studies of variants in or
around the TH gene and affective disorders have reported positive results for BPAD
(Meloni et al., 1995) and UP (Souery et al., 2001; Serretti et al., 2000b), as well as
many negative results (Burgert et al., 1998; Serretti et al., 2000b; Souery et al., 1999;
Furlong et al., 1999b; Ishiguro et al., 1998; McQuillin et al., 1999). These results
may be confounded by epigenetic factors since the 1 lpl5 region harbours a cluster of
imprinted genes and alteration of the expression of the TH gene might be due to
abnormal imprinting rather than mutation (Aranyi et al., 2002; Kim et al., 2003).
Five dopamine receptors have been identified and are classified in two
groups: i) Dl-like receptors, namely dopamine receptors D1 (DRD1) and D5
(DRD5), and ii) D2-like receptors, namely DRD2, DRD3 and DRD4. All are
transmembrane proteins of the guanine nucleotide-binding (G-protein) receptor
family. Dopamine receptors mediate stimulation of adenyl cyclase and intracellular
accumulation of cAMP (Sakolsky and Ashby, 2001). D1 -class receptors are required
for induction of transcription factors of the nerve growth family (Young et al., 1991)
and receptors in the two classes interact to modulate neural response (Walters et al.,
1987). For example, acute behavioural effects mediated by D2-class receptors
require the simultaneous activation of D1-class receptors (Capper-Loup et al., 2002).
DRD1 modulates N-methyl-D-aspartate (NMDA) receptors functions by
direct interactions (Lee et al., 2002). A haplotype at two SNPs in the upstream region
of the DRD1 gene has been associated with BPAD (Ni et al., 2002) and one of these
SNPs, in the 5'UTR, has been associated with BPAD I (Severino et al., 2005). No
evidence for the functional significance of these findings has yet been found, and
these mutations may therefore be in LD with disease causing variants (Severino et
al., 2005). DRD5 has a higher affinity for dopamine that DRD1 (Grandy et al., 1991)
21
Chapter 1 Introduction
and binds directly to the a sub-unit of the y-butyric acid (GABA) type A (GABAa)
receptor to regulate the strength of the synapse (Liu et al., 2000). DRD5 reside in the
4pl6 region which has been linked to BPAD (Visscher et ah, 1999; Polymeropoulos
and Schaffer, 1996; Blackwood et ah, 1996; Ewald et ah, 1998; Detera-Wadleigh et
ah, 1999) and schizoaffective disorder (Asherson et ah, 1998). A protective locus has
also been mapped to this region (Ginns et ah, 1998). Markers in or around the DRD5
gene do not seem to be associated with affective disorders (Kirov et ah, 1999;
Asherson et ah, 1998).
The DRD2 gene is located on llq23, which has been linked to affective
disorder (Nanko et ah, 1994). DRD2 is located on post-synaptic dopaminergic
neurons involved in reward-mediating pathways, locomotion, hormone production
and drug abuse, and is a target of drugs to treat psychoses (Neville et ah, 2004). A
microsatellite in intron 2 of the gene has been associated with BPAD but not UP
(Massat et ah, 2002). Several studies have however failed to report linkage or
association to affective disorders (Souery et ah, 1996; Bocchetta et ah, 1999; Kirov
et ah, 1999; Serretti et ah, 2000b; Holmes et ah, 2002). The DRD3 gene does not
seem to be associated with BPAD (Mitchell et ah, 1993; Shaikh et ah, 1993; Gomez-
Casero et ah, 1996; Souery et ah, 1996; Kirov et ah, 1999; Elvidge et ah, 2001).
Nonetheless, DRD3 is localised in areas of the brain implicated in cognitive,
emotional and endocrine functions, and DRD3 mRNA levels are reduced in BPAD
patients, independent of severity of symptoms and medication history (Vogel et ah,
2004). Its expression is modulated by BDNF during development and adult life
(Guillin et ah, 2001). Moreover, DRD2 and DRD3 are both implicated in some
effects of antipsychotic used to treat Parkinson's disease (Sokoloff et ah, 1990).
The role of DRD4 in the aetiology ofmood disorders is suggested by animal
(Rubinstein et ah, 1997), pharmacological (Tang et ah, 1997; Drevets et ah, 2001)
and postmortem studies (Bowden et ah, 1997). A SNP located 1.2 Kb upstream of
the first exon of the DRD4 gene has also been associated with better handling of
conflict in reaction time experiments, which correlated with brain activity (Fan et ah,
2003a; Fossella et ah, 2002). Associations studies of the 48-bp repeat in the upstream
region of the DRD4 gene have generated positive results for UP (Manki et ah, 1996)
and BPAD (Lim et ah, 1994; Muglia et ah, 2002), as well as negative results (De
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Bruyn et al., 1994; Serretti et al., 1998; Bocchetta et al., 1999; Li et al., 1999; Serretti
et al., 1999; Cusin et al., 2002a; Serretti et al., 2002). However, studies that failed to
replicate reported positive results may have lacked sufficient power to detect allelic
association with disease (Lohmueller et al., 2003). Several coding variants have been
identified, including a 48-p"b sequence, in exon 3, coding for 16 amino acids located
in the third intracellular loop and which exists in forms containing two to eleven
repeats with allele frequencies varying widely across populations (Van Tol et al.,
1992; Chang et al., 1996). Association of the seven-repeat allele has also been
reported with childhood inattention and dysphoria (Levitan et al., 2004b), binge
eating and subsequent weight gain in women with seasonal affective disorder
(Levitan et al., 2004a).
The dopamine transporter (SLC6A3) gene at 5p 15.3 is a plasma membrane
transport protein that mediates dopamine neurotransmission temporally and spatially
by rapidly re-accumulating dopamine after it has been released in the extracellular
space (Bannon et al., 2001). Some data suggest that the number of repeats in a 40 bp
VNTR in the 3' end of the SLC6A3 gene is involved in regulation of the gene in
dopaminergic neurones and is correlated with SLC6A3 ligand binding in vivo
(Michelhaugh et al., 2001). Variants in the promoter region and in introns of the
SLC6A3 gene also result in a 2-fold difference in gene expression (Greenwood and
Kelsoe, 2003). SNPs and haplotypes at these loci have been associated with BPAD
(Greenwood et al., 2001; Hawi et al., 2003; Keikhaee et al., 2005).
1.2.3.2.3 Neurotransmitter catabolism
Proteins involved in the catabolism of monoamine have also been tested for
association with affective disorders. Catecol-O-methyltransferase (COMT) is
expressed in peripheral tissues and in the brain, primarily in neurones, and is an
enzyme implicated in the catabolism of catecolamines, including dopamine,
adrenaline, noradrenaline as well as drugs used to treat hypertension, asthma and
Parkinson's disease (Mannisto and Kaakkola, 1999; Matsumoto et al., 2003a;
Matsumoto et al., 2003b; Harrison and Weinberger, 2005). The COMT gene at
22q 11, a region linked to BPAD (Kelsoe et al., 2001), has been associated with
BPAD (Shifman et al., 2004). Furthermore, the low activity allele of the COMT gene
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causes higher synaptic concentration of catecholamine and has been associated with
rapid cycling BPAD (Papolos et al., 1998).
Other enzymes may also be implicated, e.g. monoamine oxydases.
Monoamine oxidases break down excess dopamine and serotonin and are present at
both pre-synaptic terminal and post-synaptic cells. Monoamine oxidase A (MAOA) at
Xpl 1.23 encodes an enzyme that catabolises monoamines on the outer membrane of
mitochondria. MAOA deficiency has been associated with abnormal amine
metabolism, mental retardation and impulsive aggressive behaviour in human
(Brunner et al., 1993) and mouse (Cases et al., 1995). Polymorphisms in the MAOA
gene, including a microsatellite in intron 2, has been associated with BPAD, with
different alleles being associated in different populations (Lim et al., 1995; Kawada
et al., 1995; Rubinsztein et al., 1996), although some studies could not replicate these
findings (Craddock et al., 1995; Nothen et al., 1995). A functional microsatellite has
been identified 1.2 Kb upstream of the coding sequence, with short alleles causing
lower gene expression (Sabol et al., 1998; Deckert et al., 1999). This polymorphism
has been associated with affective disorders (Lin et al., 2000; Schulze et al., 2000)
but not by all studies (Kunugi et al., 1999; Furlong et al., 1999a; Syagailo et al.,
2001; Huang et al., 2004). In addition, in males with a history of child abuse, low-
expression alleles have been associated with impulsivity (Huang et al., 2004), while
long, high-expression alleles have been associated with panic disorder in females
(Deckert et al., 1999). Association studies of other variants have generated negative
studies (Muramatsu et al., 1997; Sasaki et al., 1998).
Polymorphisms in genes encoding monooxygenases of the cytochrome P450
superfamily, such as CYP2D6, have also been associated to response to
antidepressant treatment (Fukuda et al., 1999; Yoon et al., 2000; Malhotra et al.,
2004; Johnson et al., 2005) and genotypes at loci in such genes, including CYP2D6
and CYP2C19, have been proposed to establish dose of antidepressant (Kirchheiner
et al., 2001; Athanasiou et al., 2002; Guzey and Spigset, 2004; James et al., 2004a).
Another oxidase, D-amino acid oxidase (DAO) that oxidises D-serine, an activator of
the NMDA-type glutamate receptor (Heresco-Levy et al., 1996; Mothet et al., 2000),
may be involved in affective disorders since the DAO gene lies in 12q34 which may
be linked to BPAD (Ewald et al., 2002; Shink et al., 2005) but the only association
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study of DAO with BPAD generated negative results (Schumacher et al., 2004).
However, DOA physically interacts with and is activated by DAO activator
(DAOA), formerly G72 (Mothet et al., 2000; Chumakov et al., 2002). Interestingly,
the DAOA gene lies in 13q32-33, linked to BPAD (Badner and Gershon, 2002), and
has been associated with BPAD (Hattori et al., 2003; Schumacher et al., 2004).
1.2.3.2.4 Effects ofmood stabilisers
Mood stabilisers such as lithium, valproic acid and carbamazepin, which are
used to treat BPAD, interact with two signalling pathways, the first involving
intracellular inositol, and the second glycogen kinase synthase 3. These three drugs
suppress inositol signalling via an inositol depletion mechanism involving propyl
oligopepdidase, which regulates inositol metabolism, and sodium myo-inositol
transport (Harwood and Agam, 2003). They also alter neuronal morphology by
inhibiting the collapse of sensory neurone growth cones and increasing growth cone
area (Williams et al., 2004c). Lithium has been shown to reduce expression and
activity of the inositol monophosphate 2 (IMPA2) (Seelan et al., 2004). Very
recently, a SNP in the promoter of the IMPA 2 gene has been associated with
response to lithium and may be associated with BPAD (Dimitrova et al., 2005).
Glycogen kinase synthase 3 (GSK3) has numerous functions and some of its
substrates play a role in neurone organisation and function (Plyte et al., 1992). Its
activity is reduced by lithium and valproic acid, but not by carbamazepine (Klein and
Melton, 1996; Stambolic et al., 1996).
A SNP in the promoter region of the GSK3B gene, which encodes glygogen
synthase kinase 3 P, has been associated with later age of onset of BPAD (Benedetti
et al., 2004a), better antidepressant effect of sleep deprivation (Benedetti et al.,
2004b) and long-term response to lithium in BPAD (Benedetti et al., 2005).
Antidepressants also affect NMDA receptor function (Mjellem et al., 1993),
and the expression of multiple genes encoding NMDA receptor subunits (Boyer et
al., 1998). An allele of a variable microsatellite locus in the promoter of the NMDA
receptor 2A subunit (GRIN2A) gene on 16p 13 reduces transcription of GR1N2A
(Itokawa et al., 2003b), and longer alleles at this locus are preferentially transmitted
to BPAD patients (Itokawa et al., 2003a).
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As for affective disorders, the identification of genes for susceptibility to SCZ
by linkage analysis and association studies has also been successful. These genes and
relevant related polymorphisms are described in the following section.
1,2,4 Genetic basis of schizophrenia
1.2.4.1 Positional candidate genes
Several chromosomal regions have been linked to SCZ: lq21-22, lp, 3ql3.3,
5q, 6p22-24, 8p21-22, 10q22, llq, 13ql4-q21, 13q32, 15ql4, 15ql5, 18p, 22qll
(O'Donovan et ah, 2003b; Lewis et al., 2003).
1.2.4.1.1 22qll and COMT
Deletion and duplications of 1.5 to 3.0 Mb at 22ql 1 cause the chromosome
22ql 1 deletion syndrome, a variable phenotype including congenital heart defects,
hypocalcemia, neurodevelopmental delays, facial dysmorphologies, cognitive
deficits, and abnormal behaviours (Botto et ah, 2003). The disease is also associated
with a high rate of psychosis, including mood swings and SCZ (Pulver et ah, 1994;
Lachman et ah, 1996a; Carlson et ah, 1997; Bassett et ah, 1998; Murphy et ah, 1999;
Murphy, 2002). Moreover, this region has been linked to BPAD (Kelsoe et ah, 2001;
Badner and Gershon, 2002) and SCZ (Karayiorgou et ah, 1995; Blouin et ah, 1998;
Shaw et ah, 1998; Badner and Gershon, 2002; DeLisi et ah, 2002; Lewis et ah, 2003;
Williams et ah, 2003b) and deletions are more frequent in schizophrenics than in
unaffected people (Karayiorgou et ah, 1995; Arinami et ah, 2001), in particular with
patients with early onset (Usiskin et ah, 1999). Patients with chromosome 22qll
deletion syndrome and schizophrenics also share brain structural abnormalities
(Chow et ah, 1999; Chow et ah, 2002).
The COMT gene located in this region is also a functional candidate due its
involvement in the function and metabolism of monoamine neurotransmitters, in
particular dopamine (Mannisto and Kaakkola, 1999; Harrison and Weinberger,
2005). A coding SNP in COMT increases the activity of the enzyme (Lotta et ah,
1995; Lachman et ah, 1996b) by a two-fold factor (Chen et ah, 2004a; Shield et ah,
2004). This polymorphism has been associated with SCZ by several independent
studies and seems to have a small effect (Li et ah, 1996; Kunugi et ah, 1997; Li et ah,
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1998c; Li et al., 1998d; Egan et al., 2001; Glatt et al., 2003a; Chen et al., 2004c).
Other polymorphims have been identified in COMT. An association with SCZ was
found in an isolated population for two SNPs, located in the upstream and
downstream untranslated regions and both with small effect, and for a high frequency
haplotype containing these SNPs and the aforementioned coding SNP (Shifman et
al., 2002). Although these promising results remain to be replicated (Harrison and
Weinberger, 2005), quantitative measures of allele-specific expression using mRNA
from human brain suggest that the three-SNP haplotype is also associated with a 20%
reduction in expression of COMT (Bray et al., 2003b). COMT also seems to be
implicated in frontal lobe activity, characteristic of SCZ (Egan et al., 2001).
Interestingly, a five-SNP haplotype spanning a 80 Kb region suggests that two genes
in the 22ql 1 region, proline dehydrogenase (oxidase) 1 (PRODH) and zinc finger,
DHHC domain containing 8 (ZDHHC8), may also be involved in SCZ (Liu et al.,
2002b; Liu et al., 2002a).
1.2.4.1.2 22qll, PRODH, and ZDHHC8
PRODH is a mitochondrial enzyme which catalyses the first step in the
catabolism of proline, which may directly modulate glutamatergic activity in the
brain (Phang et al., 2001). Prodh mutant mice have reduced levels of glutamate and
GABA, and also show abnormal sensorimotor gating, which is an endophenotype of
SCZ (Gogos et al., 1999). Evidence suggesting the involvement of PRODH in SCZ
comes from associations studies (Li et al., 2004a; Liu et al., 2002b), although three
studies failed to replicate association of the PRODH gene with schizophrenia (Fan et
al., 2003b; Williams et al., 2003a; Ohtsuki et al., 2004). A potential mechanism in
the susceptibility to SCZ may involve the action of proline in modulation of
glutamatergic transmission (Fremeau, Jr. et al., 1992; Renick et ah, 1999) and
apoptosis (Cohen and Nadler, 1997; Nadler et al., 1992). Mutations in PRODH may
cause disturbance of neuronal function and hence predispose to SCZ (Karayiorgou
and Gogos, 2004).
One of the SNPs on 22q 11 originally associated with SCZ regulates the
retention of intron 4 of ZDHHC8 (Liu et al., 2002a; Liu et al., 2002b). This results in
higher levels of unspliced variant thought to encode a truncated protein, thereby
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modulating the expression of the fully functional transcript (Mukai et ah, 2004). The
ZDHHC8 gene is thought to encode a transmembrane palmitoyltransferase, which
seems to be involved in exploratory activity in mice (Karayiorgou and Gogos, 2004;
Mukai et al., 2004). Palmitoylation is a reversible posttranslational addition of the
saturated fatty acid lipid palmitate to proteins, which facilitate interactions between
proteins and lipid bilayers (el Husseini and Bredt, 2002). Substrates of
palmitoyltransferase include neuronal proteins that are important for neuronal
development, synaptic scaffolding proteins, and neurotransmitter receptors, implying
that synapse transmission may involve palmitoylation (el Husseini and Bredt, 2002).
This is supported by findings that zinc finger, DHHC domain containing 3
(ZDHHC3) palmitoylates gamma 2 subunit ofGABAa (Keller et al., 2004). The role
of ZDHHC8 is not yet known, but the human brain expresses ZDHHC8 widely. The
cortex and hippocampus, which are important in the pathophysiology of SCZ, show
higher expression of ZDHHC8 than other regions (Mukai et al., 2004). Furthermore,
ZDHHC8 deficiency correlated with decreased locomotor activity and greater fear of
novel environment, in female, but not in male mice, which may involve
glutamatergic transmission (Mukai et al., 2004). In humans, the aforementioned SNP
shows distortion of transmission between sexes in schizophrenics (Mukai et al.,
2004). Sexually dimorphic effects of ZDHHC8 might be related to differences
observed between males and females in onset, incidence and severity of SCZ
symptoms (Chen et al., 2004b; Mukai et al., 2004). However, follow up studies have
failed to confirm this association (Saito et al., 2005).
In addition, the SCZ linked 22ql2 region, contains several apoliprotein L
(APOL) genes (Duchateau et al., 2001; Page et al., 2001). A 2.6-fold upregulation of
apolipoprotein LI (APOL1), apolipoprotein L2 (APOL2) and apolipoprotein L4
(APOL4) has been observed in the prefrontal cortex of SCZ patients compared to that
of controls (Mimmack et al., 2002). APOL proteins play a crucial role in cholesterol
transport. The cholesterol content of membranes is important in cellular processes
such as modulation of gene transcription and signal transduction during
neurodevelopment and in the adult brain (Nimpf and Schneider, 2000).
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1.2.4.1.3 13q34 and DAOA
Report of linkage to a gene desert on 13q with SCZ (Badner and Gershon,
2002) led to the annotation of another candidate oxidase gene, the gene encoding D-
amino acid oxidase (DAO) activator (DAOA, also G72), and the G30 gene, antisense
of DAOA (Chumakov et al., 2002). Haplotypes at this locus have been associated
with SCZ (Chumakov et al., 2002; Schumacher et al., 2004; Zou et al., 2005). In
addition, four SNPs in the DAO, of which the product is activated by DAOA, have
also been associated with SCZ (Chumakov et al., 2002). SNPs in the DAOA gene
also seem to correlate with abnormal physiology and cognition in the prefrontal
cortex and hippocampus of schizophrenics (Harrison and Weinberger, 2005). There
is also evidence for a combined action of SNPs and haplotypes in these two genes
(Chumakov et al., 2002; Schumacher et al., 2004). These findings support the role in
SCZ of glutamatergic transmission via NMDA receptors because the substrate of
DAO, D-serine, is an activator ofNMDA glutamate receptors (Heresco-Levy et al.,
1996; Mothet et al., 2000).
1.2.4.1.4 6p21 and NOTCH4
Several linkage analyses have suggested that 6p is linked to SCZ (Wang et
al., 1995). Two polymorphisms in NOTCH4, which lies in this region, may be
candidate susceptibility variants: a SNP in the promoter and a microsatellite in the
first exon (Wei and Hemmings, 2000). Wei and Hemmings (2000) performed a
transmission disequilibrium test (TDT) in the major histocompatibility complex
(MHC) region at 6p21.3 in the attempt to identify a susceptibility gene in the region.
The 13 markers tested spanned 1.8 Mb. Significant association was obtained for a
locus corresponding to the NOTCH4 gene. Further analysis of five markers identified
two haplotypes strongly associated with SCZ, involving two SNPs in the promoter
and a microsatellite in the first exon. This microsatellite encodes leucine in the signal
peptide domain of the protein and an allele at this locus was transmitted in excess to
affected offspring (Wei and Hemmings, 2000). Except for one study reporting that
NOTCH4 is associated with SCZ (Glatt et al., 2005), subsequent studies failed to
replicate these findings in several populations, including the population used in the
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original positive report (Sklar et al., 2001; McGinnis et al., 2001; Wassink et al.,
2003; Anttila et al., 2003; Tochigi et al., 2004).
However, while the microsatellite in exon 1 of the NOTCH4 gene did not
seem to be associated with SCZ, this polymorphism has been reported to be
associated with endophenotypes for SCZ such as measures of cognitive performance
in the frontal lobe and volumes of the frontal lobe in the brain (Wassink et al., 2003).
Similarly, the SNP in the promoter of the NOTCH4 gene failed to show association
to SCZ, but showed strong association with earlier age of onset in male SCZ patients
(Anttila et al., 2003). In addition, a microsatellite in the promoter of this gene,
upstream of the two SNPs mentioned above and tested in the original report, has
been associated with SCZ in an African sample, but not in samples of other ethnic
backgrounds (Skol et al., 2003). These polymorphisms may also be associated with
early-onset SCZ and SCZ with negative symptoms (Takahashi et al., 2003).
Recently, association studies of the two SNPs in the promoter of NOTCH4
that have been associated with earlier age of onset, and SCZ with many negative
symptoms, showed significant association of one haplotype with SCZ in African
American but not European American populations. Furthermore the two groups
differed in frequencies of alleles and haplotypes (Luo et al., 2004). These studies
indicate that variants in NOTCH4 tested may be in LD with functional variants
(Tochigi et al., 2004). They may also be population specific and have small effects
(Takahashi et al., 2003; Luo et al., 2004; Zhang et al., 2004). Also, analysing
homogenous samples via sample stratification based on the age of onset of the
disease for example, and endophenotypes, rather than the disease status itself appears
to increase the ability to detect association. Finally, polymorphisms in NOTCH4 and
COMT have been reported to be associated with response to antipsychotics and the
combination of genotype at a locus in each gene correlate with a higher than 10 fold
difference in the risk ofbeing non-responsive (Anttila et al., 2004).
NOTCH4 is a member of the NOTCH family of transmembrane proteins,
which mediate cell-cell interactions, controlling cell fate and thereby participating in
a variety of developmental processes (Hansson et al., 2004; Schweisguth, 2004).
Notch signalling is implicated in cell fate and is expressed in a wide variety of
tissues, including the developing nervous system where it controls dendrite growth
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and formation of neuronal contacts (Sestan et al., 1999). NOTCH4 is required during
embryogenesis of the fruit fly for the correct segregation of epidermal cells from the
neuronal cell precursors (Fortini and Artavanis-Tsakonas, 1993). In mice, NOTCH4
has been detected in the developing brain (Uyttendaele et al., 1996) and is involved
in the structure and patterning of developing vasculature of embryos, including the
brain (Uyttendaele et al., 2001). The role of NOTCH4 therefore remains
undetermined, in particular in SCZ.
7.2.4.1.5 6p24 and DTNBP1
The short arm of chromosome 6 contains another positional candidate gene:
dysbindin (dystrobrevin binding protein, DTNBP1). The DTNBP1 gene is located on
the linked region 6p24-22 (Straub et al., 1995) and has been associated with SCZ
(Straub et al., 2002). DTNBP1 is present in the synapse termini of many neurones
across the brain (Straub et al., 2002) and may mediate trafficking of NMDA,
nicotinic and GABAa receptors, and of signal transduction proteins (Husi et al.,
2000; Inoue and Okabe, 2003). A rare risk haplotype has been identified in an Irish
sample which spans intron 2 to 5 of the DTNBP1 gene (van den Oord et al., 2003).
Another study of Irish sample did not support these findings (Morris et al., 2003).
Subsequent studies of samples from different populations reported association of a
common haplotype in introns 2-5 in samples from Germany, Hungary and Israel
(Schwab et al., 2003), as well as association for different SNPs in a sample from
England (Williams et al., 2004a), for a common haplotype in a Chinese sample
(Tang et al., 2003), and for yet another haplotype in a Swedish sample (Van Den
Bogaert., 2003). The existence of different risk haplotypes in different samples,
including samples of similar geography and ancestry, suggest that several mutations
with small effect have occurred in the DTNBP1 gene leading to allelic heterogeneity
(Harrison and Weinberger, 2005). One of these SNPs has been associated with
difference in the expression of the DTNBP1 gene (Bray et al., 2003a). The role of
functional non-coding polymorphisms, including potential variants altering splicing
and translation of the gene, is further supported by finding of lower levels of
DTNBP1 mRNA and proteins in schizophrenics than in unaffected individuals
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(Weickert et al., 2004), and the absence of coding variants in the DTNBP1 gene
(Harrison and Weinberger, 2005).
1.2.4.1.6 8pl2 and NRG1
A recent study of a sample from Iceland has reported linkage and association
of SCZ with the 1.4 Mb long Neuregulin (NRG1) gene on 8pl2-21 (Stefansson et al.,
2002), previously linked to SCZ (Badner and Gershon, 2002; O'Donovan et al.,
2003b; Lewis et al., 2003). Although no single SNP was associated, a rare and low
risk seven-SNP haplotype was associated which spanned 290 Kb of the upstream
region up to the first exon of NRG1 (Stefansson et al., 2002). In the same study,
support for a role of the NRG1 in the aetiology of SCZ was obtained via NRGl+/~
transgenic mice with halved NRG1 levels which showed abnormal behaviour akin to
SCZ in mouse, such as hyperactivity triggered by exposure to novel environment
(Stefansson et al., 2002). Association of NRG 1 with SCZ has subsequently been
reported in samples from several geographic origins, such as Scotland for the original
haplotype (Stefansson et al., 2003), England and Ireland (Williams et al., 2003c;
Corvin et al., 2004), and China (Yang et al., 2003; Li et al., 2004b; Zhao et al., 2004)
for different haplotypes at the original SNPs (Williams et al., 2003c; Yang et al.,
2003), and haplotypes at other SNPs (Tang et al., 2004; Corvin et al., 2004; Li et al.,
2004b; Zhao et al., 2004). These findings strongly suggest that the NRG1 gene
manifests allelic heterogeneity, with variants clustered in two regions; one in the 5'
regulatory region and one further downstream (Harrison and Weinberger, 2005).
NRG1 has various roles mediated via several signal transduction pathways during
development of the brain and periphery, such as neuronal migration and cellular
differentiation, and neurotransmission and synaptic plasticity (Falls, 2003). These
functions are mediated by the 15 NRG1 isoforms which are expressed in various
areas of the brain and localised in several places in neurones (Law et al., 2004).
NRG1 is present in glutamatergic synaptic vesicles and interacts with 'v-erb-b
erythroblastic leukemia viral oncogene homolog' (ErbB) receptors to modulate
NMDA receptor expression (Stefansson et al., 2002; Corfas et al., 2004). Although
weak imbalance ofNRG 1 isoforms was reported in schizophrenics (Hashimoto et al.,
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2004), this finding has not yet been replicated and no functional variants have been
identified (Harrison and Weinberger, 2005).
In addition, haplotypes associated with modulation by nicotine of attentional
and sensory processing and possibly SCZ have also been identified in the promoter
the a7 nicotinic receptor (CHRNA 7) gene (Leonard et ah, 2002), in the 15ql3-14
region linked to SCZ (Freedman et ah, 2001). Several of these haplotype SNPs were
functional in a gene reporter assay (Leonard et ah, 2002). Although these findings
are not yet replicated, they are promising because CHRNA7 is recruited to the
synapse by NRG1 (Yang et ah, 1998) and modulates dopamine and glutamate
signalling pre- and post-synaptically (George et ah, 2000; Fabian-Fine et ah, 2001;
Frazier et ah, 2003; Paterson and Nordberg, 2000).
1.2.4.1.7 lq21, KCNN3 and RGS4
Several studies have reported linkage of 1 q21 -22 to SCZ (Brzustowicz et ah,
2000; Gurling et ah, 2001). Also, anticipation has been suggested by comparison of
age of onset between affected probands and parents, which could be due to a gene
with trinucleotide repeat expansions or other repeats affecting the expression of that
gene (Stober et ah, 1995; O'Donovan et ah, 1996; Bassett and Husted, 1997; Mclnnis
et ah, 1999b; Vincent et ah, 2000b). Genes with unstable trinucleotide repeats are
therefore candidate genes. At 1 q21.3, the 'small-conductance calcium-activated
channel, subfamily N, member 3' (KCNN3) gene is a candidate gene not only
because it is involved in neuronal signalling but also because it contains two
stretches of trinucleotide repeats coding for polyglutamine, one being highly
polymorphic with allele size ranging from 4 to 28 repeats (Chandy et ah, 1998;
Gargus et ah, 1998; Laurent et ah, 1998; Antonaralcis et ah, 1999; Austin et ah, 1999;
Bonnet-Brilhault et ah, 1999; Laurent et ah, 2003). Expanded CAG repeat in KCNN3
have been associated with ataxia (Figueroa et ah, 2001) and anorexia nervosa
(Koronyo-Hamaoui et ah, 2004). Calcium-activated potassium channels are
expressed in the brain and are involved in memory and learning (Stackman et ah,
2002). They control calcium-mediated events via the regulation of neurone
membrane by modulating the pacemaker duty cycle, in particular by creating slow
after-hyperpolarisations, and spike frequency (Faber and Sah, 2003; Sah and Davies,
2000). Small-conductance calcium-activated potassium channels open upon increase
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in concentration of cytosolic calcium. These channels are formed from homo- or
hetero-dimers of subunits KCNNC1-4 (Faber and Sah, 2003).
KCNN3 is predominantly expressed in areas of the brain containing
dopaminergic neurones (Dror et al., 1999; Rimini et ah, 2000), involved in reward,
working memory and voluntary movement (Goldman-Rakic, 1999; Kitai et ah, 1999;
Spanagel and Weiss, 1999). In dopamine neurones, blockage of these channels
inhibits post-spike after-hyperpolarisation, changing the pacemaker-like discharge
into multiple bursts, which are associated with increased release of dopamine (Ping
and Shepard, 1999; Morikawa et ah, 2000) and serotonin (Dawson and Routledge,
1995). Long alleles at the coding microsatellite locus have been reported to be
associated with BPAD (Chandy et ah, 1998) and also with SCZ, in particular
negative symptoms (Bowen et ah, 1998; Cardno et ah, 1999; Dror et ah, 1999;
Mclnnis et ah, 1999a; Ritsner et ah, 2002; Ritsner et ah, 2003). Many studies
however did not replicate these findings (Laurent et ah, 1998; Li et ah, 1998b;
Antonarakis et ah, 1999; Bonnet-Brilhault et ah, 1999; Hawi et ah, 1999; Rohrmeier
et ah, 1999; Wittekindt et ah, 1999; Chowdari et ah, 2000; Stober et ah, 2000;
Saleem et ah, 2000; Ujike et ah, 2001; Laurent et ah, 2003), or revealed association
of short alleles (Stober et ah, 1998b; Joober et ah, 1999). However, a patient with
SCZ had a 4-bp deletion in the CAG repeat region, creating a frameshift thought to
result in a truncated protein (Bowen et ah, 2001), and which erroneously localises to
the nucleus, conferring dominant suppression of channel conductance and firing
pattern involving KCNN2 (Miller et ah, 2001). Longer alleles at the coding
microsatellite might predispose to disease by stabilising the channel because they
result in longer polyglutamine tracts, and thereby enhance the channel function
(Gargus et ah, 1998; Vincent et ah, 2000b), in keeping with important discharge
regularisation of dopaminergic neurones in animal models of SCZ (Svensson, 2000),
but in contrast to the effects of apamin (Ping and Shepard, 1999) and the effect of the
4-bp deletion (Miller et ah, 2001). These conflicting results and interpretations, as
well as negative reports may reflect the fact that most studies tested association of
the length of the allele with the disease, while some studies, including some that
generated negative results for SCZ, detected association of negative and paranoid
symptoms and early age of onset of SCZ, with the difference between allele sizes,
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rather than the allele size itself (Cardno et al., 1999; Saleem et al., 2000; Ritsner et
al., 2002). These findings are consistent with the heterodimeric association of the
calcium-activated potassium channels, disruption of which might be the mechanism
for the role of KCNN3 variation in SCZ (Saleem et al., 2000).
Similarly, haplotypes spanning the upstream region up to intron 1 of the
regulator of G-protein signalling 4 (RGS4) gene have been associated in several
populations by several studies (Chowdari et al., 2002; Williams et al., 2004b; Morris
et al., 2004). Although no functional variants have been identified (Chowdari et al.,
2002), RGS4 mRNA levels are lower in SCZ patients than in controls (Mimics et al.,
2001), and RGS4 is also an attractive functional gene since it is regulated by the
dopaminergic pathway (Chowdari et al., 2002), inhibits G-protein mediated
signalling via dopamine and glutamate receptors (De Vries et al., 2000; Ross and
Wilkie, 2000), and is implicated in neuronal differentiation (Grillet et al., 2003).
1.2.4.1.8 lq42 andDISC1/DISC2
Linkage between a t( 1; 11 )(q43;q21) reciprocal translocation and major
psychiatric illness, including recurrent major depression, BPAD and schizophrenia
was found in a Scottish family (St Clair et al., 1990; Muir et al., 1995). Evidence for
linkage to lq42 independent of the t( 1; 11) was reported in studies of the Finnish
population (Hovatta et al., 1999; Ekelund et al., 2001; Hennah et al., 2003; Ekelund
et al., 2004) and the Taiwanese populations (Hwu et al., 2003). A detailed haplotype
map of the DISC locus was constructed based on previously and newly described
SNPs, and these were tested for association with SCZ, schizoaffective disorder and
BPAD (Thomson et al., 2005). Evidence for association was found for all three
illnesses but not for a risk haplotype in common with those reported earlier in the
Finnish (Hennah et al., 2003), Taiwanese (Hwu et al., 2003) or North American
population (Hodgkinson et al., 2004). Further evidence for the existence of a
candidate locus in this region comes from report of linkage and association of a
polymorphic marker in the lq42 region with spatial working memory, an
endophenotype of SCZ, obtained by QTL analysis in schizophrenic individuals and
their unaffected co-twins via QTL analysis (Gasperoni et al., 2003). There is as yet
no convincing evidence for functional SNP association in DISCI despite evidence
for association in several independent studies. It remains to be seen whether
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functional SNPs in linkage disequilibrium with the associated markers will be found
and whether there will be a common ancient variant or multiple risk variants relating
to the multifunctional role of DISCI. In DRD2, a synonymous SNP alters the
stability of the encoded mRNA and the level of expression of the DRD2 protein,
dependant on the allele at another synonymous SNP locus in DRD2 (Duan et al.,
2003). Also, non-coding SNPs in the ZDHHC8 (Mukai et al., 2004) and DTNBP1
(van den Oord et al., 2003; Owen et al., 2004) were reported to be associated with
SCZ. In a similar fashion, the functional variant(s) in TRAX/DISC1 may be non-
coding, in regulatory regions or splice sites (Thomson et al., 2005). On the other
hand, DISCI is involved in various functions via interactions of different domains to
several protein families suggesting that DISCI function could be influenced by
allelic heterogeneity (Harrison and Weinberger, 2005). It would therefore be
valuable to integrate knowledge on functional domains in proteins and functional
conservation across species (Thomson et al., 2005).
1.2.4.2 Functional candidate genes
As for affective disorders, drugs with a beneficial effect on SCZ symptoms,
such as clozapine, affect the function of neurotransmitters or their receptors. Genes
implicated in the dopaminergic and serotonergic systems, and the y-butyric acid
(GABA) pathway are therefore potential candidate genes (Harrison and Weinberger,
2005). In addition, histological observations of abnormal localisation and clustering
of neurones in the brain of schizophrenics suggest the existence of mutations in
genes implicated in neuronal migration, survival and connectivity (Roberts, 1990;
Harrison and Weinberger, 2005; Harrison, 1997).
1.2.4.2.1 Serotonergic pathway
The role of serotonin in SCZ is supported by the observation that serotonin
receptors and sites for reuptake are altered in the limbic system in schizophrenics
(Joyce et al., 1993). Furthermore, the HTR2A gene at 13q 14 may be associated with
affective symptoms (Fanous et al., 2004) and has been associated with response to
clozapine (Arranz et al., 1998). Also, the VNTR in intron 2 of the serotonin
transporter (SCL6A4) gene described above has been associated with SCZ (Tsai et
al., 2002; Kaiser et al., 2001; Liu et al., 1999), while the 44 bp indel in the promoter
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has also been associated with schizoaffective and schizoparanoid subtypes (Kaiser et
ah, 2001) and endophenotypes of SCZ (Malhotra et ah, 1998), but not susceptibility
to SCZ (Rao et ah, 1998; Tsai et ah, 2002). In addition, genotypes at the SLC6A4
promoter variant and at loci in HTR2A and 5HT2C have been used to predict
response to clozapine in schizophrenics (Arranz et ah, 2000; Malhotra et ah, 2004;
Johnson et ah, 2005).
1.2.4.2.2 Dopaminergic pathway
The efficiency of antipsychotic drugs is correlated with affinity for dopamine
D2 receptors, suggesting brain dopamine hyperactivity in SCZ (Malhotra et ah,
2004). Typical antipsychotic drugs which block DRD2 are effective in treating
positive symptoms, but less so for negative symptoms (Kane and Freeman, 1994).
DRD2 is located on post-synaptic dopaminergic neurons involved in reward-
mediating pathways, locomotion, hormone production and drug abuse, and is the
target of drug to treat psychoses, such as haloperidol for SCZ (Seeman, 1987; Neville
et ah, 2004). Several polymorphisms in DRD2 have been associated with SCZ in
samples with different ethnic origin: i) a functional single nucleotide
insertion/deletion in the promoter in some (Arinami et ah, 1994; Ohara et ah, 1998;
Inada et ah, 1999; Jonsson et ah, 1999) but not in all studies (Li et ah, 1998a; Glatt et
ah, 2004), ii) a SNP in a coding exon (Shaikh et ah, 1994; Arinami et ah, 1996;
Arinami et ah, 1997; Glatt et ah, 2003b), also associated with delusions in major
psychoses (Serretti et ah, 2000a), iii) two TaqI variants in intron 2 (Dubertret et ah,
2001; Golimbet et ah, 2003) and iv) a microsatellite in intron 2 (Golimbet et ah,
2003), which is also associated with Parkinson's disease and with levodopa
treatment-induced dyskinesia in patients (Oliveri et ah, 1999).
Many drugs used to treat SCZ are dopamine receptor antagonists and can
have secondary effects in schizophrenics such as rigidity, bradykinesia, dyskinesia
(Malhotra et ah, 2004). The more recent drug clozapine is used to treat positive and
negative symptoms (Leucht et ah, 2003). Clozapine has a 10-fold greater affinity for
DREW than for DRD2 suggesting an important role for DRD4 in SCZ (Van Tol et ah,
1991). A SNP located at -521 with respect to the initiation codon reduces expression
of the DRD4 gene by 40% in transient expression assay, with the high-expression
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allele being associated with SCZ (Okuyama et ah, 1999), and novelty seeking
(Okuyama et ah, 2000; Ronai et ah, 2001). Similarly, a 120 bp tandem repeat
polymorphism located 1.2 Kb upstream of the initiation codon has been associated
with SCZ (Xing et ah, 2003), ADHD (McCracken et ah, 2000; Mill et ah, 2003),
methamphetamine abuse (Li et ah, 1997b), and novelty seeking in bipolar and
alcoholic families (Rogers et ah, 2004). Haplotypes at the VNTR and SNPs closer to
the gene, including the functional SNP at -521, have also been associated with SCZ
(Xing et ah, 2003). The 120 bp duplicated sequence contains binding sites for several
transcription factors and polymorphisms within these sites may affect regulation of
transcription ofDRD4, as it has been observed in gene reporter assays in human cells
where the long allele showed lower expression (D'Souza et ah, 2004). Mice lacking
DRD4 are less active in open fields tests, but are more active on rotarod and display
increased locomotor sensitivity to ethanol, cocaine, methamphetamine (Rubinstein et
ah, 1997).
Polymorphisms in other genes of the dopamine pathway have been associated
with SCZ. A microsatellite, named DRD5 and located 18.5 Kb upstream to the
DRD5 gene has been associated with SCZ (Williams et ah, 1997; Muir et ah, 2001)
and ADHD in some (Daly et ah, 1999; Tahir et ah, 2000; Maher et ah, 2002;
Kustanovich et ah, 2004; Lowe et ah, 2004), but not all studies (Barr et ah, 2000;
Payton et ah, 2001) but not with BPAD nor UP (Muir et ah, 2001). This marker is
also thought to be in LD with one or more causal variants and variation in LD
between these variants may confound results of these association studies (Daly et ah,
1999; Muir et ah, 2001; Mill et ah, 2004). Several non-synonymous mutation have
been identified in transmembrane domains and intra-and extra-cellular loop of
DRD5, some of which resulted in small to 10-fold increase in dopamine affinity
(Cravchik and Gejman, 1999). A microsatellite, D4S615, located 131 Kb
downstream of the DRD5 gene has been associated with SCZ (Muir et ah, 2001). A
microsatellite in a trans-activation domain in the promoter of DRD5 has been
associated with dystonia, which is often co-morbid with SCZ, by some studies
(Placzek et ah, 2001; Misbahuddin et ah, 2002). These findings were not replicated
by other studies (Sibbing et ah, 2003). Because of conflicting results obtained by
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linkage and association studies of DRD5, it has been suggested that the markers
tested may be in LD with variants in other genes (Muir et al., 2001).
Polymorphisms in the DRD3 gene have been associated with SCZ (Crocq et
al., 1992; Spurlock et al., 1998; Lohmueller et al., 2003), but not by all studies
(Anney et al., 2002). DRD3 deficient mice showed hyperactivity and increased
rearing behaviour (Accili et al., 1996). A non-synonymous mutation in the DRD3
gene has also been associated with eye movement disturbances, which are used as a
marker for SCZ (Holzman, 2000) and could be used as a marker itself (Rybakowski
et al., 2001). A rare allele at a microsatellite locus in the first intron of the tyrosine
hydroxylase (TH) gene, implicated in the synthesis of dopamine, has been associated
with SCZ in some studies (Meloni et al., 1995) but not by others (Jonsson et al.,
1998; Burgert et al., 1998). A 40bp VNTR polymorphism in the 3' untranslated
region of the dopamine transporter (SLC6A3) gene may be associated with negative
symptoms, in keeping with the possible role of abnormal prefrontal dopamine
function in negative symptoms (Goldman-Rakic and Selemon, 1997), the modulation
of the activity of dopamine at all types of dopamine receptors by SLC6A3 (Fanous et
al., 2004), and the amelioration of negative symptoms by clozapine treatment,
possibly via activation of dopamine release in the prefrontal cortex (Youngren et al.,
1999).
1.2.4.2.3 Neurotrophins
Neurotrophins may play an important role in SCZ as they are crucial for
neurodevelopment (Labelle and Leclerc, 2000; Murer et al., 2001). For example,
brain derived neurotrophic factor (BDNF) has been associated with SCZ (Muglia et
al., 2003). BDNF promotes survival of neurons in the hippocampus and cerebral
cortex, which both express BDNF in adults brains (Murer et al., 2001), axonal
outgrowth (Labelle and Leclerc, 2000) and synaptic plasticity (Ying et al., 2002).
BDNF mediates long-term neuronal adaptations by governing the response to
dopamine of target neurones, by modulating the expression of DRD3 during
development and adult life, for example (Guillin et al., 2001). Together with BDNF,
neurotrophin-3 (NT3) activate a phosphatidylinositol (PI) 3-kinase (PIK3C3),
thereby generating PI(3)P and activating AKT1 (Yoshimura et al., 2005). GSK3B is
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inactivated by 'v-akt murine thymona viral oncogene homolog 1' (AKT1) in
response to neurotrophins (Yoshimura et al., 2005). GSK3B appears to regulate the
activity of microtubule-associated proteins. Its inactivation may promote axon
outgrowth (Yoshimura et al., 2005). Furthermore, the decrease in levels of
phosphorylation of GSK3B and the association of a haplotype in AKT1 with lower
AKT1 proteins levels observed in the prefrontal cortex and hippocampus of
schizophrenics suggest that AKT1 may be involved in SCZ (Emamian et al., 2004).
AKT1 is a multifunctional kinase that mediates multiple responses via several
signalling pathways, and numerous protein-protein interactions (Hallmayer, 2004).
Implication of AKT1 in the aetiology of SCZ is further supported by greater
sensitivity to disruption of sensorimotor gating by amphetamine in Aktl knockout
mice, and by the amelioration of this phenotpe upon treatment with the drug
haloperidol which is used to treat SCZ (Emamian et al., 2004).
1.2.4.2.4 Glutamatergicpathway
As shown by linkage analyses, genes in the glutamatergic system, such as
DAO, are also potential candidates for susceptibility to SCZ, in particular glutamate
receptors (Schiffer, 2002; Collier and Li, 2003). Haplotypes at two to five SNPs
spanning intron 3-5 of the glutamate receptor 3 (GRM3) gene have been associated
with SCZ (Fujii et al., 2003; Egan et al., 2004). Intriguingly, a SNP in intron 2 is
associated with SCZ, and with cognitive and brain activity defects which were
observed not only in patients but in normal individuals too (Egan et al., 2004).
Effects of GRM3 on the aetiology of SCZ may be mediated via its action in
modulating dopamine, serotonin, and NMDA receptor (NMDAR) transmission
(Cartmell and Schoepp, 2000; De Blasi et al., 2001; Spooren et al., 2003).
These findings show that although association of several genes with SCZ has
been replicated, specific alleles have not, with risk alleles typically varying between
studies (Harrison and Weinberger, 2005). This may be due to the fact that these
studies rely on samples from populations with different ancestral genetic
backgrounds and hence harbouring different haplotypes (Botstein and Risch, 2003;
Schwab et al., 2003). Candidate genes for SCZ identified support the view that SCZ
is a disorder of synaptic signalling, especially in dopaminergic and glutamatergic
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signalling, including receptors such as DRD2, DRD4, GRM3, CHRNA7, DAO and
DAOA (Harrison and Weinberger, 2005), as well as signal transduction, via RGS4
for example, and synapse plasticity and formation, involving NRG1, DNTBP1 and
DISCI.
1.2.5 Genetic components common to affective disorders and
schizophrenia
Although standardised criteria to define affective disorders and SCZ exist,
symptoms for these three illnesses overlap widely (American Psychiatry Association,
1994). The existing classification of these illnesses remains uncertain due to the
current lack of reliable biological and genetic markers, and the disorders may share
genetic and nongenetic risk factors (Berrettini, 2000; Berrettini, 2004). This is
supported by the existence of both illnesses in the same kindreds, together with
intermediate phenotypes, such as schizoaffective disorder, and the transition from
one phenotype to the other in some patients (Blackwood et al., 1996; Wildenauer et
al., 1999). The co-localisation of regions linked to SCZ and BPAD, such as the DISC
locus and 1 Op 13-p 12, llq23, 13q32, 18p, 18q and 22ql 1-q 13, further suggests that
some genetic susceptibility factors are shared between the two diagnoses
(Wildenauer et al., 1999; Berrettini, 2004).
Studies of functional candidate genes also indicate common pathways, such
as the serotenergic pathway implicating genes harbouring polymorphisms associated
with both psychoses, or symptoms of these illnesses, such as one of the serotonin
receptors (Fanous et al., 2004; Malhotra et al., 2004), serotonin transporter (Rotondo
et al., 2002), dopamine transporter (Greenwood and Kelsoe, 2003; Hawi et al., 2003;
Fanous et al., 2004; Keikhaee et al., 2005), or a monoamine oxidase (Shifman et al.,
2002; Shifman et al., 2004).
There is also evidence that genes implicated in glutamatergic transmission
contribute to both diseases too, such as in the case of DAO and the activation of the
NMDA-type glutamate receptor (Heresco-Levy et al., 1996). The DAO gene is
located in a region linked to BPAD (Ewald et al., 2002; Shink et al., 2005) and has
been associated with SCZ (Schumacher et al., 2004). The gene coding for the
activator of DAO, DAOA, is located in 13q32-33, which shows linkage to SCZ and
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BPAD (Badner and Gershon, 2002), and has been associated both with SCZ and
BPAD (Chumakov et al., 2002; Hattori et al., 2003; Schumacher et al., 2004; Zou et
al., 2005).
Similarly, neutrophins may contribute to both disorders. For example, a
VNTR in the 3' untranslated region UTR of BDNF was reported to be associated
with BPAD (Neves-Pereira et al., 2002), with SCZ (Muglia et al., 2003) and with
negative and affective symptoms in SCZ (Fanous et al., 2004). This variant and a
polymorphism in the upstream region of BDNF, reported to be associated with
negative symptomes, only explains a small proportion of the variance in the SCZ
symptoms reflecting the possibility that complex traits may involve several genes
and interactions between these genes (Fanous et al., 2004). In addition, the
AKT1/GSK3B signalling pathway, target of lithium and valproic acid, seems to be
implicated in BPAD (Benedetti et al., 2005) while a polymorphism in the AKT1 gene
has been associated with SCZ (Emamian et al., 2004).
Apart from the polymorphism in the coding sequence of COMT, most
polymorphisms found so far and associated with affective disorders and SCZ are
non-coding. Although evidence is still lacking for the functional role of most of the
non-coding variants, and these variants may therefore not contribute to the aetiology
of psychosis, but rather be in linkage disequilibrium with coding variants, it is likely
that many alter the expression of the genes (Harrison and Weinberger, 2005).
The sequence of the human genome has allowed fast progress in the
identification of sequence variants. The next section introduces the Human Genome
Project on which many findings mentioned above derived and on which the further
elucidation of the molecular basis for genetic risk depends.
1.3 The Human Genome Project
The completion of the Human Genome Project conducted by the International
Human Genome Sequencing Group is a landmark event and is having a profound
impact on biomedical research (Collins et al., 2003). Knowledge of the human
genome sequence permits the comprehensive determination of the structural and
functional elements it encodes, the organisation of genetic networks and biochemical
pathways, as well as the description of the genetic variation. This wealth of
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information should in turn enable the elucidation of the interplay between genetic
and environmental factors and how it translates into organismal phenotypes, such as
disease and response to treatment (Davies, 2001; Collins et al., 2003). Four features
of the Human Genome Project enabled important progresses in the understanding of
complex disorders, such as psychiatric diseases: creation of physical maps,
annotation of the genomic sequences, identification of numerous nucleotide
polymorphisms and comparative genomics (Collins et ah, 2003).
The publicly available sequence covering 90% of the human genome was first
announced in February 2001 (Venter et ah, 2001; International Human Genome
Sequencing Consortium, 2001). It was freely available from GenBank in the form of
unfinished and fragmentary BAC clone sequences (http://www.ncbi.nlm.nih.gov/
Genbank/). Although the Human Genome Project was completed in April 2003, the
second, 'finishing' phase is now completing sequence of the existing clones (National
Human Genome Research Institute web site, http://www.nhgri.nih.gov). The
assembly of the human genome sequence is regularly updated
(http://www.ncbi.nlm.nih.gov/genome/human/release_notes.html) by incorporating
these new sequences. The human genome shows variation in the distribution of CG
content, recombination rate, CpG island, genes, and transposable elements. It also
contains approximately 30,000 genes, that is only twice as many as in worm or fly
(International Human Genome Sequencing Consortium, 2001). Most additional
genes in human are however not entirely novel but instead derived from duplication
of existing ones. Human genes also undergo more complex regulatory events, such
as splicing, leading to a greater variety of proteins. Furthermore, human proteins
seem to contain more diverse combinations of domains. (International Human
Genome Sequencing Consortium, 2001; Levine and Tjian, 2003). Transposable
elements comprise about half the human genome, but their activity appears to have
declined dramatically (International Human Genome Sequencing Consortium, 2001).
Also, most mutations appear in males, as shown by a mutation rate in male meiosis
being twice that of female meiosis (International Human Genome Sequencing
Consortium, 2001). Finally, at least one crossover occurs per chromosome arm in
each meiosis and recombination rates tend to be higher in distal regions of
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chromosomes and on short arms (International Human Genome Sequencing
Consortium, 2001).
The assembly of the human genome generated by the National Center for
Biotechnology Information (NCBI) and its annotation can be consulted online at the
Entrez Genomic Biology page for Human (http://www.ncbi.nlm.nih.gov/
genome/guide/human/). One can also access this sequence and the annotation
generated by Ensembl, a joint project of the European Bioinformatics Institute and
the Wellcome Trust (Hubbard et al., 2002), and that generated by the University of
California at Santa Cruz (Kent et al., 2002). Finally, Celera Genomics also generated
an assembled sequence, available from its online site under various restrictions
(http://public.celera.com/index.cfm). With the completion of several genome
sequencing projects and the development of new experimental approaches to study
gene expression patterns and proteomics, the volume and complexity of biological
data will continue to increase dramatically (Collins et al., 2003). These databases and
related web sites have therefore become a tool important to many biologists. The
successful completion of the Human Genome Project led to other genome projects
for vertebrate model organisms, such as mouse (Waterston et al., 2002), rat (Rat
Genome Sequencing Project Consortium, 2004), chimpanzee (Olson and Varki,
2003), dog (Kirkness et al., 2003) and chicken (Hillier et al., 2004). As sequences of
genomes are released, they are incorporated into the aforementioned databases,
enabling research progress within and between organisms (Clamp et al., 2003; Kent
et al., 2002). Together with genome sequences of the fruit fly and nematode, this data
directly helps to understand human diseases, as it appears that important genes
involved in development and complex traits, such as behaviour, in these model
organisms share conserved function with human genes. For example, transgenic mice
with low expression level of the NMDA receptor showed abnormal behaviours akin
to symptoms in schizophrenia, which were ameliorated upon treatment with
haloperidol and clozapine which are used to treat schizophrenic patients (Mohn et al.,
1999). While the Human Genome Project covered the entire genome, including the
99,9% of the bases shared by all humans, it also enabled the characterisation of the
0.1% remaining bases that vary between individuals.
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1.4 Human genetic variation and Single Nucleotide
Polymorphisms
Human genomic sequence variation includes single nucleotide, micro- and
mini-satellite repeat, insertion and deletion polymorphisms (International Human
Genome Sequencing Consortium, 2001). Single Nucleotide Polymorphisms (SNPs)
are a powerful tool to uncover associations of specific loci with diseases (Risch and
Merikangas, 1996; Bentley, 2000). They present two advantages over other types of
markers. First, it is relatively easy to automate SNP typing assays which can be
performed on a large-scale and remain cheap and robust (Gonen et al., 1999; Bartlett
et al., 2001; Ranade et al., 2001; Xu et al., 2003). Second, SNPs are abundant
throughout the genome and can be found on average every 100 to 300 bases
(http://www.ncbi.nlm.nih.gov/SNP/). SNPs can be detected using targeted or non-
targeted techniques. The latter approach consists of large-scale shotgun sequencing
of libraries of total genomic DNA or individual chromosomes (Taillon-Miller et al.,
1998). This method was used by a consortium of pharmaceutical companies, the
Wellcome Trust and international genome centres: The SNP Consortium (TSC,
http://snp.cshl.org/). The NCBI dbSNP database has been designed to act as a central
repository for SNP data, including those from large projects such as TSC (Smigielski
et al., 2000). The recent dbSNP build 122 (http://www.ncbi.nlm.nih.gov/SNP/)
contains approximately 9.8 million SNPs, of which approximately 5 million are
validated (Mooney, 2005). The increasing density of SNPs on the human genome
facilitates genome-wide association studies and replication studies, as well as the
understanding of variation in response to treatment observed between patients and
the identification of population stratification (Roses, 2000; The International
HapMap Consortium, 2003; Malhotra et al., 2004; Johnson et al., 2005). Estimates of
the density of SNPs required for powerful genome-wide association studies has
initially varied from 1 per 3 Kb to 1 per 100 Kb (Risch, 2000; Hirschhorn and Daly,
2005). Most functional human genetic variation appears not to be population-specific
(Stephens et al., 2001; Hinds et al., 2005), although some examples that link
population specific polymorphism and phenotypic differences exist (Xiao and
Casero, Jr., 1996; Nakayama et al., 2002a; Nakayama et al., 2002b; Nakayama et al.,
2002c; Nakayama et al., 2002d; Duggal et al., 2003).
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As described above, the indirect approach for association studies is thought to
be able to capture most human sequence variation with greater efficiency than the
direct method for two reasons. First, common variants account for approximately
90% of inter-individual sequence variation (Kruglyak and Nickerson, 2001; Reich
and Lander, 2001). Second, single historical events generated most of these variants,
which are thus associated with neighbouring polymorphisms also present on the
ancestral chromosomes (The International HapMap Consortium, 2003).
The aim of the HapMap Project is to characterise common patterns of
sequence polymorphism in the human genome by determining the frequencies of
alleles and genotypes at millions of loci across the genome and the association
between them (The International HapMap Consortium, 2003). This data should allow
any given disease to be tested indirectly for association with common variants spread
across the entire genome, chromosomal regions identified by linkage analysis, or in
and around functional candidate genes (The International HapMap Consortium,
2003). Identification of rare disease-causing variants will also benefit from this data
as these polymorphisms will be linked to common variants enriched in cases
compared to controls (The International HapMap Consortium, 2003), reminiscent of
the identification of the cystic fibrosis transmembrane conductance regulator
(CFTR) gene responsible for cystic fibrosis (Kerem et ah, 1989). Most of the genetic
variation observed in the world's human population is predicted to occur at
approximately 10 million SNPs, namely one locus every 300 bp, where alleles have a
frequency of at least 1%. The remaining 10% of the inter-individual genetic
variation would be accounted for by rare variants (Kruglyak and Nickerson, 2001;
Reich and Lander, 2001).
Empirical studies have shown that most of the human genome harbours a
block-like structure with regions a high LD between nearby SNPs, separated by
regions of low LD (Abecasis et ah, 2001; Jeffreys et ah, 2001; Dawson et ah, 2002;
Gabriel et ah, 2002; Reich et ah, 2002). The regions of high LD usually contain only
a few haplotypes that jointly account for most of the observed variation (Rioux et ah,
2000; Patil et ah, 2001; Dawson et ah, 2002). It follows that alleles at many loci
within these regions of high LD can be deducted by genotyping a few linked SNPs
only, termed 'tag' SNPs (Johnson et ah, 2001; Goldstein et ah, 2003). The practical
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impact of these findings is that, accounting for the variable extent of LD in the
human genome, between 200,000 and 1,000,000 tag SNPs are expected to capture
most of the common genetic variation in human populations due to the 10 million
common SNPs in the human genome. The small loss of information inherent to this
deduction is outweighed by the large reduction in the amount of genotyping (The
International HapMap Consortium, 2003). For common SNPs, which are thought to
be older than rare SNPs, historical recombination and demographic events can
account for the observed patterns of LD (Chakravarti, 1999). Some recombination
events tend to be clustered in recombination hotspots (Chakravarti et al., 1984;
Jeffreys et ah, 2001). These findings are consistent with the observation that
unrelated chromosomes and some populations shared haplotypes and patterns of LD
(Gabriel et al., 2002). Elucidation of LD patterns in the human genome will
contribute to the identification of polymorphisms involved in diseases, in particular
functional variants in non-coding sequences, likely to be involved in gene expression
(The International HapMap Consortium, 2003).
Gene expression can be altered by non-coding polymorphisms in the
promoter and introns at the level of transcription (Greenwood and Kelsoe, 2003;
Laws et al., 2002; Lemonde et al., 2003; Theuns et al., 2003). In introns, SNPs can
alter transcript and isoform abundance via splicing or mRNA stability (Tokuhiro et
al., 2003), and in the 3'untranslated region at the level of mRNA and translation
(Mill et al., 2002; Miller and Madras, 2002). Variation in gene expression is
presented in the following section.
1.5 Gene expression variation
1.5.1 Impact on morphology
Variation in gene expression may influence evolution more strongly than
variation in protein isoforms (King and Wilson, 1975) and differences in gene
expression account for a major part of the variation within and between species
(Levine and Tjian, 2003). Polymorphisms in cA-acting regulatory regions have been
implicated in morphological features in insects, such as the conversion of swimming
limbs into feeding appendages in certain crustaceans, or the conversion of hindwings
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in butterfly into rudimentary wings in Drosophila, due to mutations creating bindings
sites for a repressor transcription factor Ultrabithorx (Ubx) (Weatherbee et al, 1999).
Recently, novel regulatory elements in the fruit fly have been identified in existing
regulatory regions and shown to affect the pigmentation of the abdomen and wings in
males, and may therefore influence mating selection (Gompel et al., 2005). Similarly,
analysis of sequences of the homeobox C8 (HOXC8) gene, which controls axial
morphology in vertebrates, from fish and mammals, led to the identification of
functional nucleotide substitutions in non-coding regions, as well as species specific
set of functional regulatory elements (Shashikant et al., 1998; Anand et al., 2003;
Wang et al., 2004). In human, a mutation in the intron of the 'chromosome 7, open
reading frame 2' (C7orf2 or limb region 1, LMBR1) gene, directly disrupts a ex¬
acting regulator of the 'sonic hedgehog homo log' (SHH) gene located 1Mb away
(Lettice et al., 2002). This variant may be implicated in limb malformation, namely
Preaxial Polydactyly (PPD), since mis-expression of the Shh gene in mouse is a
common requirement for creating extra digit (Lettice et al., 2002).
1.5.2 Role in diseases
The major cause of disease known to date is mutation in coding regions of
genes which affect protein quantity and/or quality (Cargill et al., 1999), as in
Hungtington's disease for example, which is caused by trinucleotide repeat
expansion leading to enlarged repetitive series of the encoded amino acid in the
protein (The Huntington's Disease Collaborative Research Group, 1993). However,
some of these mutations affect proteins involved in gene expression regulation, such
as in the Rett syndrome for example (Caballero and Hendrich, 2005). Furthermore,
polymorphisms in regulatory regions have been shown to increase risk of diseases
(Risch and Merikangas, 1996; Collins et al., 1997; Wray et al., 2003; Knight, 2005).
At present, approximately 26,000 mis-sense and nonsense mutations are
known, whereas only 545 regulatory mutations have been identified (Stenson et al.,
2003). This difference is probably biased and may reflect the relative ease of
identifying mutations in coding regions, mainly because they alter the structure of the
protein, compared to the difficult characterisation of non-coding functional mutations
(Knight, 2005). Non-coding mutations may also have smaller effects, as observed for
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mutations with milder effects affecting complex traits (Toma et al., 2002), and, in
isolation, may not be sufficient to cause disease (Botstein and Risch, 2003). Early
examples of regulatory variants causing disease include substitutions in regulatory
elements in the f-globin gene cluster implicated in (3-thalassemia (Antonarakis et ah,
1984), in the promoter of the low density lipoprotein gene involved in
hypercholesterolemia (Koivisto et ah, 1994), the factor IX gene in haemophilia
(Picketts et ah, 1994), the chemokine receptor 5 gene in acquired immune deficiency
syndrome (McDermott et ah, 1998), a 2-bp insertion in the promoter of the bilirubin
UPD- glucuronosyltransferase gene reducing the expression of the gene and causing
the jaundice in the Gilbert syndrome (Monaghan et al., 1996), and splicing variation
of CFTR variants in cystic fibrosis (Rave-Harel et al., 1997). Inherited variation in
gene expression may thus play an important role in susceptibility to complex
diseases (Lander, 1996; Peltonen and McKusick, 2001). Supporting this hypothesis,
regulatory polymorphisms are increasingly recognised to contribute to complex
disease traits, although the number of examples with both a clear-cut genetic
association and defined molecular mechanism remain small (Knight, 2005). For
example, the fragile X syndrome, characterised by mental retardation, is caused by
alteration of the expression of the fragileXmental retardation-1 (FMR1) gene due to
expanded repeats in its promoter (Kenneson et al., 2001). Several other recent studies
have reported non-coding polymorphisms, notably in the regulatory region of genes,
associated with complex diseases, such as lupus erythematosus (Werth et al., 2000),
asthma (Moffatt and Cookson, 1997), diabetes (Horikawa et al., 2000b),
inflammatory bowel disease (Horikawa et al., 2000a), autoimmune disease (Ueda et
al., 2003), rheumatoid arthritis (Suzuki et al., 2003), myocardial infarction and stroke
(Helgadottir et al., 2004), and schizophrenia (Wei and Hemmings, 2000; Stefansson
et al., 2002; Straub et al., 2002; Bray et al., 2003b; Schwab et al., 2003).
1.5.3 Heritability
Variation in genome-wide gene expression has been associated with
phenotypic variation in a number of different organisms: the budding yeast (Brem et
al., 2002; Townsend et al., 2003; Fay et al., 2004), drosophila (Rifkin et al., 2003),
teleost fish (Oleksiak et al., 2002), primate species (Enard et al., 2002) and human
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(Pastinen et al., 2004; Knight, 2004; Yan et al., 2002; Cheung et al., 2003). Analysis
of the intra- and inter-specific variation in primate gene expression patterns has
shown that gene and protein expression have evolved extensively in the human brain,
and that global differences in gene expression between the few individuals tested is
as great as that observed between human and chimpanzee (Enard et al., 2002).
In human, recent studies have shown that gene expression variation is
common for autosomal genes that do not show genomic imprinting (Rockman and
Wray, 2002; Buckland, 2004). Out of 107 genes with variants in the 5' flanking
region that were experimentally verified as functional in reporter gene assays in
physiologically relevant cell lines, most polymorphisms were in the proximal
promoter regions, but over a quarter were located more than 1 Kb upstream or 3'
downstream to the transcriptional start site (Rockman and Wray, 2002). This study
also revealed that 67% of the variants showed allelic differences in the rate of
transcription of at least 2-fold, and 10% had differences of at least 10-fold. It was
also estimated that 30% of genes have functional promoter SNPs (Rockman and
Wray, 2002). In a different study of gene expression in human using two cell lines
under basal conditions, 11% of 249 genes tested had promoter haplotypes showing
differences in gene expression of at least 1.5, and more than half of these effects
could be ascribed to variants with minor allele frequency less than 5%, suggesting
that more functional variant would be found ifmore individuals, conditions and cell
lines had been screened (Buckland, 2004). Recent in vivo studies of relative allelic
expression in normal tissues or cell lines for hundreds of human genes suggest that
25% to 50% of genes and 5% to 25% of heterozygotes show evidence of unequally
expressed alleles (Yan et al., 2002; Bray et al., 2003a; Lo et al., 2003; Pastinen et al.,
2004). Finally, robust allele differences in gene expression appear to be of modest
amplitude, typically 1.5 - 2.0 fold, in mouse (Cowles et al., 2002) and human (Yan et
al., 2002; Bray et al., 2003a; Pastinen et al., 2004).
Some studies have also shown that gene expression variation is heritable in
human (Yan et al., 2002; Cheung et al., 2003; Pastinen et al., 2004). For example,
Cheung and co-workers reported that microarray analysis of 5000 randomly chosen
cDNAs using human cell lines established from unrelated and related individuals
allowed the identification of genes whose transcript levels varied most among normal
individuals (Cheung et al., 2003). Valid observations on at least three out of four
replicates in at least 30 out of 35 unrelated individuals were obtained for 813 genes.
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Further analysis of the gene expression of five highly variable genes in unrelated
individuals, offspring and monozygotic twins showed that the variance in gene
expression among unrelated individuals was 3-11 times greater than that between
monozygotic twins, and that the variance among sibling was 2-5 times greater than
that between twins, suggesting the existence of genetic basis for gene expression
variation (Cheung et al., 2003). Other studies provide evidence for the inheritance of
some differences in gene expression in humans, and also show that difference in
transcript abundance among non-imprinted genes support existence of regulatory
polymorphisms (Yan et al., 2002; Pastinen et al., 2004).
1.5.4 Functional variants
Factors hindering the characterisation of the extent of cw-regulatory variation
include: i) the current limited ability to recognise regulatory regions of most genes
and to predict which of these variants might affect gene expression given the vast
amount of polymorphisms in the human genome (International Human Genome
Sequencing Consortium, 2001; Cowles et al., 2002), and ii) linkage disequilibrium
between functional and non-functional variants (Knight, 2005). In addition,
experimental screens for regulatory variation in human solely based on transcript
levels are complicated by the possibility that such differences could also be caused
by trans-acting and environmental factors (Cowles et al., 2002). Confounding trans¬
acting and environmental factors can be controlled for by studying F1 hybrids from
crosses of two strains or populations so that both alleles are expressed in identical
conditions. This was applied to yeast (Cohen et al., 2000; Brem et al., 2002), fruit fly
(Wittkopp et al., 2004), fish (Shapiro et al., 2004) and mouse, where difference in
expression of 1.5 fold or greater can be confidently detected (Cowles et al., 2002). In
yeast, genetic linkage analysis of genomewide expression patterns in a cross of two
yeast strains identified cis- and trans- modulators with a handful of trans-acting
modulators each affecting the expression of a few genes to almost a hundred genes
(Brem et al., 2002). Evidence that some closely linked genes are influenced by the
same cw-regulator and have correlated expression profiles was also found in yeast




Genome-wide linkage analysis of gene expression variation in human
identified putative chy-regulators, and for some of them, confirmation of the
association at a population and familial level was obtained by typing additional SNPs
(Morley et ah, 2004). On the other hand, trans-acting regulatory variation appears to
be the source ofmost of the expression variance in yeast (Yvert et ah, 2003), mouse
(Schadt et al., 2003) and human (Whitney et al., 2003; Morley et ah, 2004). These
studies suggest that only a minority of effects are likely to be operating in cis, and
that a number of regions show strong linkage to expression ofmany genes, possibly
representing hotspots of transcriptional regulation (Morley et ah, 2004). These
polymorphisms could participate to diseases, as some diseases are caused by trans¬
acting polymorphisms, including for example familial Alzheimer's disease and Rett
syndrome (Gabellini et ah, 2003).
At present, most approaches used to measure differential gene expression,
such as single-base extension genotyping of RT-PCR products (Cowles et ah, 2002;
Yan et ah, 2002) or hybridisation ofmRNA to Affymetrix HuSNP genotyping arrays
(Lo et ah, 2003), rely on the presence of an exonic or intronic SNP in the transcripts.
This restriction is alleviated by a recent approach called 'haploChip' which allows
indirect measure of gene expression in vivo, namely phosphorylated Pol II loading
on DNA in living cells (Knight et ah, 2003). By allowing the analysis of any SNP
within 2 Kb 5' or 3' to the gene, including promoter and 3'UTR SNPs, this method
considerably expands the number of haplotypes that can be interrogated (Knight et
ah, 2003). It is noteworthy that elucidation of allele-specific gene expression using
SNPs to discriminate transcribed RNA serves to identify functionally important
haplotypes, rather than specific variants, unless sufficient complexity of the
underlying haplotypic structure can be resolved to fine map observed differences
down to a specific region or individual polymorphism (Knight, 2004). Furthermore,
consequences of regulatory polymorphisms are highly context dependent on other
genomic sites, both within and outside the locus, on the cell type, and on




Gene expression is the fundamental process governing protein content and
turn-over in cells of unicellular and multi-cellular organisms whereby the genetic
information stored in the relatively inactive DNA is transferred into active molecules
(Svejstrup, 2004). Gene expression follows three main steps: transcription,
translation, and post-translation modification. Transcription is the step in which
mRNA molecules are produced according to the information coded in a gene and
occurs in the nucleus (Proudfoot et al., 2002). Three RNA polymerases function in
eukaryotes, and transcription of protein-coding genes is mediated by DNA-
dependent RNA-polymerases II (RNApolII). In the nucleus, DNA is coiled around
histones, forming primary elements of packaged DNA, or nucleosomes, themselves
further organised into chromatin (Dillon, 2004; Verschure, 2004). Access to DNA by
RNApolII requires chromatin remodelling, via histone modifications (Workman and
Kingston, 1998; Cho et al., 2004; Li et al., 2004c). RNApolII binds to general
transcription factors to form the pre-initiation complex which binds DNA, allowing
RNApolII to start initiation (Forget et al., 1997; Muller and Tora, 2004; Cramer,
2004). It has recently emerged that, after initiation, transcription and mRNA
processing do not occur in the series of distinct events as thought previously but
instead happen simultaneously (Orphanides and Reinberg, 2002). Initiation of
transcription is followed by elongation, which is accompanied by maturation of the
transcript as it is produced (Orphanides and Reinberg, 2002; Proudfoot, 2004;
Shilatifard, 2004), involving its capping, for protection from nucleases and then
transport to cytoplasm and translation, its splicing, and its termination by poly-
adenylation (Stamm et al., 2005; Proudfoot et ah, 2002). RNA performs various
structural and catalytic functions, but its main role, however, is to be transcribed into
proteins. This requires its transport into the cytoplasm (Reed and Hurt, 2002), where
it is transcribed into a chain of amino acids by ribosomes (Ramakrishnan, 2002;
Dever, 2002), which is then folded into a protein (Daggett and Fersht, 2003). Most
proteins are then modified so that they can carry out structural and metabolic
processes required for the cells to function properly (Morrison et al., 2002;
Aebersold and Goodlett, 2001). Transcription affects all biological processes from
development to response to environmental factors. Although gene expression is also
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controlled at the level of translation and beyond, regulation of gene expression is
mostly achieved by transcription mechanisms (White, 2001). Furthermore, initiation
of transcription is one of the most important levels of gene expression regulation
(White, 2001).
Regulatory elements can be divided into two major groups, depending on
whether they are recognised at the DNA or RNA level. The first group includes
elements important at the DNA level: promoters, enhancers, locus control regions
(LCRs) as well as matrix attachment regions/scaffold attached regions (MAR/SARs)
(Fessele et al., 2002; Frisch et ah, 2002). The second group is composed of elements
recognised at the RNA level and involved in post-transcriptional processes, namely
cA-elcments affecting regulation of processing, transport, translation and stability of
mRNAs (Reed and Hurt, 2002; Ramakrishnan, 2002; Dever, 2002). Transcription is
regulated by elements in the first group and its initiation requires transcription factors
(TFs), which recognise and bind to short motifs on the DNA in the vicinity of the
gene: Transcription Factor Binding Sites (TFBSs).
1.6.1 Promoter elements
TFBSs are typically 5-25 bp long degenerate sequence motifs (Stormo,
2000a). The binding of TFs to TFBSs guides the binding of the RNA-polymerase to
the DNA (Stormo, 2000a; Muller and Tora, 2004; Cho et ah, 2004; Cramer, 2004).
The combination of short sequence elements to which the RNA polymerase binds in
order to initiate transcription of a gene is referred to as promoter (Smale and
Kadonaga, 2003). The formation of a complex of proteins containing general
transcription factors and the RNA-polymerase II, the Pre-Initiation Complex (PIC),
and its binding to the TATA box located 25 bp upstream of the Transcription Start
Site (TSS) in Metazoans, activates RNA-polymerase and triggers production of
mRNA (Kadonaga, 2004). There is growing evidence that integration of signals at
the promoter relies on the specificity and flexibility of the promoter, which in turn
are mediated by the organisation of these elements, rather than on an individual
element (Fessele et ah, 2002; Dvir, 2002).
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Another important regulatory element is the Initiator region (Inr), a loosely
conserved region around the TSS. It is one of the determinants of the strength of the
promoter. In the absence of a TATA box, the Inr can substitute for it and determine
the position of the TSS. The TATA box and Inr are interchangeable to some extent.
Some proteins can bind to the Inr. These proteins may have a role in the specificity
of transcription initiation. In addition, only half of the promoters contain a TATA-
box. Most of the promoters without a TATA box contain a loosely conserved
sequence element resembling CCAAT, recognised by the CCAAT/Enhancer-binding
protein (Kadonaga, 2004).
Another important feature of promoters is the presence of CpG islands close
to or overlapping them. CpG islands indicate a lack ofmethylation at CpG doublets
and correlate with the open chromatin configuration. Overall, CpGs occur at less
than one fourth of the frequency expected from the C+G content in the human
genome. The reason for their rarity seems to be the frequent mutation of the
methylated C into a T in most regions of the genome that are not transcriptionally
active (Strathdee et al., 2004; Caiafa and Zampieri, 2005).
1.6.2 Non-promoter regulatory elements
The promoter located immediately upstream of the TSS, together with the
PIC and specific regulatory elements control the location of the initiation of
transcription (White, 2001; Muller and Tora, 2004; Kadonaga, 2004). The latter also
determine the specificity of gene expression at the tissue and developmental levels,
or any biochemical context (Kadonaga, 2004). Some of these regulatory regions
contain several binding sites for specific TFs and have a synergetic action. These
regions are therefore referred to as activators or repressors. Enhancers are activators
that contain several TFBSs, can be located up to tens of kilobases from the TSS, and
are functional independent on their orientation and to some extent their location
(Kadonaga, 2004; Lettice et al., 2002). The inducibility of an activator depends upon
the sequence of the promoter, and upon the capability of a TF to bind DNA and
interact with other TFs (Muller and Tora, 2004; Cramer, 2004; Kadonaga, 2004). In
addition, it is not yet well understood how the differences in the promoter sequence
translate into differences in receptivity to specific TFs. The PIC composition and the
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alternative splicing of some proteins associated with TATA-box-binding proteins
may however be involved (Kadonaga, 2004).
Gene expression is also regulated by the three-dimensional structure ofDNA.
Three structural factors appear to be involved in the sequence specificity in the
TATA box: the structure of the DNA bound by TATA-box-binding proteins, the
competition between histones and TFs in gene activation or repression, and the
existence of TFs that reshape the DNA to bring distant sites to proximity (Muller and
Tora, 2004; Dillon, 2004; Cramer, 2004).
1.6.3 Evolution of transcriptional systems
Several studies have reported conservation of regulatory sequences across
species, as distantly related as mouse and fish. For example, divergence of axial
morphologies has been shown to involve variations in regulatory regions of
developmental control genes, such as HOXB4 and HOXC8. An early study showed
that regulatory regions for the murine Hoxb4 gene could be identified by comparing
its non-coding sequence to that of the puffer fish Takifugu rubripes (Aparicio et al.,
1995), despite the fact that ancestors of these two species diverged over 400 millions
years ago (Powers, 1991). The authors first identified Hoxb4 in T. rubripes, and then
aligned the non-coding sequences of the gene sequences from the two species. Three
highly conserved sequences were identified and were localised in regions of the
mouse sequence known to contain enhancers. One was intronic and controlled
expression in the mesoderm, ectoderm and in the central and peripheric nervous
system, and two were in the sequence downstream of the gene and controlled the
expression in the ventral neural tube, with a clear anterior boundary. The function of
these conserved sequences was tested using gene reporter constructs in transgenic
mice. The first region, 92 bp, was deleted from the enhancer and tested in transgenic
embryos, which lost the major domains of expression in the mesoderm and ectoderm,
but retained expression in the neural tube. This indicated that the enhancer could still
function at multiple sites, and more importantly, that this 92-bp sequence was crucial
for expression in the mesoderm, and central and peripheric nervous system. The
function of each of the remaining two conserved sequences was tested using
constructs including the corresponding fish sequence. The second region, 250 bp, did
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not show consistent pattern of expression, in contrast to the third region, 300 bp,
which mirrored the spatial boundary of expression observed in mouse, identifying a
neural element that governs a subset ofHoxb4 expression conserved in mammals and
fish (Aparicio et al., 1995).
Using a similar approach, based on several mammalian species, another study
identified a even smaller region in the early enhancer of the HOXC8 gene showing
that new functions or expression patterns can arise by independent loss or gain of
regulatory elements (Shashikant et ah, 1998). In one of the five known cA-acting
elements in the early enhancer, which are almost invariant in Mammals, the authors
identified a 4-bp deletion in the baleen whales. Transgenic mouse embryos carrying a
construct with the whale enhancer showed patterns of expression different from that
observed in wild-type mice: a loss of expression in the posterior mesoderm, and a
gain of expression in the neural tube in more posterior areas. The authors therefore
suggested that the expression ofHoxc8 is different in whales than in other mammals
analysed, and that this may impact on variation in axial morphology (Shashikant et
al., 1998). Follow-up studies further characterised existing elements and identified
novel elements in the early enhancer, and extended the analysis to fish, supporting
further the role ofHoxc8 in axial morphology in vertebrates (Anand et al., 2003).
Some novel functions and expression patterns have also been caused by
mutations in genes encoding TFs (Veraksa et al., 2000; Hsia and McGinnis, 2003;
Levine and Tjian, 2003), resulting in additional function (Galant and Carroll, 2002;
Ronshaugen et al., 2002), or completely new roles via alteration of interaction with
cofactors (Alonso et al., 2001; Brown et al., 2001; Lohr et al., 2001). Mechanisms of
the evolution of gene transcription, such as those concerning the organisation of
promoters or the binding of TFs to DNA, and especially its specificity, are not well
described (Stone and Wray, 2001; Rockman and Wray, 2002; Wray et al., 2003).
TFBSs can be highly degenerate and initiation of transcription is dependent upon
modules of such sites, rarely upon individual sites (Dvir, 2002; Fessele et al., 2002;
Smale and Kadonaga, 2003; Kadonaga, 2004). The degeneracy of TFBS sequences
appears to be beneficial because it allows promoter flexibility, and would therefore
have been selected through evolution (Stormo, 2000a; Stone and Wray, 2001; Bulyk,
2003; Rockman et al., 2003). The small size of TFBSs, the weak sequence
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requirement for TF binding and the modular organisation of TFBSs clusters suggest
that: i) mutations may allow for the presence of conservative substitutions in TFBSs,
and ii) mutations may eliminate existing TFBS and generate new ones resulting in
new expression patterns or functions (Shashikant et ah, 1998; Stone and Wray, 2001;
Dermitzakis and Clark, 2002; Ludwig, 2002).
To test whether the function of promoters in mammals is conserved despite
sequence degeneracy as reported in the fruit fly, Dermitzakis and Clark (2002)
identified genes with a promoter containing TFBSs where the binding ability and
function had been experimentally verified from the literature. They then performed
pairwise comparison of the sequence of the 51 identified human genes to that of
homologous sequences in macaque, mouse and rat. Results of the human-macaque
comparisons revealed a slow accumulation of substitutions in TFBSs, and showed
that these substitutions were not spread evenly across TFBSs but instead
concentrated in a few sites only. This was also observed later in comparison of
human, mouse and dog sequences (Dermitzakis et al., 2004). The heterogeneous rate
of substitution observed among TFBSs could be explained by higher flexibility of the
binding ability of some TFs or by selective constraints being more relaxed in some
binding sites than others (Dermitzakis and Clark, 2002). Comparisons of human and
mouse sequences for 43 gene pairs revealed that the divergence of TFBSs was lower
than the average synonymous divergence, but higher than the non-synonymous
divergence. Moreover, it was not correlated with the divergence of the amino acid
sequences, and therefore could not be explained by rapid overall gene divergence.
Results from comparisons of human and macaque, and human and rodent, also
suggest that selective constraints on TFBSs are sometimes independent in the two
lineages. Finally, comparison of the function of 64 TFBSs in 20 genes, representative
of the entire set, in human and rodent showed that TFBSs diverged substantially; 33
were functional in both species, 14 in human only, and 17 in rodents only, leading
the authors to estimate that between 32% and 40% of human functional TFBSs are
not functional in rodents.
These findings are relevant to the understanding of disease mechanisms, as
rare mutations in highly conserved TFBSs may have a strong effect and cause
monogenic illnesses, while mutations in less conserved TFBSs, missed by
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comparisons between distant species, may have smaller effects, be common and
implicated in complex diseases (Dermitzakis and Clark, 2002). This is supported by
accumulating evidence showing that polymorphisms in promoter sequences account
for a substantial amount of genetic and phenotypic variation observed in populations
(Wray et al., 2003; Levine and Tjian, 2003). In addition, selective pressures acting
upon non-coding sequences have been shown to vary between loci and clades (Wray
et ah, 2003; Levine and Tjian, 2003; Rockman et ah, 2003). Alignments of sequences
from human and vertebrates show that regulatory regions are conserved to a certain
degree and comparative genomics has been used successfully to identify regulatory
regions (described below). The following section summarises the two types of
computational methods used to predict the genes themselves, and describes the
methods used to predict cA-elements involved in gene transcription.
1.7 Prediction of regulatory regions
To fully understand gene transcription requires the identification of all genes
involved and the unravelling of their function. Reciprocally, to understand the
function of genes, it is necessary to identify sequence elements that control their
expression. Identification of genes and regions responsible for their regulation is one
of the main goals of large-scale genome sequencing projects, which now determine
hundreds of megabases each year. The most recent and significant advances are the
near completion of the assembly of the following vertebrate genomes: human
(International Human Genome Sequencing Consortium, 2001), mouse (Waterston et
al., 2002), rat (Rat Genome Sequencing Project Consortium, 2004), dog (Kirkness et
al., 2003) and chicken (Hillier et al., 2004). One of the major challenges is to extract
information from the huge amount of data to detect genes and decipher their
function. This is particularly difficult in eukaryotes, even more so in higher
eukaryotes, because most of the genomic sequence is non-coding.
1.7.1 Gene prediction
Gene prediction aims to correctly define the structure of a gene, and when a
sequence contains several genes it aims to partition a set of predicted exons among
these genes. This problem can be approached by two types of techniques, based on
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statistical methods or on homology searches. The first type of technique aim to
predict the overall gene structure by identifying coding regions using statistical
means and pattern recognition for sites for transcription, splicing and translational
control (Burset and Guigo, 1996; Stormo, 2000b; Brent and Guigo, 2004). The main
problem these programs face is the confusion of internal exons with initial and
terminal exons, which is inherent to the difficult identification of the signals for start
and stop of transcription and translation and location of the splicing sites (Burset and
Guigo, 1996; Stormo, 2000b; Brent and Guigo, 2004). The second type of technique
relies on homology searches for close homologs in the databases to one of the genes
in the sequence under analysis. The main drawback of this approach is its
dependency upon the presence of homologs in the databases whereas novel genes by
definition are not related to known genes closely enough so that homology can be
detected. In addition, when a homolog is identified, these homologous genes may
differ due to insertion and deletion (Stormo, 2000b; Morgenstern et ah, 2002; Brent
and Guigo, 2004). Therefore, an important goal of gene prediction is to design means
of recognising the beginning and end of genes (Davuluri et al., 2001; Down and
Hubbard, 2002).
1.7.2 Prediction of Cis-elements in promoters
Although DNA conformation plays an important role in gene transcription
initiation, little data on structural aspects of transcription initiation is available
(Workman and Kingston, 1998; Cho et ah, 2004; Li et ah, 2004c; Brent and Guigo,
2004). For this reason, most promoter prediction programs are based on the
specificity of protein-DNA contacts at the sequence level (Werner, 2000). Initiation
of the transcription of a gene depends on the co-ordinate binding ofmany proteins to
the promoter and sometimes to enhancers (Kadonaga, 2004). The combination of
different binding sites determines the particular expression context of a gene
(Kadonaga, 2004; Smale and Kadonaga, 2003; Dvir, 2002). Comprehensive
annotation of regulatory sites therefore requires identification of individual sites and
their functional combination (Gailus-Durner et ah, 2001; Bulyk, 2003; Werner,
2003a; Werner, 2003b; Werner et ah, 2003; Pavesi et ah, 2004)
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1.7.2.1 Identification of known Transcription Factor Binding Sites
To identify known TFBSs in a sequence, one can use data obtained
experimentally and publicly available, and determine which known regulatory
element is present in the sequence. DNA-protein binding specificity of a site can be
modelled in two ways: by a consensus sequence or by a position weight matrix
(PWM) (Werner, 2000; Stormo, 2000a; Bulyk, 2003). A consensus sequence is
created from a collection of known TFBS by determining the most frequent base at
each position within a site. Matching the consensus sequence to the sequence under
scrutiny identifies occurrences of the motif. Mismatches must therefore be allowed to
represent variation of the pattern. The main drawback of this approach is thus its
inherent loss of information (Werner, 2000). A weight matrix is computed based on a
collection of TFBS by measuring the frequency of each element at each position of
the site. Any putative site is assigned a score computed from the sum of the matrix
values for that sequence. The first limitation of PWM is that a threshold must be
defined to select predicted motifs. The second limitation is that different positions are
assumed to make independent contributions to DNA binding (Werner, 2000; Bulyk,
2003).
Four main databases exist that contain information on known promoters:
Eukaryote Promoter Database (Perier et al., 2000), TRANSFAC (Knuppel et ah,
1994; Matys et al., 2003), TRRD (Heinemeyer et al., 1998) and JASPAR (Sandelin
et al., 2004). There are several computational tools for the prediction of TFBSs based
on consensus sequences (EMBOSS tool tfscan, http://www.emboss.org) or based on
sets of position weight matrices, e.g. Matlnspector (Quandt et al., 1995) and
MATCH (Kel et al., 2003). To reduce the large sequence space to search and
increase chances to identify location of genuine functional sites, numerous studies
have focused on sequences of genes that show highly similar expression patterns
(Roth et al., 1998; Tavazoie et al., 1999; Hughes et al., 2000; Bussemaker et al.,
2001; Werner, 2003b; Werner et al., 2003). It is noteworthy that the accuracy of the
prediction is directly influenced by the quality of the library of weight matrices used.
In particular, many of the sets used to calculate the PWM are small and predictions
may therefore not be accurate (Roulet et al., 2000).
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As for gene prediction, two types of approach exist to predict regulatory
elements. The first type integrates biological knowledge to delineate a set of
definitions to determine regulatory elements (Ohler and Niemann, 2001; Stormo,
2000a; Bulyk, 2003; Pavesi et ah, 2004). The second type of approach is based on
the comparative analysis of homologous sequences, also called phylogenetic
footprinting (Tagle et ah, 1988; Dubchak and Frazer, 2003; Frazer et ah, 2003).
These methods have been increasingly used since the genomes of several vertebrate
model organisms have been sequenced (Thomas et ah, 2003).
1.7.2.2 Identification of putative novel regulatory sequence motifs
Methods used to detect motifs in sequences rely on the computation of the
expected frequency of motifs in these sequences in order to identify motifs that occur
more frequently than expected by chance alone. Two types of approach exist to
detect motifs over-represented in a set of sequences, which rely on sequence
alignment or enumeration ofmotifs.
The underlying principle of methods based on sequence alignment is to align
sequences of interest to identify elements in several or all sequences. Two methods
can achieve this goal: Gibbs sampling, implemented in AlignACE (Roth et ah, 1998)
and expectation-maximisation in MEME (Bailey and Elkan, 1994). The typical
output is a model for each motif identified, usually a PWM.
Enumerative methods rely on the frequency of all nucleotide oligomers of
various size in the genome of interest to identify motifs that are over-represented in
the searched sequences. This approach is implemented in the programs Oligo-
analysis, which detects simple oligomers (van Helden et ah, 1998), and Dyad-
analysis, which detects homo- or hetero-dimer motifs separated by a fixed or variable
spacer length (van Helden et ah, 2000). The typical output of these two programs is a
list of over-represented oligomers, represented in the form of a consensus sequence
(van Helden et ah, 2000).
Methods based on sequence alignment have the advantages over enumerative
methods of finding potentially longer motifs and delivering a weight matrix as a
comprehensive model for a motif, which is more flexible than the consensus
sequence generated by enumerative methods. In addition, parts of this consensus
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sequence may come from different sequences. The main advantage of enumerative
methods is that they search all possible oligomers (Stormo, 2000a; Werner, 2000).
Due to the small size and relative sequence degeneracy of TFBSs, prediction
of such motifs generates many false positives (Werner, 2000; Stormo, 2000a). The
problem can be addressed by considering only those located in sequences conserved
in another organism.
1.8 Comparative genomics
1.8.1 Human-mouse sequence comparison
The underlying assumption of the comparative genomics approach, or
phylogenetic footprinting, is that sequences conserved through evolutionary time
have not diverged because they have a necessary function (Tagle et ah, 1988). Early
examples of comparative sequence analysis in mammals include the study of globin
genes, in the context of thalassemia, in human and rabbit (Hardison et ah, 1991),
with a dot-plot software to visualise the pairwise alignment along the sequence
annotation (Hardison et ah, 1991; Schwartz et ah, 1991), and squirrel (Gumucio et
ah, 1996; Hardison et ah, 1997), and further developed in a database, Hbvar
(Hardison et ah, 2002; Patrinos et ah, 2004). Comparative genomics of the human
and mouse sequences has been successfully used to identify coding sequences
(Batzoglou et ah, 2000), and integrated in gene prediction programs, such as SLAM
(Alexandersson et ah, 2003) and TWINSCAN (Korf et ah, 2001; Flicek et ah, 2003)
Comparative sequence analysis of human and mouse sequences has been
applied to the evolution of chromosome structure and organisation (Dehal et ah,
2001), as well as specific regions of a chromosome involved in human diseases, such
as the Wolfram syndrome, leading to the identification of novel genes (DeSilva et ah,
2002), and regulatory regions (Wasserman et ah, 2000; Pennacchio and Rubin, 2001;
Dermitzakis and Clark, 2002). For example, Loots and co-authors (2000) reported
that comparison between sequences of approximately 1 Mb from human and mouse
allowed the identification of regions of at least 100 bp with percentage of identity
higher than 70% (Loots et ah, 2000). Analysis of 15 of these sequences showed that
70% were conserved in mammals and characterisation of the largest conserved non-
63
Chapter 1 Introduction
coding sequence in transgenic mice showed that it controlled the expression of three
genes (Loots et ah, 2000). In another study, an analysis of individual TFBSs,
Wasserman and colleagues (2000) showed that 74 out of 75 experimentally defined
binding sites were located in the 19% of the human sequences that are the most
conserved in the mouse orthologous sequence (Wasserman et ah, 2000). Similarly,
by combining searches of TFBSs in TRANSFAC with comparative analysis of
sequences from human and mouse, Levy and Hannenhalli (2002) found that although
only half of the 481 TFBSs were found in non-coding sequences conserved in
mouse, the predictive power was increased by a up to three-fold factor using
evolutionary conservation (Levy and Hannenhalli, 2002). Another more elaborate
approach attempted to distinguish between functional and neutrally evolving non-
coding sequences, based on sequences features (Elnitski et ah, 2003). Percentage
identity plots of aligned sequences and other tools have also enabled clearer
visualisation, such 'PipTools' (Schwartz et al., 2000; Elnitski et ah, 2002), Alfresco
(Jareborg and Durbin, 2000) and VISTA (Mayor et ah, 2000; Loots et ah, 2002).
The main difficulty in the comparative analysis of long non-coding sequences
is the detection of weak similarities. Several programs have been developed to solve
this problem: MUMmer (Delcher et ah, 2002), Bayes Block Aligner (Zhu et ah,
1998), BLASTZ (Schwartz et ah, 2003b), and LAGAN (Brudno et ah, 2003). For
example, Bayes Block Aligner identifies colinear conserved blocks separated by non-
conserved sequences of certain length and identifies blocks with identity > 60%. This
method was used to show that the 100 bp upstream of the gene start site was
conserved in 70% of the gene pairs (Jareborg et ah, 1999). LAGAN identifies
conserved sequences by joining together very sensitive local alignments constructed
based on multiple inexact words (Brudno et ah, 2003).
Bioinformatics approaches are rapidly evolving in pace with the increase in
genome sequence and annotation. The work presented in chapter 4 aimed to annotate
regulatory elements of genes in the 4p region linked to psychoses. The protocol
presented was designed in 2002 and combined the three types of computational
approach for predicting regulatory elements: comparative genomics, prediction of
known TFBSs and identification of over-represented motifs. This protocol was tested
on a set of genes for which functional TFBSs were available publicly (Dermitzakis
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and Clark, 2002). First, human repeat-masked non-coding upstream regions of the
test genes were searched against upstream regions of mouse genes. Conserved
sequences were then scanned for known TFBSs in TRANSFAC, and over-presented
motifs were predicted using programs implementing the enumerative oligo-counting
approach and programs based on sequence alignment. Accuracy of the protocol was
assessed by determining its ability to predict motifs that match TFBS. In view of the
results of this work, a purely comparative genomics approach was used to identify
non-coding regions conserved in several vertebrates species.
1.8.2 Multiple species comparative genomics
It has recently been suggested that 5% of the mammalian genome is under
selective constraint (Waterston et ah, 2002), while a substantial proportion of the
conservation between human and rodents includes neutral sequences that may not
have diverged yet (Rat Genome Sequencing Project Consortium, 2004). Comparing
genomic sequences from more than two species has the advantage over studying two
species of reducing the amount of conserved neutral sequences, as divergence
eliminates these sequences differently in each species and lineage (Duret and Bucher,
1997; Thomas et ah, 2003). Various multiple alignments programs have recently
been published, such as MultiPipMaker (Schwartz et ah, 2003a), MAVID (Bray and
Pachter, 2004), and MLAGAN (Brudno et ah, 2003), which should allow for a
sensitive detection of conserved functional non-coding sequences (Frazer et ah,
2003; Nobrega and Pennacchio, 2004). Methods for scoring sequence conservation
in multiple alignments have ranged from simple schemes (Tagle et ah, 1988;
Nobrega et ah, 2003; Chapman et ah, 2004) to more sophisticated ones (Sumiyama et
ah, 2001; Elnitski et ah, 2003) and performed with sequences from many species
(Margulies et ah, 2003; Thomas et ah, 2003; Chapman et ah, 2004).
The human 'dachshund homolog V (DACH1) gene, for example, is located in
a gene desert and is involved in the development of brain, limbs and sensory organs,
and seems to lack upstream control regions (Caubit et ah, 1999; Davis et ah, 1999;
Machon et ah, 2002). Phylogenetic footprinting was applied to human and mouse
sequences of approximately 2.6 Mb to identify enhancers for the human DACH1
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gene (Nobrega et al., 2003). Out of approximately 1000 sequences at least 100 bp
conserved in human and mouse, 32 remained after including sequences from frog,
zebrafish and two species of pufferfish. Out of these, nine were tested in mouse
transgenic reporter gene assays, and seven reproduced the expression pattern of the
endogenous DACH1. The linear relationship of the newly discovered regulatory
elements was also conserved in all species tested (Nobrega et ah, 2003). In addition,
Gottgens and colleagues (2000) identified a neural enhancer of the T-cell acute
lymphocyte leukemia 1 {TALI) gene which encodes a transcription factor involved in
hemopoiesis and vasculogenesis, by i) comparing human, mouse and chicken
sequences, ii) identifying a conserved sequence with no previously known function,
and iii) showing in a transgenic Xenopus reporter assay that this sequence was
functional (Gottgens et al., 2000). Follow-up studies identified additional important
regulatory regions using sequences from zebrafish and pufferfish (Gottgens et al.,
2002), and dog and rat, showing the advantage of multiple species over pairwise
sequences analysis (Chapman et al., 2004). Furthermore, a recent study using
alignments of sequences of the CFTR region from 12 vertebrate species showed that
human functional sequences are best identified by considering a wide range of
mammalian sequences (Thomas et al., 2003). However, for most genes in
vertebrates, the readily available genomic sequence is restricted to human
(International Human Genome Sequencing Consortium, 2001), dog {cams vulgaris)
(Kirkness et al., 2003), mouse {Mus musculus) (Waterston et al., 2002), rat {Rattus
norvegicus) (Rat Genome Sequencing Project Consortium, 2004), chicken {Galius
gallus) (Hillier et al., 2004), zebrafish {Danio Rerio) (http://www.zfin.org), and two
species of pufferfish; T. rubripes (Aparicio et al., 2002) and Tetraodon nigroviridis
(Crollius et al., 2000). The accuracy of multiple species comparative genomics has
usually been assessed in terms of its ability to detect exons (Margulies et al., 2003)
since a recurring problem in the prediction of non-protein-coding sequences is the





The aims of this research were to develop and use computational tools to
facilitate the characterisation of candidate genes in the 4p 15-16 region linked to
psychosis. Specifically, the aims were:
• the development of a computational tool to assist ongoing laboratory
work by allowing association data management and analysis,
• the in silico determination ofputative functional non-coding sequences,
• the identification of SNPs located in these regions which are candidate
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2 Material and methods
2.1 Allelic association data
Data were managed in an ACeDB database (http://www.acedb.org). The CGI
script was written in Perl and uses the CGI.pm Perl5 library
(http://stein,cshl.org/WWW/software/CGI/cgi_docs .html).
2.2 Combination of human-mouse comparative genomics
with sequence motif prediction
2.2.1 Protocol
A schema describing the protocol is shown in figure 2.1. Repeats in human
sequences containing known functional cis- regulatory elements and upstream
sequences of known genes in mouse were masked using RepeatMasker (Smit and
Green, unpublished). Repeat-masked human sequences were searched against repeat-
masked mouse sequences. Human sequences conserved in mouse were selected
based on the percentage of identity and length of the alignment. Non-conserved
functional cA-elements were not considered further. Known Transcription Factor
Binding Sites (TFBS) were predicted on the selected conserved regions of the human
sequences by searching TRANSFAC by using the tfscan program
(http://www.emboss.org). Selected conserved regions of the human sequences
matched by at least four mouse sequences were used together with the matching
mouse regions to predict novel motifs using four motif prediction programs.
Location of the conserved functional cA-elements was then compared to that of
predicted motifs to determine which of these cA-elements were identified by
predicted motifs. Accuracy was assessed for each motif prediction program as well
as for a series of flexible combinations of these programs.
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Figure 2.1: Prediction of regulatory motifs using human-mouse comparative
genomics and prediction of known and novel sequence motifs. The repeat-masked
human sequence containing functional cis- regulatory elements, that is a region (open
rectangle) and sequence motifs (square, disc, circle and triangle within the open
rectangle), is searched against sequences upstream of known genes in mouse. Hits
are mapped onto the human sequences to identify conserved sequences. Conserved
sequences are searched for known Transcription Factor Binding Sites from the
TRANSFAC database. The sub set of conserved sequences matched by at least four
hits is used to predict novel motifs. Accuracy of detection is then assessed by
comparing the location of the predicted motifs to that of the conserved known
functional cw-elements.
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2.2.2 Sequence data
2.2.2.1 Human sequences
Human genes were chosen from sets available publicly (Dermitzakis and
Clark, 2002). These genes were selected on the basis of experimental identification
of functional regions in promoter sequences. These functional regions were derived
based on direct experimental confirmation of binding ability (footprinting, gel shift
assay) and function (promoter deletion experiments, directed mutagenesis,
expression of reporter genes) (Dermitzakis and Clark, 2002). Two types of functional
cw-elements were considered: i) 'regulatory regions', which are required for the
activity of the promoter, and ii) 'regulatory motifs', which are shorter sequences,
such as TFBS. The list of 28 genes selected is shown in Table 4.1.
2.2.2.2 Mouse sequences
Regions spanning 2 Kb upstream of the translation start site of known genes
and genes predicted by ab initio gene prediction programs supported by similarity to
Expressed Sequence Tags and/or protein sequences, were retrieved from the Ensembl
web site using the EnsMart tool available on this site (Clamp et ah, 2003). Flanking
sequences were retrieved for 13 591 genes from the mouse genome assembly 12.3.1
(as in March 2003).
2.2.3 Conservation of human sequences in mouse
Human sequences were each searched against the set of upstream regions of
genes in the mouse genome using LAGAN (Brudno et ah, 2003) with the default
parameters. Human sequences longer than 50 bp and sharing more than 65% identity
with mouse sequences were selected for further analysis. These sequences are
hereafter referred to as 'CSSs' (for 'Conserved Sub-Sequence with single mouse
sequence').
Evolutionary conservation of each human functional cz's-element was
analysed by comparing the location of the cA-element to that of human conserved
sequences (i.e. 'CSSs'). Conservation was defined based on the proportion of the
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length of the cA-element overlapped by the selected human conserved sequence.
Each czs-element which was overlapped by a conserved sequence by at least 50% of
its length was considered conserved between human and mouse.
2.2.4 Prediction of known and novel motifs
2.2.4.1 Prediction of known transcription factor binding sites
Known TFBSs were identified in conserved human sequences by searching
the TRANSFAC 'vertebrate' database using the EMBOSS tool tfscan
(http://www.emboss.org), not allowing mismatches. Predicted motifs known in
human, mouse and rat, and at least 6 bp long were considered in the analysis.
2.2.4.2 Prediction of novel motifs
Conserved human sequences were separated into two classes according to the
number of regions they matched in the set ofmouse sequences (Figure 2.1). The first
class contained conserved human sequences matched by less than four mouse
sequences. The second class contained conserved human sequences matched by at
least four mouse sequences. For each human sequence in the second class, a set of
sequences was created that contained the human conserved region and mouse regions
that matched this human region. In each set of human and mouse sequences,
redundant mouse sequences were identified as sharing a percentage of identity higher
than 80%. Such redundant mouse sequences were removed from each set. Sets of
sequences were thereby created that contained the human conserved sequence and
the selected mouse sequences matching the human region. These sets of sequences
are referred to as 'CSSm' (for 'Conserved Sub-Sequence with multiple sequences')
hereafter. These sets were used to predict novel motifs using the following programs:
AlignACE, based on Gibbs sampling (Hughes et al., 2000), MEME, based on
Expectation-Maximisation (Bailey and Ellcan, 1994), and Oligo-analysis (van Helden
et al., 1998) and Dyad-analysis (van Helden et al., 2000) which both implement the
oligo-counting method. MEME was ran in 'oops' mode. Oligo-analysis was set to
predict motifs of 6 bp. Dyad-analysis was set to identify motif with a spacer of length
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varying from 0 to 20. Selection thresholds used for these four programs were: i) a
minimum score of 10 for motifs predicted by AlignACE, ii) an e-value less than 10"3
for motifs predicted by MEME, and iii) a score higher than 3 for motifs predicted by
Oligo- and Dyad-analysis.
2.2.5 Detection of conserved functional cis-elements
2.2.5.1 Individual prediction methods
Known and novel motifs were predicted on sequence regions conserved
between human and mouse. Known functional cE-elements not conserved between
human and mouse were therefore not considered further and only those that were
conserved between human and mouse were included in this analysis. Identification of
conserved known functional cA-elements by known and novel predicted motifs was
assessed by comparing the location of these cA-elements to that of each motif
predicted on the conserved human region containing these cA-elements. A conserved
element was considered to be identified by a predicted motif if the length of the
overlap of the cA-element by the predicted motif was greater than 50% of the length
of the ens-element. Individual prediction methods were compared based on this
information.
2.2.5.2 Flexible combinations of motif prediction methods
For each conserved human sequence, regions matched by one or several
motifs predicted by one or more prediction programs were identified. Clusters of
predicted motifs were defined as a set of overlapping predicted motifs. The region on
the conserved human sequence corresponding to each cluster of motifs was defined
as the segment overlapped by this cluster. Clusters of overlapping motifs each
contained motifs predicted by one or more prediction programs. These clusters were
classified based on the number of programs which predicted these overlapping
motifs, i.e. clusters made of motifs predicted by only one program, clusters made of
motifs predicted by any two programs and so on.
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2.2.5.3 Accuracy of detection of known functional c/s-elements
Each predicted motifwas classified as a True Positive (TP) if at least 50% of
its length overlapped known functional c/s-elements, and as a False Positive (FP)
otherwise. Each known functional cz's-element was classified as a False Negative
(FN) unless 50% or more of its length was overlapped by predicted motifs. Each
known non-functional sequence was classified as True Negative (TN) if less than
50% of its length was overlapped by predicted motifs. Sensitivity (SS) was measured
as the ratio of the number of conserved functional cw-elements identified to the total
number of conserved functional cA-elements (SS = TP / (TP + FN)). Specificity (SP)
was computed as the percentage of true negatives correctly predicted (SP = TN / (FP
+ TN)). The positive predictive value (PPV) was computed as the proportion of
predicted motifs that identified known functional m-elements (PPV = TP / (TP +
FP)).
2.3 Evaluation of scoring schemes formultiple species
comparative genomics
2.3.1 Sequence data
Fluman genes were chosen from a publicly available set of genes known to
have one or more experimentally verified regulatory regions (Elnitski et al., 2003)
situated within the 2 Kb region upstream of the transcription start site of the gene.
For each human gene, its orthologs in mouse, rat, chicken, zebrafish and pufferfish T.
rubripes (referred to as 'fugu' hereafter) were identified using the Ensembl web site
(http://www.ensembl.org and http://pre.ensembl.org/Galllus_gallus, as in April 2004)
by curating reciprocal best BLAST hits reported by Ensembl (Clamp et ah, 2003)
and generated manually by searches using the Ensembl online blast tool. For each set
of orthologs, conflicting data, often due to the presence of paralogs and incorrect
annotation, was resolved by manually inspecting the extent of synteny conservation.
Genomic sequences used in the analysis comprised of the gene sequences and their 2
Kb flanking regions. These sequences and their annotation were obtained from
Ensembl (Clamp et ah, 2003). Four sets of sequences were studied. First, the 'HMR'
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set consisted of each human gene and its orthologs in both mouse and rat ('HMR'
stands for 'Human-Mouse-Rat'), and contained 40 such groups of orthologs. Second,
the 'HMRC' set consisted of the human genes and their orthologs in both rodents and
in chicken ('HMRC' stands for 'Human-Mouse-Rat-Chicken'), and contained 22
groups of orthologs. Third, the 'HMRZF' set consisted of the human genes and their
orthologs in both rodents, and in zebrafish and fugu ('HMRZF' stands for 'Human-
Mouse-Rat-Zebrafish-Fugu'), and contained 19 groups of orthologs. The fourth set,
'HMRCZF', consisted of the human genes and their orthologs in both rodents,
chicken, zebrafish and fugu ('HMRCZF' stands for 'Human-Mpuse-Rat-Chicken-
Zebrafish-Fugu'), and contained 11 sets of orthologs.
2.3.2 Measure of neutral evolution
For each human gene, rates of synonymous substitution, dS, were computed
by maximum-likelihood relative to each non-human species using the program
codeml from the PAML package (Yang, 1997) based on multiple alignments of the
coding sequence from the species considered in the analysis. Gaps from multiple
alignments of protein sequences built using CLUSTALW (Thompson et al., 1994)
were propagated to coding DNA sequences.
2.3.3 Multiple alignment of genomic sequences
Multiple alignments of the genomic sequences were built using MLAGAN
(Brudno et ah, 2003) with repeat-masking by RepeatMasker (Smit and Green,
unpublished). MLAGAN is a global multiple alignment tool based on LAGAN
which is an anchored global pairwise alignment program that detects the best global
alignment by joining an ordered set of local alignments between two sequences.
LAGAN uses the CHAOS program to generate local alignments. CHAOS is a highly
sensitive method that identifies local alignments based on multiple short inexact
words, rather than longer exact words (Brudno et al., 2003).
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2.3.4 Scoring systems
2.3.4.1 Principle
Multiple alignments were scanned using a sliding window to compute the
pairwise percentages of identity between the human sequence and each of the non-
human sequences. These were used to derived a score for each window. Four scoring
systems were compared, which are described in the following two paragraphs. Three
values were used for the window length: 20 bp, 40 bp, 100 bp, sliding by 10 bp, 20
bp and 20 bp, respectively.
2.3.4.2 Scoring schemes using weighted percentage of identity
The first system was the simple mean of the non-human species' pairwise
percentage of identity to the human sequence. The second and third systems involved
weighting the pairwise percentage of identity to the human sequence. The second
system was based on a simple weight reflecting the relative evolutionary distances
between human and the other species, that is 1 for the rodent sequences, 3 for the
chicken sequences and 4.5 for the fish sequences, since the evolutionary distance
between human and rodent is approximately 100 millions years, that between human
and chicken is approximately 300 millions years and that between human and fish is
approximately 450 millions years. For the third measure, the weight was the estimate
of synonymous substitutions, dS, for each species, or 1 if dS was greater than 1.
2.3.4.3 Scoring scheme based on the rate of neutral evolution
The fourth scoring system used binomial probabilities. Such a scoring system
was recently shown to perform well on multiple mammalian sequences (Margulies et
al., 2003). This scoring system involves computing the probability of observing the
calculated pairwise percentage of identity given the estimate of the rate of neutral
evolution, dS, of the gene in the species being compared to human. The score
assigned to each window for a given pair of species is the cumulative binomial
probability of observing at least as many sites containing identical nucleotides as
counted, given dS for the species compared to human. When dS was greater than
one, the probability of the two nucleotides at a site being identical was set to 0.25.
Otherwise, this probability was the sum of the probability that no substitution
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occurred (1-dS) added to the probability that a substitution occurred (dS) multiplied
by the probability that the substituted nucleotide is identical to the nucleotide in
human (0.25) hence (l-dS)+(0.25*dS), or l-3dS/4. The score for each clade was
computed by averaging over the species in the given clade. For each scoring system
the window's final score was obtained by averaging over clades (Margulies et ah,
2003). The highest scoring windows were selected until the total length of sequence
included in the selected windows reached the proportion of coding sequence in the
human sequence analysed. This threshold was therefore specific to each human
sequence considered. Conserved segments were then identified by determining the
boundaries of the regions covered by the selected windows.
2.3.5 Accuracy of detection of known regulatory regions
To assess the accuracy of the detection of known coding and regulatory
regions, positive sites were defined as bases in the coding and regulatory regions and
negative sites were the remaining bases. The accuracy of each prediction method was
assessed at the nucleotide level by counting the number of true positives (TP), true
negatives (TN), false positives (FP) and false negatives (FN). Sensitivity (SS =
TP/(TP+FN)), specificity (SP = TN/(TN+FP)) and positive predictive probability
(PPV = TP/(TP+FP)) were then derived. Since the sequences examined are likely to
contain unknown regulatory sequences, these estimates should be regarded as
conservative.
2.3.6 Sequence conservation in dog, opossum and frog
Whole genome shotgun read sequences for the dog (Canis familiaris), gray
short-tailed opossum (Monodelphis domestica) and western clawed frog (Xenopus
tropicalis) were obtained from the Ensembl Trace server (http://trace.ensembl.org as
in March 2004). Human sequences larger than 40 bp were searched against the
sequences of these four species using BLAST (Altschul et al., 1990). Sub-sequences
conserved in the dog, opossum and frog were inferred by defining the regions on the
query sequences that were matched by at least one shotgun read. The quality of the
conservation of the sub-sequences was measured using their score density
(score/length) which was computed for each conserved sub-sequence by calculating
the mean score-density over the overlapping hits constituting the conserved sub¬
sequence.
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2.4 Comparative analysis of genes in a chromosomal region
linked to psychosis
2.4.1 Sequence data
Genes in human chromosome 4p 15-16 region linked to psychosis were
selected based on the annotation from Ensembl. Only known genes were analysed.
These genes corresponded to ab initio prediction supported by expression data
(Clamp et ah, 2003). For each human gene, its orthologs in mouse, rat, chicken,
zebrafish and fugu were identified using the Ensembl web site
(http://www.ensembl.org and http://pre.ensembl.org/Gallus_gallus, as in April 2004)
as described in section 2.3.1. Genomic sequences used in the analysis comprised of
the gene sequences and their 10 Kb flanking regions. These sequences and their
annotation were obtained from Ensembl (Clamp et ah, 2003). Several sets of
sequences were considered depending on the species in which orthologs could be
identified (see section 2.3.1).
2.4.2 Analysis
Rates of synonymous substitution were computed as described above (section
2.5.2). For each human gene, the sequence and that of the orthologs from the
different species were aligned using MLAGAN as described in section 2.3.3.
Multiple alignments were then scanned and scored, and highly conserved regions
were identified using the scoring scheme based on the probability of the observed
level of conservation given the rate of neutral evolution (see section 2.3.4). Accuracy
of detection of known coding sequences was assessed in terms of sensitivity,
specificity and positive predictive value (as in section 2.3.5).
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3 Allelic association datamanagement
3.1 Introduction
The large-scale case-control association study of the 4p 15-16 region aimed to
narrow down the large linkage region and to test specific candidate genes. This
approach was expected to include approximately 400 individual DNAs for each
disease phenotype and 400 individual DNAs from controls, genotyped at hundreds of
SNPs and microsatellites. When the thesis project presented here began, a
methodology was being developed in the laboratory by S. LeHellard to cope with the
large number of markers and samples to be tested. The protocol tested aimed at
genotyping markers in pooled samples of DNA from cases or control individuals,
and performing rigorous comparisons of allele frequencies in pooled DNA limiting
labour and cost. Markers showing association to the phenotype tested would then be
typed in individuals to perform classical case-control association studies. Three
genotyping methods were tested by S. LeHellard to type pooled DNA at SNP loci:
primer extension followed by allele detection using either dHPLC or mass
spectrometry, and SNaPshot (Le Hellard et al., 2002). This chapter provides brief
information on the above-mentioned methodology that is necessary to understand the
following description of the computational tool developed to manage data generated
by association studies based on pooled DNA and individual genotypes.
Inferring allele frequencies from pooled DNA is hindered by experimental
difficulties inherent to DNA pooling. Techniques used to distinguish alleles
according to the size of the corresponding PCR products generate data in the form of
peaks. In the typical output of SNP genotyping, the two alleles are represented by
two peaks (figure 3.1a). In a pool, the size of each peak is measured by its area or
height and positively correlates with the number of alleles in the sample
corresponding to that peak. In an ideal situation, both alleles of a heterozygote are
amplified equally (figure 3.1a) and allele frequencies can be derived directly (figure
3.1b). However, due to features inherent to genotyping methods, alleles of a locus are
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not amplified with the same efficiency. It follows that the two peaks generated by the
genotyping of a heterozygote, which contains one copy of each allele, have a
different size (figure 3.1c). The phenomenon is known as 'unequal allele
amplification' and needs to be accounted for to infer allele frequencies in pooled
DNA (figure 3.Id). The principles of allelic association studies based on pooled
DNA are to: i) measure peak heights obtained for a series of heterozygotes, hence for
known allele numbers and frequencies, ii) compute the correction factor for unequal
allelic amplification, which is the mean ratio of peak heights over the several
heterozygotes ('k' in figure 3.1c), iii) correct peak heights obtained for pooled DNA
for unequal allelic amplification, iv) derive allele frequencies and numbers in pooled
DNA (figure 3.1) and v) use these estimates in the x2 test to assess whether alleles at
the locus typed are associated to the phenotype tested (Barcellos et ah, 1997; Risch
and Teng, 1998). For each marker, unequal allele amplification was measured in-
house by genotyping several heterozygotes and performing several replicates for
each individuals. The ratio of the peak height observed for each allele was then
derived. This ratio was found to vary between replicates of individual heterozygotes
and between different heterozygote individuals (Le Hellard et ah, 2002). Estimating
frequencies from peak heights was therefore likely to introduce a non-negligible
error. However, the mean peak height ratio for unequal amplification could be
accurately measured for any given SNP typed deriving a correction factor, k. This
correction factor was used to infer allele frequencies from the reported allele peak
heights for SNPs typed in pools, allowing comparison of allele frequencies between
pools of DNA (Le Hellard et al., 2002). Genotyping hundreds of markers in DNA
pools or hundreds of individual samples generates a large amount of data. This
research project therefore required an easily accessible database to store and analyse
association data. The next section considers the suitability of available technologies
in this context and describes the issues that influenced the design of the tool
developed to allow the management of association data in our laboratory.
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Figure 3.1: Determination of allele frequencies at a SNP locus in pooled
DNA. Graphs represent peaks obtained by genotyping a heterozygote and pooled
DNA at a locus with alleles A and B. In an ideal situation, both alleles of a
heterozygote are amplified equally (a) and allele frequencies in pooled DNA can be
derived directly (b). In practice, both alleles are not amplified with the same
efficiency (c) and peak heights obtained by genotyping pooled DNA must be
corrected prior to deriving allele frequencies. In the example shown in (d),
amplification of allele B is more efficient than that of allele A. It follows that the
peak height observed for allele B must be reduced by a factor proportional to the
difference in the efficiency of the amplification of the two alleles to account for this
phenomenon. This factor is taken as the ratio of peak heights obtained for
heterozygotes: the correction factor k. H: peak height obtained by genotyping a
heterozygote when alleles are amplified equally; Ha: peak height obtained for allele
A; Hb: peak height obtained for allele B; k: ratio of peak heights obtained for a
heterozygote; Hbc: peak height obtained for allele B, corrected for the better
amplification of allele B compared to that of allele A; Freq(A): frequency of allele a
in pooled DNA.
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3.2 Choice and design of the database and interface
3.2.1 Database and interface requirements
The computational tool had a two-fold aim. It aimed to enable: i) the storage
of raw and processed association data, using a database, and ii) the submission and
analysis of raw association data, using an interface to the database.
Several types of data required storage:
• the individual samples, groups of individual samples with the same
phenotype (e.g. bipolar affective disorder, unipolar depression,
schizophrenia or control), heterozygote references and pools ofDNA,
• the combination of information on several samples of individual DNAs,
or DNA pools,
• the markers tested and protocols for genotyping assays,
• the results of the genotyping assays of individual samples and DNA
pools,
• allele frequencies in DNA pools, which are derived from peak heights,
and in sets of individual DNAs,
• the tests for allelic association of the alleles at the loci tested with the
phenotypes under scrutiny.
The interface to the database aimed to:
• compute allele frequencies in sets of individual DNAs and in DNA pools,
• perform tests of allelic association based on individual genotypes or DNA
pools,
• integrate these data to the annotated sequence of the candidate region,
• be user-friendly and hence accessible to any bench scientist involved in
the project,
• reduce the need for direct access to the data by users in order to prevent
erroneous manipulation of data,
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• be flexible to allow: i) decisions by the user to validate the data submitted
and analysed, ii) re-submission of data necessary to cope with technical
difficulties inherent to large-scale genotyping, and iii) addition of
protocols for genotyping assays not yet developed.
The approach developed to solve the problem caused by the wealth of data
generated by association studies consisted of modifying the ACeDB database
(http://www.acedb.org) to store the information generated, and of creating a CGI
front-end to submit, analyse and format these data.
3.2.2 Database choice and design
3.2.2.1 Database choice
The ACeDB database engine is an object-oriented system capable of storing,
retrieving and displaying complex biological information (Walsh et al., 1998; Kelley,
2000). The term 'ACeDB' stands for 'A Caenorhabditis elegans DataBase' and
reflects the original role of ACeDB in the C. elegans sequencing project, namely the
coordination of the sequencing effort and the integration of the worm sequence with
the genetic and physical maps (Waterston and Sulston, 1995). ACeDB is now used in
WormBase, an extension of the C. elegans sequencing project (Stein et al., 2001;
Chen et al., 2005). Several technologies allow direct access to biological databases.
Relational databases such as SyBase (Kirkwood, 2000), Oracle (Mishra and
Beaulieu, 2002), and MySQL (Dubois, 1999) enable software programs to consult
remote databases using structured query language (SQL) and retrieve the results.
These application programming interfaces (APIs) can usually be used for databases
from different commercial sources and are operating system independent. However,
in such relational databases, a DNA sequence and the data associated with it are
scattered among many tables for the sake of efficiency, rendering the design of the
database large and difficult (Stein and Thierry-Mieg, 1998). A standard to share data
objects across the Internet provided by the Common Object Request Broker
Architecture (CORBA) solves this problem (Orfali and Harkey, 1998). However,
standardised biological data types for CORBA have been difficult to define and the
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development of interfaces based on CORBA is complicated (Stein and Thierry-Mieg,
1998). In contrast, ACEDB does not fragment the biological object and provides
simple queries searches, and allows complex queries using the powerful retrieval
query language ACEDB Query Language (AQL), similar to SQL
(http://www.acedb.org/Software/whelp/AQL/).
Storage of sequences, gene structure, genome features and corresponding
annotations has recently become available by using Ensembl (Hubbard et al., 2002)
and the University of California at Santa Cruz (UCSC) genome browser (Karolchik
et al., 2003). However these tools were not readily available at the time when this
project started. In addition, these tools do not provide storage for textual data
necessary for manual annotation (Searle et al., 2004).
On the other hand, ACeDB provides intuitive object oriented modelling of
biological data designed specifically for handling scientific data flexibly, and a
graphical user interface with many displays and tools for genomic data such as a
genetic map viewer and a sequence annotation display (Walsh et al., 1998; Kelley,
2000). ACeDB has been adapted by multiple groups for use with various organisms,
including the human sequencing projects at the Sanger Centre and the Washington
University Genome Sequencing Center (Waterston and Sulston, 1998), the budding
yeast genome project, SGD (Cherry et al., 1998), the nematode Pristionchus
pacificus (Srinivasan et al., 2004), several crop plant and livestock genome analysis
projects (Wixon, 2000), and other organisms such as the rice blast fungus
Magnaporthe grisea (Martin et al., 2002), bacteria (Bergh and Cole, 1994), and
trypanosomes (Degrave et al., 1997; Blackwell and Melville, 1999). Several other
applications based on ACeDB have been developed for various biological studies,
such as sequence motifs in the Helicobacter pylori genome (Saunders et al., 1998),
neurotoxins (Lebeda, 2004), receptors (Nakata et al., 1999), ATP-binding cassette
(ABC) protein domains (Quentin and Fichant, 2000), specific enzymes (Cousin et al.,
1998), cell signalling (Igarashi and Kaminuma, 1997; Takai-Igarashi et al., 1998),
gene expression in human (Miller et al., 1997) and in Xenopus laevis embryos (Pollet
et al., 2000), and paralogous regions in Vertebrate genomes (Leveugle et al., 2003).
A tool has recently been released for the analysis of complex diseases (Burren et al.,
2004).
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Last but not least, our laboratory already used an ACeDB database when the
work presented here started in early 2001 for two purposes: i) to manage the
sequence of the disease susceptibility region on chromosome 4p as BAC clone
sequences were being released by the Human Genome Project annotated, and ii) to
annotate these sequences (Evans et al., 2001). Because it was required that the allelic
association data be stored and integrated with the sequence data and because the
latter was already managed using the ACeDB database specifically designed for this
purpose, it was decided that the tool to develop for the storage of allelic association
data would be build on ACeDB.
3.2.2.2 ACeDB
In ACeDB, a 'model' defines the format of the information content of a
'class'. A class is a group of items (or objects) characterised by the same set of
features (Figure 3.2). A model is represented as a tree which harbours five type of
nodes: i) tags, which are words that must be enumerated in a separate file, ii) basic
data types (integer, float, text), iii) modifiers, to indicate uniqueness of fields by
UNIQUE or REPEAT, and to create links between objects, using XREF, iv) class
names, which contain a '?' as the first character, such as ?Allele, and v) constructed
types names, such as #MACH1NE. Tags can also be leaves in the tree.
An instance of a class, that is an object belonging to that class, matches the
model and is also represented as a tree, containing tags, data items and pointers to
other objects (Figure 3.2). In this object, tags appear in positions set in the model,
data types are conform to those in the model and pointers refer to objects of the class
indicated in the model. An object does not need to match the entire tree specified by
its model, but instead is allowed to match only a subtree in the model. The modifier
XREF is used for automatic cross-referencing between objects. It is followed by the
name of the tag pointed to. Because XREF is not reciprocal, links between objects
can be versatile and two-way double links are specified by XREF in the model of the
two classes linked together. Constructed types allow a recursive specification of data
within a model. Data fields can be of normal data types such as free text, integers and
real numbers, dates, or pointers to other objects in the database.
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Figure 3.2 : Data representation in ACeDB. The top window shows the model
'?Allele' used to store data related to SNP loci, organised as a tree with nodes in
brown and leaves in black. The smaller window on the left shows the model
'?Machine' used store the name of the genotyping machine used in genotyping
assays (tag 'SNaPshot'), themselves stored using in the '?ABIdata' model shown in
the bottom right window. The window at the bottom shows an instance of the
'?Allele' object, 'ih2'. In this object, tags appear in positions set in the model, data
types are conform to those in the model and pointers refer to objects of the class
indicated in the model.
87
Chapter 3 Allelic association data management
ACeDB also provides powerful search tools, such as complex queries using
AQL. In particular, the tace program allows text-based access to the ACeDB
database. This program is a key component of the tool developed here because it
allows queries to be incorporated into scripts for automated consultation of the
database.
3.2.2.3 Design of the ACeDB extension for allelic association data
The allelic association data to be stored related to various components of
association studies, such as markers and experimental conditions of the genotyping
assays, or samples used, as well as raw genotyping results at the level of the
individual samples and groups of samples sharing a common feature, such as disease
status, and finally, results of tests for association with disease. The design of the
database followed naturally from the different types of data to store.
To comply with the settings already existing in the ACeDB database in use to
store information of markers and experimental conditions of genotyping assays, it
was decided that microsatellite data would be stored in 'STS' objects, while SNP
data would be described by 'Allele' objects (Figure 3.2). For both types of locus,
these objects would also contain information relating to genotyping assays for
individual samples and pooled DNA. However, because the type of data on
genotyping assays are similar for both types of marker, and for the different
genotyping machines, the data would be stored in a novel constructed type common
to both types of markers, such as '#Machine' and '#ABIdata' but accessed from
models for both types of markers, 'STS' and 'Allele' (Figure 3.2).
As for samples, three novel models would be used: i) '?Individual', for
individuals, ii) '?Pop_pooT, for groups of individual samples and for pooled DNA,
and iii) '?Pop_pool_meta', for groups of population samples or groups of DNA
pools. Individual samples are distinguished from other types of sample because they
are entities different from a 'population' or a pool. On the other hand, a population
sample and a pool sample would be described in the same manner because they both
comprise individuals and their description would for example include the list of
individual samples they contain, although they are distinguished in a population
sample, but not in a DNA pool. This would be indicated in an '?Individual' object by
a pointer after the tag 'Gridded', to a '?Grid' object, which shows the position of
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individual samples in 96-well plates for an individual sample used in a population
sample, but not for an individual in a pool of DNA. Similarly, a 'meta' sample made
of several population sub samples can be described with the same terms as a 'meta'
sample made of several pooled DNA sub samples, so both 'meta' would be stored in
a 'Pop-pool-meta' object.
Genotypes of individual samples would be stored in the ?Individual model,
while a novel model '?Stat_des', for 'statistical description' would store raw
genotyping results for both population and DNA pool sample types, as well as results
from their analysis, including allele and genotype frequencies. To store details of the
analysis, such as a list of peak heights for a given allele obtained for several
replicates of a DNA pool genotyping assay, or a list of derived frequencies used to
compute the single value of the allele frequency average, a novel model
'?List_values' was required. It would store the raw or derived data while excluding
them from the display in the '?Stat_des' objects containing the main results of the
analysis. It would be accessed from the '?Stat_des' object using links to objects of
the '?List_values' class. Finally, results from tests of association of alleles with
phenotype would be stored in a novel model, 'Stat-cmp', for 'Statistical comparison',
indicating which samples are compared at which locus, based on which set of data.
To allow for easy navigation from an object to another, these models would
also provide several links to one another (Figure 3.3). For example, the user would
be able to consult results from an association test, (Figure 3.3,'Stat_cmp', bottom
right) based on two sets of population samples, and use links in the object to navigate
to one of the data sets to consult allele frequencies (Figure 3.3, 'Stat_des' far right),
and continue by following links to the individual samples in the set and obtain their
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3.2.3 Interface choice and design
To facilitate the analysis and the integration of data into the database, an
interface was required. It was decided that this front-end would be developed using
Perl and the Common Gateway Interface (CGI) for four reasons. First, Perl is an
accessible programming language and is widely used in bioinformatics for local data
management, conversation of data format and access to databases (Wall et al., 2000).
Second, CGI allows the creation ofHTML forms and scripting to analyse submitted
information. Third, the combination of Perl and CGI had already been used in
various ACeDB-based projects, such as the WebAce (http://webace.sanger.ac.uk)
and AceBrowser (Stein and Thierry-Mieg, 1998) web interfaces to the ACEDB
database, which both provide basic functionality for searching and navigating
ACeDB databases. Finally, our laboratory already used this strategy and had
developed Perl/CGI scripts to generate forms for the submission of STS data. A
Perl/CGI tool was thus selected to keep the set of tools homogenous and because
support for this project would be available, in contrast to alternative strategies based
on JAVA, or the generation ofHTML pages using PHP.
A CGI script would provide an interface to the novel database and generate
HTML forms, thus achieving three goals. First, these forms avoided direct entry of
data into the database, reducing the risk for erroneous manipulation of existing and
novel data. HTML form fields allowed data to be handled and files created in the
correct format, before being read into the database. As finding errors incorporated in
the database can prove time consuming, it was concluded that integration of novel
data should not be automatic but, instead, verified first by the user. Second, CGI
scripts also enabled the retrieval of data of interest from the database, so that the user
could only choose appropriate data necessary for the description and analysis of the
data submitted. For example, it was important for the sake of reproducibility that
peak height ratio values for a pool typed at a given marker were obtained with the
experimental conditions stored in the database. Third, the major advantage of these
CGI scripts was to allow the analysis of the data submitted. This front-end would
allow the submission of DNA pool data and of individual genotypes using a format
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similar to the tools used by bench scientists. Furthermore, it would also be able to
respond to needs expressed by bench scientists after its initial design. For example,
this occurred when they gained access to a facility for high-throughput genotyping
assays. Results from these assays are generated in the form of an Excel file that
contains data for a dozen of sets of individual samples genotyped at a given marker.
A routine was developed and integrated into the software that parses these files and
analyses each of the sets automatically. In addition, the front-end would be used to
merge DNA pools sets of individual samples into meta samples and analyse the
merged data sets. Last but not least, the user would be able to perform statistical
analyses of allelic association.
The following sections describe the representation of the allelic association
data, as well as the CGI front-end and the ACeDB extension developed to manage
the data. The CGI front-end and the ACeBD extension were developed on a Unix
workstation and on a PC running Windows XP Home.
The interface design involves seven interacting areas, as indicated by blue
ellipses with a white box label in Figure 3.4: i) 'first access', when the user starts a
session, she/he is given the choice between several task, ii) 'parameter verification',
to test the integrity of selected parameters or submitted data, iii) 'manual
submission', to display a form for submission of peak heights, or individual
genotypes, iv) 'database query', to consult the database, for example to verify
submitted parameters and data, v) 'statistical analysis', to treat submitted data and
write file in ACEDB format, vi) 'association study', and vii) 'data integration', to
read created files in the database, and subsequently update related objects if
necessary. Each area consists of several subroutines. Subroutines mediating the
different tasks performed by the interface are highlighted in Figure 3.4, such as
'upload_analysis' for uploading of file generated by high-throughput analysis,
'get_grid' to retrieve the display of the plates used for submission of individual
genotypes and heterozygote reference peak heights, 'group_analysis' to analyse data
from population, pool and meta samples, 'assoc' to perform association studies,
'cgi_ace_read' to read data into the database, or 'update_analysis' to test whether
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3.3 Protocol for the management of allelic association data
3.3.1 Individual samples
Each individual DNA was represented in the database as a distinct entry. The
entry would contain its accession number, disease status and data from studies it was
used in.
3.3.2 Sets of individual samples
In the rest of the chapter the term 'population' refers to a group of individual
samples with the same phenotype, e.g. disease status. In a population, allele
frequencies at any given locus are inferred from the direct counts of alleles in each of
the individuals included in that population. Allele frequency differences between
populations or groups of populations are analysed using the standard x2 test (Sokal
and Rohlf, 1997).
3.3.3 Pooled DNAs
In the rest of the chapter the term 'pool' refers to a pool of DNA from
individual samples with the same phenotype. Inference of allele frequencies at any
given locus in a pool of DNAs requires genotyping a set of heterozygotes at this
locus and measurement of the mean ratio of the height of the peak obtained for each
of the two alleles (Figure 3.1). Peak heights obtained for each heterozygote, their
ratio and results of the analysis of the set of heterozygotes form a data set that is
referred to as 'heterozygote reference' hereafter. These data are used to correct for
unequal allelic amplification and infer allele frequencies in pools. They must
therefore be submitted before peak heights obtained for a DNA pool at a given locus
can be analysed. The genotyping assay of a pool of DNAs should be replicated at
least four times (Le Hellard et al., 2002). Genotyping of pooled DNA at
microsatellite loci is hindered by the number of alleles, and hence peaks to measure,
and by slippage of the polymerase, or 'stutter', typical of microsatellite genotyping.
94
Chapter 3 Allelic association data management
Microsatellite genotyping in pooled DNA is not considered here. The statistical
analysis of data obtained for a DNA pool at a locus includes a set of descriptive
statistics based on the series of replicate values. The mean peak height ratio and
allele frequencies obtained for a pool are characterised by the following statistics:
arithmetic mean, median, standard deviation (SD) of the mean, standard error for the
mean (SEM), coefficient of variation of the mean, and 95% confidence interval (CI)
for the mean or the median. To decide whether the CI should be calculated for the
mean or the median, a test for the normal distribution of the allele peak height ratios
must be performed. Here, the Shapiro-Wilk test for goodness-of-fit to normal
distribution is used (Shapiro and Wilk, 1965). The test has been shown to be a
reliable test for normality (Pearson et al., 1977) and can be used for samples with just
3 and up to 2000 individuals (Royston, 1982). If a normal distribution can be
assumed, the computation of CI then uses the Student statistic. Otherwise, the non-
parametric Wilcoxon test for the symmetry of the dispersion is performed to decide
which of the Sign (asymmetry) or Wilcoxon (symmetry) statistics should be used to
calculate the CI (Sokal and Rohlf, 1997). Allele frequency differences between pools
or samples of pools are analysed using a modified x2 test that accounts for the
variance of the correction factor computed for the heterozygote reference, and for the
variance of allele frequencies derived from replicating the genotyping of pooled
DNAs (Le Hellard et al., 2002).
3.3.4 Meta samples
The extension of the ACeDB database and the CGI front-end developed for
the management of allelic association data also allowed the meta-analysis of data
from several populations, or several DNA pools. Such groups of populations or DNA
pools are referred to as 'meta samples' hereafter.
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3.4 Submission and analysis of allelic association data
The type of task, e.g. submission of pool data, association study, creation of
meta sample, is chosen using a form shown in figure 3.5. Each task is described in
the following sections.
3.4.1 Submission of genotyping data
The submission of the new genotypes for a population, a series of peak
heights for a heterozygote reference or a pool obtained with a given marker uses four
distinct steps: i) selection of parameters to identify the data set to create, ii)
submission of the data to be analysed and stored, iii) analysis of the data and display
of results, and iv) integration of these data and results of analysis into the database.
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http://127 0.0.1/cgi-bin/aceoc.cgi - Microsoft Internet Explorer
Fichier Edition Affichage Favoris Outils ? 3?
Q Precedents * ,J ■ @ 0 f, Rechercher Favoris (J* Media tp
Adresse http://127.CI.0.1/cgi-bin/aceoc.cgi v 0OK
j Please select a task:
j Submit
The write access to the database is not available.
If you are using the database now, drop the write access ifyou have it.
Else, try again later as someone is currently writing to the database.
... genotypes manually [Go]
... genotypes to upload |Go [
... a heterozygote reference | Go |
... pool peak heights |Go |
Or:
... merge populations |GoJ
... merge pools |Go|
Or:
... perform an association study | Go
- Termine tfi Internet
Figure 3.5: CGI form for the selection of task. The first page displayed by the
CGI front-end to the ACeDB database contains two frames. The left frame is used to
select the task to perform, and, later, parameters necessary for the analysis selected.
The right frame is used to display error messages and results of the analysis. For
example, the write access to an ACeDB database is granted to only one database user
a time. The front-end therefore starts by determining whether it is available. If it is
not, the user is warned, as he or she would not be able to read into the database the
results of the analysis performed.
97
Chapter 3 Allelic association data management
3.4.1.1 Identification of data sets
First a CGI form is displayed which requests the submission of the following
compulsory parameters: the names of the user, of the population or pool, of the
marker and of the genotyping platform, and the number of replicates. These data
must be chosen from pull-down lists. Some lists are retrieved from the database
using the tace program, e.g. the name of the populations, heterozygote references,
pools and markers. After verification of the validity of the parameters submitted, any
missing compulsory data is indicated to the user by an error message. Once
parameters are correct, the tace program is used to retrieve the data related to the
marker (name, polymorphism, position) and the experimental conditions used to
obtain data being submitted (genotyping method, name of the
oligonucleotide/primer, size of the alleles, number of replicates). These are then
displayed to allow the user to verify that they correspond to the conditions used to
obtain the current data set (see Figure 3.15 for an example of data stored for a SNP
locus). If all data are correct, the user can then submit them. A CGI form is
subsequently displayed, the format of which depends on whether the data type relates
to a population, heterozygote reference or pool. Analysis of these different data types
produces statistical descriptive values, which are common to all types of data
analysed.
3.4.1.2 Statistical description of allele frequencies
For heterozygote references and pools, the statistical description of submitted
peak height ratios or derived allele frequencies consists of the following statistics:
arithmetic mean, median, standard deviation (SD) of the mean, standard error for the
mean (SEM), coefficient of variation of the mean, and 95% confidence interval (CI)
for the mean or the median. The Shapiro-Wilk test for goodness-of-fit to normality of
the ratios is performed, and the key values and the decision of the test are displayed.
For meta samples of pools, values from each pool are gathered in the single list and
analysed as such (section 3.3.1.6).
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The allele frequencies in a population, heterozygote reference or pool are then
displayed in a table. A file named after the names of the population, reference or pool
and the marker is also created in an appropriate '.ace' format so it can to be read into
the database. If the user wishes to integrate the data into the database, the file is
subsequently read into the database. This causes the creation of a new object in the
class named 'Stat_des' ('statistical description'), which contains the values submitted
and results of their analysis, such as peak height ratios, allele numbers and
frequencies (figure 3.10).
3.4.1.3 Submission of population data
In the laboratory, individual samples are stored in 96-well plates, where a
well contains a single sample. In ACeDB, the content of such a plate is stored in a
'Grid' object (Figure 3.6a). In the case of manual submission of individual
genotypes, once parameters for the identification of a data set linked to the
population are submitted and verified, the CGI script retrieves from the database the
accession number and position of samples in the population selected. This
information is used to display a form that simulates the format of the 96 well plate.
Each well is represented by a pull-down list containing the possible genotypes at the
locus of interest (Figure 3.6b). This allows the submission of individual genotypes
for use in classical association studies.
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a) A population in the ACeDB grid format
%\ Grid pop_CTL1 - ng
pop_CTLl Gridded item:
I"" »°ael na«iu.u
1 2 3 4 5 6 7 8 9 10 11
ft ct1_425 ct1_429-A ct1_681-A ctl_475 ctl_499 ctl_440 Ct1_430 ct1_406 ct1_412 ct1_431 ct1_47
B ctl_605-A ct1_429-B ctl_746 " ct1_423 - ctl_424 ct1_762 ct1_469 ct1_47
C ctl 553 ctl_899 ct1_895 ctl__861 ctl_411 ctl_525 - ct1_797 ct1_858 - ct1_52
D ct1_602 " ctl_609 ct1_897 ctl_590 ctl_661 ctl_747 ctl_801 ct1_810 " ctl_57
E ct1_407 ct1_866 ct1_799 " ctl_710 ct1_403 ctl_516 ctl_526 ct1_559 ct1_578 ct1_59
F Ct1_508 ct1_893 ctl_830 Ctl_719 " ctl_487 Ctl_497 ctl_504 ct1_529 Ct1_505 ctl_48
G ct1_493 ct1_520 ct1_509 ctl_449 ctl 528 ctl_435 ct1_453 ct1_500 ct1_416 - ct1_45
H ct1 498 ctl 502 ctl 501 ctl 486 ctl 450 ctl 496 ctl 503 ctl 489 ctl 494 - ctl 49
b) Form for submission of genotypes for the individuals in the population
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Submit genotypes
Termine Internet
Figure 3.6: Manual submission of individual genotypes. The form simulates
the format of the ACeDB 'Grid' object that stores the location of the individual
samples in the plate used for genotyping assays (a). In the form, each individual
sample is identified by its name (e.g. 'ctl_425' in row A, column 1) and its genotype
is selected from a pull-down list of genotypes possible at the studied locus (b).
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To submit genotypes for several populations obtained via high-throughput
genotyping and stored in an Excel file, the user first selects the file to upload. This
content of the file is then parsed and data for each population are analysed. Results of
each analyses are then displayed (Figure 3.7).
£] http://127 0.0 1/cgi-bin/aceoc .cgi -Miciosoft Internet Exploiei MS
Fichier Edition Affichage Favoris Outite ?
Q PrAcidente » > Rechercher Favoris M6dia ^
Adressv- http://127.0.0.1/cgi-bin/aceoc.cgi -ia
Please select paiameteis to submit the file
Parameter Field








Excel file C:\tmpfys2280204_0302 [ Porcourir... |
upload file
Checking excel file C:\impfis2280204_030227.xls done
The file contams 17 sets.
Dataset.
Name of the population Name of the maikei Nmnbei of valid genotypes
pop_CRF_BPl rs2280204 90
Allele numbers and frequencies















Figure 3.7: Uploading of individual genotypes. The file to upload is selected
using the form in the left frame. Results of the analysis are displayed on the right
frame for each set contained in the uploaded file. These include the numbers and
frequencies of alleles and details of the test for the Hardy-Weinberg equilibrium,
which is used to determine whether the data submitted are valid, as shown here for
the set of genotypes 'pop CRF BPl'.
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3.4.1.4 Submission of heterozygote reference data
Heterozygote reference data are obtained by genotyping a set of individual
samples and recording peak heights. After selection of the locus and genotyping
platform, the form to submit individual genotypes (Figure 3.6b) is used to indicate
which of these individuals are heterozygous at the locus studied. A form similar to
that for the submission of individual genotypes is then displayed for the user to
submit peak heights obtained for these heterozygotes. In this form, the pull-down list
used to select the genotype for each individual is replaced by two text fields, one for
each peak height to submit (Figure 3.8). The peak heights submitted are then
checked. If correct, they are used to compute the correction factor used to analyse
data obtained for pooled DNA at the locus studied.
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Figure 3.8: Submission of peak heights for heterozygote individuals. The
form simulates the format of the plate containing the samples used to detect
heterozygotes. The first column indicates the name of the row in the plate (eg 'row
A'). Each row in the plate is represented by several rows in the form. The first row
indicates the name of the sample (eg '690', '698', ...), while the second row displays
the name of the alleles detected (e.g. 'c' and't'), based on data stored in the database
for the studied locus (tag 'ABI3700', sub-tag 'List_alleles' in Figure 3.15). The
following rows each correspond to one replicate (e.g. 'rep 1', for 'replicate 1'. Here,
the genotyping assay was performed only once). For each individual, a text field is
displayed for each of the two alleles, for the user to indicate the peak height
observed. Text fields for homozygotes contain the default value '0' as these
individuals are not included in the analysis.
102
Chapter 3 Allelic association data management
3.4.1.5 Submission of pooled DNA data
As for individual genotypes, submission of pooled DNA data first requires
the selection of parameters, such as the locus studied, the genotyping platform used
and the number of replicates performed. The correct completion of the form is then
verified. If no error is detected the database is consulted to retrieve the heterozygote
reference for the marker and genotyping platform selected. If no such set can be
found, an error message prompts the user to submit data for a heterozygote reference
prior to submitting pooled DNA peak heights. If several heterozygote references are
found the user selects one of them, via a pull-down list, which is later used to infer
allele frequencies in the pool of DNAs. Figure 3.9 shows the form used to submit
peak heights. The validity of the values submitted is then verified. Allele frequencies
and numbers in the pool ofDNAs are finally derived and displayed in a table (Figure
3.10).
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Figure 3.9: Submission of peak heights obtained for pooled DNA. Peak
heights obtained by typing pooled DNA (e.g. 'poolCTLSLH') at a locus (e.g.
'ihl') using a given genotyping platform (e.g. 'ABI3700') are submitted via the form
displayed in the right frame. Each row represents a replicate and contains a text field
for each of the allele detected with the assay.
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Figure 3.10: Analysis of pooled DNA peak heights. Results of the analysis of
peak heights obtained for a pool of DNAs (e.g. 'pool CTL SLH') at a locus (e.g.
'ih2') with a given genotyping platform (e.g. 'ABI3700'), based on the selected
heterozygote reference, are displayed in four tables. These are shown here in two
screen shots. The first three tables display descriptive statistics of the peak height
ratio and of the frequency of both alleles. The fourth table indicates the frequency
and number of each allele in the pool.
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3.4.1.6 Creation of meta samples
Data sets from several populations or DNA pools can be merged and analysed
as a single data set, referred to as a 'meta sample'. This is necessary, for example,
when an association study has been carried out on several pools of DNA from
individuals of one phenotype, which must be combined before comparison with the
allele frequencies obtained for individuals with a second phenotype. Single data sets
to merge must relate to the same locus and have been obtained with the same
genotyping machine. A form is first displayed for the user to indicate the name of the
novel meta sample and to select the populations or pools to merge. An error message
is displayed if the name is already used, or if a meta sample containing the same
group of populations or pools submitted already exists in the database. If this is not
the case, the database is consulted to identify data sets suitable for merging. Figure
3.11 illustrates the creation ofmeta samples. Meta samples are created by indicating
the name of the meta sample to create and by selecting populations or pools to merge
from a list of populations or pools. The database is then consulted to determine, for
each genotyping platform, the list of markers for which data sets exist for each of the
populations or pools to merge. If suitable data sets are found, these are merged and
analysed as a single set. As shown here for the meta sample of population of patients
affected by BPAD (pop_BPl, pop_BP2, ...) or schizophrenia (pop SCZl,
pop_SCZ2, ...) and for the genotyping platform 'ABI377', no data sets could be
found at SNP loci, but a series of data sets were found for a microsatellite locus and
analysed as a single set (a). If no data sets can be found for any marker with any
platform, the meta sample can still be created, as shown here for a meta sample of
pools of DNAs from patient suffering from unipolar depression (pool_UP), BPAD
(pool_BP) or schizophrenia (SCZ) (b), and updated as data are later submitted (see
section 3.3.1.7). Analysis and integration in the database of these data lead to the
creation of a 'pop_pool_meta' object and of objects for the results of their analysis
(Figure 3.18 and 3.19).
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a) Creation of a 'meta sample' of populations
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b) Creation of a 'meta sample' of pools
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Figure 3.11: Creation ofmeta samples.
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3.4.1.7 Updating meta samples
When individual genotypes or pool data are submitted, analysed and read into
the database, the CGI script determines whether the novel data set can be used to
update meta samples the population or pool is a member of, if any. For each of these
meta samples, the novel data sets are merged with those of the other populations or
pools in the meta sample, and the merged data set thereby created is then analysed
(Figure 3.12).
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Figure 3.12: Update of meta sample. Peak heights obtained for the pool
'pool_UP' at the SNP locus 'ih3' with the genotyping platform 'ABI377' (see left
frame) was submitted, analysed, and read into the database. Prior to submitting these
data, a meta sample of pools, 'mpoolcases' was created (Figure 3.11b), and peak
heights obtained for pools 'poolBP' and 'pool_SCZ' for 'ih3' with platform
'ABI377' were submitted, analysed, and read into the database. After integration of
the data set for 'pool_UP', the database was automatically consulted to identify the
meta samples that 'pool_UP' belongs to, and for each of those, determine data sets
that are also available for the other pools in the meta sample. This search led to the
identification of a data set obtained for 'ih3' with 'ABI377' for all three pools in the
meta sample 'mpool cases'. These data sets were then merged and analysed as a
single set (right frame).
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3.4.2 Allelic association studies
The user selects parameters necessary for the identification of the data set,
such as his or her name, the SNP assayed, and whether the comparison will be done
between populations, pools, or meta samples. The user then chooses the samples to
compare from pull-down lists. These lists were derived by consulting the database to
determine the samples for which data sets are available for the marker and
genotyping platform selected. If the populations, pools or meta samples chosen have
already been compared, the user is informed and given the opportunity to abort the
analysis or change his or her selection. Otherwise, a modified x test is performed on
the allele frequencies. Results are displayed in a table on the screen (figure 3.13) and
an output file is created in the 'ace' format, which is named after the names of each
population, pool or meta sample, marker, and genotyping platform. Data are stored in
the database if the user so wishes after verification of the results. The file contains
the results of the comparison, which will be stored in a database object of the class
'Statcmp' ('statistical comparison', figure 3.21). It also contains information that
will be stored in each object related to the analysis, e.g. the population, pool or meta
sample.
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studies. This figure shows results of
the association studies based on meta
samples of pools 'mpool_ctl' and
'mpool_cases' at the SNP locus 'ih3':
the value of the classical x2 statistic
obtained without correcting for errors
introduced by the use of allele
numbers inferred from pooled DNA
rather than directly counted by
genotyping individual samples, the
value of the modified x2 statistic
accounting for errors introduced by
computing allele numbers in pooled
DNA, the value of the correction
factor used to derive it, and the p-
value associated with these two
statistics.
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3.5 Storage of allelic association studies data
3.5.1 Allelic association data management in ACeDB
Curating allelic association data in the ACeDB database required a adaptation
of the architecture of the database and various models were therefore modified, e.g.
to allow the management of data relating to the markers typed. Also, new models
were created to store data on populations, heterozygote references, pools and meta
samples of populations or pools. Novel models also allowed the storage of results of
the statistical description of the genotyping data for a given population, heterozygote
reference, pool or meta sample with a given marker. Additional novel models
allowed storage of results of the comparison of two populations, two pools or two
meta samples typed at a marker locus.
3.5.2 Main window
The main window is split horizontally in two sections (Figure 3.14). The
upper section is common to ACeDB databases and provides access to tasks available,
such as integration of data from file (Edit button) or consultation of the database
(Query button). The lower section is novel and provides links to four columns of
objects modified or created to manage allelic association data. Clicking on a link
brings a window listing the objects of that type, which can be queried in more detail.
The list of links displayed is configurable.
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in the selected class or in all classes
objects named or related to
Select a class: Other class Selection
STS Individual Stat_des KeySet
Allele Pop_pool Stat_cmp Table
Grid Pop pool meta List values Model
Figure 3.14: Main window of the ACeDB database for allelic association
data. The lower section displays links to frequently consulted classes. The left most
column has links to markers (STS and Allele) and to grids. Grids provide
information on the location of the individual samples on the plates used in
genotyping assays. The second column provides access to the samples: i) individual
samples (Individual), ii) populations and pools (Pop_pool) and iii) 'meta' datasets
that result from the merging of data sets from several populations or pools
(Popjpool_meta). Results of the analysis of genotyping assays of the samples
(population, pool and merged set) and results of association studies can be viewed
via links in the third column. Saved sets of objects (Keyset), results of a previous
query (Table) and the definition of the objects (Models) can be accessed through
links in the fourth column.
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3.5.3 Modified models
The 'STS' and 'Allele' models were modified to store information on
microsatellites and SNPs, respectively (Figure 3.15). With respect to the information
managed, the main difference between these STS and Allele classes resides in the
storage of experimental conditions. However, data on genotyping assays are stored
via a single novel model "Machine" (see below) used for both types of markers.
Also, both models provide links to the populations, pools (see model 'Pop_pooT
below) and meta samples (see model 'Pop_pool_meta' below) that have been typed at
these loci, and the statistical analysis of the results obtained (see models
'List values', 'Stat_des' and 'Stat_comp' below).
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Figure 3.15: Management of SNP data in ACeDB.
Ill
Chapter 3 Allelic association data management
Figure 3.15 shows the data stored for the SNP 'ih3'. Data on SNPs are stored
in 'Allele' objects. This example shows data stored for 'ih3'. The tag 'SNP_assay'
displays data on the genotyping assay of this SNP. In particular, tags 'SNaPshot' and
'ABI3700' concern the assay performed on a 'ABI3700' platform and display the
mean peak height ratio obtained for the heterozygote reference (tag 'Av_ratio'). The
latter is the correction factor, k, used to account for unequal allelic amplification
when inferring allele numbers in pooled DNA. The tag 'assoc_table' displays the list
of populations, pools or meta samples included in association studies for that locus.
Each entry comprises six columns: i) the name of the platform used to obtain allele
numbers (e.g. ABI3700), ii) the name of the first sample (e.g. 'mpool_ctl'), iii) the
accession number of the data set used in this analysis (e.g. '1', or '2', '3', and so on
as more recent data sets are added to the database for that sample, marker and
platform), iv) the name of the second sample (e.g. 'mpool_cases'), v) the accession
number of the data set for this second sample (e.g. '1'), and vi) the link to the
'Stat_cmp' object that stores results of the association study
(mpool_ctl.l_vs_mpool_cases.l_w_ih3.a3700). The tag 'Assoc_snp' and sub-tags to
its right provide links to objects related to the marker 'ih3' such as the object storing
data on the samples, tags 'pop_pool_typed' and 'pop_pool_meta_typed', or results of
their analysis at that locus, tag 'Statistical_des'.
3.5.4 Novel models
3.5.4.1 Genotyping assays
The novel model 'Machine' stores the list of genotyping platforms used in the
laboratory. It displays the experimental conditions used for genotyping samples using
these platforms. This data is stored by the novel model 'ABIdata'. An example of
such data for the genotyping of the SNP 'ih3' on the ABI3700 sequencing machine is
shown in figure 3.15 to the left of the tag 'SNaPshot': tag 'ABI3700'.
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3.5.4.2 Individual samples
The 'Individual' model was created to record which population, pool and
meta sample an individual DNA sample belongs to, with links to these objects and
the Grid object for populations in which the sample is included. This model also
indicates the genotype of the sample at SNPs and microsatellite loci, and provides
links to these markers (Figure 3.16).
Individual: ctl 425 Kya
ctl 425
Attach.. .








216-218 ABI377 set 1
/
Figure 3.16: DNA sample data management in ACeDB. Example of the
sample 'ctl_425' indicating that this individual is heterozygote c-t at SNP 'ih3' and
216-218 at microsatellite 'stD4S1091b', and included in the population of control
samples 'pop_CTLl' and that its DNA was used in the pool 'pool_CTL'.
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3.5.4.3 Populations and pooled DNAs
The 'Pop_pool' model provides links to each of the DNA samples that
constitute the population or pool, the markers that have been typed, the genotyping
results, results of comparison of allele frequencies with those of other pools and
information regarding inclusion of the population or pool in meta samples (Figure
3.17).



















In pool meta ui>ool cases
Pool stat des
IT
Figure 3.17: Management of pooled DNAs in ACeDB. Clicking on the tag
'Pool_indi' displays the list of links to individual samples in the DNA pool. The tag
'snp_assoc' lists the SNP loci for which the pool has been typed. For each of these
markers, the genotyping platform is indicated and a link is provided to the data set
for the heterozygote reference at that locus used to infer allele frequencies in this
pool. The tag 'Pool_stat_des' provides links to data sets for genotyping assays at
these SNP loci. The tag 'Injpool meta' indicates that genotyping results for this pool
have been merged with that for other pools forming the meta sample 'mpool cases'.
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3.5.4.4 Groups of populations or pooled DNAs
The 'Pop_pool_meta' model stores data on the sets of populations or pools
combined; the markers typed on the items, the statistical description of the merged
data sets, and information on the comparison of allele frequencies with those of other
populations, pools, or meta samples (Figure 3.18).
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Figure 3.18: Management of meta sample of DNA pools in ACeDB. This
example shows data stored for the meta sample of pools 'mpool cases' which
comprises three pools listed to the right of the tag 'Contains_pooT. The tag
'snp_assoc_meta' displays links to the marker studied and to the heterozygote
references used to infer allele frequencies, accessible via the links of the tag
'Pool_meta_stat_des'. The tag 'pop_pool_meta_stat_cmp' provides links to
'Statcmp' objects containing data on the association studies involving this meta
sample (compared here to the meta sample 'mpool_ctl').
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3.5.4.5 Descriptive analysis of genotyping assays
The novel model 'List_Values' was created to store genotyping data of
individual samples used in heterozygote references, as well as lists of peak height
ratios and of allele frequencies in pools and groups ofpools (Figure 3.19).
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% List values: ih3-ratio geno c-t-ref HeteioZ panel.a3700.1 ™ Ul1
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Figure 3.19: Management of genotyping data for heterozygote references in
ACeDB. 'List_values' objects store sets of raw data. The example shown here shows
the list of peak height ratios, displayed with the tag 'List', obtained for the SNP 'ih3'
(tag 'Marker') with the heterozygote reference 'ref_HeteroZ_panel' (tags 'Name'
and 'Type') using the 'ABI3700' platform (tag 'Genotyping platform').
The statistical description model 'Stat_des' stores the results of the statistical
analysis of genotyping data at a given marker for a given pop, pool or meta sample,
such as allele frequencies (3.20). It also provides links to other relevant objects, such
as the list ofpeak height ratios used to infer allele frequencies (Figure 3.20).
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Freq_alleles_des ih3-treq_c-i®ool_cases.a3700.1 ih3-freq_t-ri>oolcases. a3700.1
Nb_alleles 1225.7 310.3
List_geno c-c c-t t-t
Freq_geno_obs 0.6367 0.3224 0.0408
Nb geno obs 489 247.6 31.4
Figure 3.20: Management of genotyping results in ACeDB. 'Stat_des' object
for results of the analysis of the meta sample 'mpoolcases' (tag 'Of_pool_meta') at
the SNP 'ih3' (tag 'SNP'), using the heterozygote reference indicated by the tag
'Hetz_ref_used'. The object display links to the data sets that were merged to create
the data set detailed here (tag 'Dataset'), to the object containing values of peak
heights used (tag 'peak heights') to derive peak height ratios (tag 'Ratio'). It also
stores details on the peak height ratio (eg tag 'mean', Variance'), and numbers and
frequencies of alleles. It also provides links to the 'Stat des' objects for details on
allele frequencies (tag 'Freq_alleles_des').
117
Chapter 3 Allelic association data management
3.5.4.6 Allelic association studies
The model 'Statcomp' (for 'statistical comparison') stores the results of
classical and pooled DNA-based association studies (Figure 3.21).
Stat crnp: mpool ctl.1 vs mpool cases.1 w ih3.a3700 - □ §
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Classic P value 1.407e-12
Corrected P value 0.0012532




Figure 3.21: Management of allelic association data in ACeDB. Strings in
bold are links to other relevant objects, such as the marker (ih3), the samples (here
two meta samples of pools: 'mp_mood' and 'mpool_test'), or genotyping results
used in the comparison of the samples (to the right of the samples names). The
remaining data are test statistics, associated p-values, and in the case of pooled DNA,
the correction factor used to account for error in the inference of allele numbers in
pooled DNA.
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3.6 Discussion
Large scale case-control association studies involve the genotyping of
hundreds of markers in DNA pools or hundreds of individual samples and thus
generate a large amount of data. No appropriate software existed to manage allelic
association produced by the group and one was developed to address issues of data
submission, analysis, storage, access, integrity and flexibility. The ACeDB database
used in the laboratory was extended to allow storage of all information relevant to: i)
genotyping assay experimental conditions and results, ii) DNA pool construction, iii)
meta data sets, and iv) allelic association studies based on single DNA pools, single
set of individual samples in a population, or merged data sets. This was achieved by
modifying existing models and creating new ones. With these new models, one can
now navigate from a marker to the pools or populations tested with that marker, to
the data obtained, and to the results of the comparison of allele frequencies in that
pool or population to those of other pools or populations. In addition, a user-friendly
CGI front-end to the database was written to allow easy and accurate submission of
new data by consulting the database and using a series of HTML forms, as well as
their automatic examination, via descriptive statistical analysis and association
studies.
For classical association studies, based on individual sample genotypes at a
chosen marker, allele numbers in each selected population, or group of populations,
are calculated from the genotypes of all individuals. A classical chi-square test is
then performed on this data and its results are displayed. These are read into the
database on demand. In the literature, most studies reporting the use ofDNA pools in
an association study perform a x2 test to detect the independence of the allele
frequencies and phenotypes (Risch and Teng, 1998). On the other hand, allele
numbers in pool of individual DNAs are not counted but must be inferred from peak
height in heterozygotes and the pool itself. Once entered in a form, peak height ratios
obtained for a set of heterozygote references or a set of single DNA pool replicates
are run through a script that carries out a statistical analysis necessary for subsequent
association studies (mean frequencies of the alleles, standard deviation, standard
error). In association studies based on pools, the adjusted x2 test (Tadj) that accounts
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for errors in inferring allele frequencies is used in place of the classical x2 test. The
interface also allows the analysis of a data set produced by combining data from
several populations or pools. A table of results is then displayed. The new data and
their statistical description can then be read into the database.
DNA pooling aims to accelerate association studies by identifying SNPs of
interest out of hundreds ofmarkers. The conventional method of direct counting of
alleles by genotyping individuals separately is then necessary to confirm the
association of the highlighted SNP alleles with the disease. The interface for ACeDB
therefore also allows the submission and analysis of DNA pool data and individual
genotypes. As association studies are often hindered by the limited size of the
samples used, the possibility of merging data sets from different phenotypes, or
geographic location is also an advantage. The two tools described here are not
specific to the diseases studied by the group and can potentially be used to support
allelic association studies aiming to identify susceptibility loci of any disease. It may
also be possible to extend the ACeDB database further to facilitate allelic association
studies based on haplotypes.
The goal of an association study is to detect differences in allele frequencies
between affected and unaffected people that are expected to indicate differences in
the function or regulation of genomic sequence variants at the loci identified.
Markers tested are either evenly distributed throughout a region or entire genome or
chosen within candidate genes and putative or known regulatory elements. Once a set
of candidate genes has thereby been refined, the next step in identifying
susceptibility loci for a complex disease is to characterise these genes. An accurate
structure of the genes and related sequences is in turn important to determine which
markers should be tested in the association study. Annotation of functional elements,
either known or predicted, in the 4p region is hence highly valuable.
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4 Evaluation of in silico identification of cis-
regulatory sequences
4.1 Introduction
A protocol was designed to predict Transcription Factor Binding Sites
(TFBS) in upstream regions of genes by combining comparative genomics in human
and mouse to prediction of known TFBS and prediction of novel motifs. This
protocol was benchmarked against publicly available upstream regions of 28 human
genes for which the function of TFBS had been verified experimentally (Dermitzakis
and Clark, 2002). These sequences were masked for repeats and searched against a
database of repeat-masked 2 Kb regions upstream of known genes in the mouse
genome. Conserved human regions were selected on the length and percentage of
identity of their alignment with mouse sequences. These conserved human sequences
are referred to as 'CSSs' (for 'Conserved Sub-Sequence with single mouse
sequence') and were searched for known TFBS in the TRANSFAC database. The
subset of these human conserved regions which were matched by at least four mouse
sequences, 'CSSm' (for 'Conserved Sub-Sequence with multiple sequences'), were
also used together with the corresponding mouse regions to identify motifs over-
represented in these sets of sequences. Accuracy of this protocol was assessed for
each prediction programs separately, as well as for flexible combinations of these
prediction programs.
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4.2 Human-Mouse comparative genomics
4.2.1 Sequence conservation
Results of the comparative genomics analysis of upstream regions of the
human genes containing experimentally verified cis-elements are shown in Table 4.1.
Conserved regions larger than 50 bp and sharing more than 65% identity with mouse
sequences were selected for further analysis. These sequences, 'CSSs', overlapped
64% of the length of the 28 searched sequences. These conserved human sequences
were 153 bp long on average and their length ranged from 50 bp to 573 bp. The
average percentage of identity shared between human and mouse sequence was
66.6% and ranged from 65% to 89%. These CSSs were used to predict known TFBS.
Human conserved regions matched by at least four regions ofmouse sequences were
used together with the non-redundant matching sequences in mouse to identify
motifs over-represented in these sets of sequences. Seventeen such sets, CSSm, were
defined, for 11 genes (Table 4.1), and contained on average five sequences. The
length of these CSSm was 52 bp on average and ranged between 50 bp and 58 bp.
The total length of these conserved regions was 0.9 Kb, which represents 3% of the
total length of the 28 human sequences.
4.2.2 Conservation of functional cis- regulatory elements
The location of each functional cry-element in the set of human sequences
were compared to that of regions conserved between human and mouse to determine
whether it had been conserved through evolution. Human sub-sequences showing at
least 65% identity to the mouse sequence over at least 50 bp were chosen as
conserved sequences (CSSs). Each cw-element was classified as conserved if at least
50% of its length was overlapped by a conserved sequence. Out of a total of 100
functional human TFBS, 79 were conserved in mouse.
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Sequence CSSs CSSm Regions motifs
Name igth nr igth nr igth nr Lgth scon mcon nr Igth scon mcon
ABCC2 3000 9 1007 0 0 1 234 1 0 1 14 1 0
AGT 590 2 561 0 0 2 42 2 0 5 41 4 0
AKR1C1 1132 4 957 1 51 1 581 1 0 7 58 7 0
ALB 1286 7 1145 2 107 1 37 1 1 1 37 1 1
ALDH2 721 4 498 0 0 1 602 1 0 3 74 2 0
ALDOB 200 1 162 0 0 1 200 1 0 2 39 1 0
APOB 1980 11 1481 1 51 3 277 0 8 157 5 0
APOCIII 1435 5 1056 2 110 1 857 1 0 2 22 1 0
C4BPB 577 1 573 0 0 1 201 1 0 2 14 2 0
CFTR 843 3 664 0 0 1 843 1 0 11 615 7 0
CYP1A2 3293 4 955 1 53 1 259 0 1 7 0 0
CYP7A1 200 1 198 1 50 1 200 1 0 4 49 4 1
F10 814 3 505 1 52 1 197 1 0 2 65 2 0
F7 1017 2 570 0 0 1 201 1 0 2 45 2 0
G6PC 200 1 197 1 53 1 200 1 0 10 74 10 3
HBB 204 1 191 0 0 1 204 1 0 7 91 6 0
HBE1 168 1 167 0 0 1 168 1 0 6 129 6 0
HMGCR 1227 9 899 0 0 1 200 1 0 1 16 1 0
IGF1 200 1 191 0 0 1 200 1 0 2 26 2 0
IGF2 1523 7 1286 1 53 1 22 1 0 1 9 1 0
INS 200 1 194 2 101 1 200 1 1 1 15 1 0
LIPC 1728 4 689 0 0 2 433 1 0 3 21 0 0
PAH 200 1 197 0 0 1 200 1 0 2 53 2 0
PRL 3300 15 2070 4 211 1 905 1 0 1 21 1 0
PROC 200 1 173 0 0 1 200 1 0 8 60 8 0
SEPP1 1812 10 1289 0 0 1 201 0 0 2 21 0 0
SLC2A2 1823 11 1037 0 0 1 46 0 0 3 24 0 0
UGT1A1 200 1 198 0 0 1 200 1 0 2 23 2 0
sum 30073 121 19110 17 892 32 8110 28 2 100 1820 79 5
Table 4.1: Conservation in mouse gene upstream flanking regions of human
sequences with known functional cis- regulatory elements. Data were obtained by
searching the repeat-masked non-coding sequence of each of the 28 human genes
listed that contain functional cis- regulatory elements to repeat-masked 2 Kb
sequences upstream of the translation start site of genes in the mouse genome
retrieved from the Ensembl web site. Out of all conserved regions, regions longer
than 50 bp and sharing more than 65% identity with the mouse sequences were
included in the analysis. Lgth: total length in pb; nr: number of elements: CSSs :
Conserved Sub-Sequences with Single mouse sequence; CSSm: Conserved Sub-
Sequence with Multiple mouse sequences; regions: region required for promoter
activity; motifs: regulatory motifs, which are located within the 'regions'; scon:
number of c/T-elements located in CSSs regions; mcon: number of cfs-elements
located in CSSm regions.
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4.3 Detection of functional cis- regulatory elements
4.3.1 Accuracy of individual prediction methods
Prediction of known functional cfy-elements was performed on human
regions conserved in at least one mouse sequence, 'CSSs', using the EMBOSS tool
tfscan to search the TRANSFAC database. Total number and total length of these
conserved regions are displayed in the third and fourth columns of Table 4.1.
Prediction of novel motifs was carried out by identifying motifs over-represented in
sets of sequences each containing the human conserved region and the mouse
sequences matching this region ('CSSm'). Total number and total length of these
conserved regions are displayed in the fifth and sixth columns of Table 4.1.
Searching TRANSFAC for known motifs in CSSs regions ('tfscs' in figure
4.1) was the most sensitive approach as 18% of regions and 57% of motifs were
matched by motifs predicted by tfscan. However, searching TRANSFAC for known
motifs in CSSm regions ('tfscm' in figure 4.1) performed poorly, with only 4% and
6% of regions and motifs identified respectively. Low sensitivity was also observed
with the other programs tested. Only 7% of regions and 10% of motif were identified
by motifs predicted by AlignACE, which performed best out of the four programs for
novel motif discovery. Prediction methods differed in the number of false positives
(predicted motifs that do not match functional regulatory regions or motifs)
generated. Prediction by tfscan on CSSs generated 387 and 528 false positives for
'regions' and 'motifs' respectively. With CSSm, the highest number of false
positives, for regulatory regions and motifs, was produced by tfscan, followed by
AlignACE, MEME, Oligo-analysis and Dyad-analysis (Figure 4.2). However, all
programs performed equally badly in terms of false positive rates (Figure 4.3).
Indeed all programs over-predicted massively, with a rate of false positives for each
method higher than 70%.
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rfl rfl rfl f rflf rflrflrnrFI
tfscs tfscm oligomer dyad alignace meme combi_1 + combi_2+ combi_3+ combi_4+ combi_5+
regions 17,9 3,6 3,6 3,6 7,1 3,6 7,1 7,1 3,6 3,6 3,6
motifs 57.0 6.3 5.1 5.1 10.1 7.6 10.1 8.9 7.6 5.1 5.1
□ regions ■ motifs
Figure 4.1: Percentage of known functional cw-elements detected with the
method combining human-mouse comparative genomics to motif prediction. Each
functional cfs-element was classified as detected if it was overlapped by predicted
motifs by more than 50%. The percentage of correctly identified cA-element was
computed for both type of m-elements, regulatory regions, required for the activity
of the promoter ('regions'), and known sequence motifs within these regions
('motifs') for each prediction program, and for flexible combinations of these
programs, 'tfscs': tfscan ran on CSSs; 'tfscm': tfscan ran on 'CSSm'; 'oligomer':
Oligo-analysis; 'dyad'; Dyad-analysis; 'alignace': AlignACE; 'meme': MEME;
'combi_l+': any one of the following five methods: 'tfscm', 'oligomer', 'dyad',
'alignace' and 'meme'; 'combi_2+': any two of the above mentioned five methods;
'combi_3+': any three of the above mentioned five methods; 'combi_4+': any four
of the above mentioned five methods; 'combi_5+': all five methods.
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tfscm oligomer dyad alignace meme combi_1 + combi_2+ combi_3+ combi_4+ combi_S+
regions 17,0 6,0 3.0 15.0 7,0 10,0 7,0 7.0 3,0 2
motifs 30 13 5 25 14 20 12 12 5 3
□ regions ■ motifs
Figure 4.2: Number of false positives generated by the method combining
human-mouse comparative genomics to motif prediction. Details are as in figure 4.1.
u,u-
tfscm oligomer dyad alignace meme combi_1 + combi_2+ combi_3+ combi_4+ combi_5+
regions 72,8 86,0 91,3 73,2 71,2 70,8 71,8 71,8 84,6 91,3
motifs 78,0 88,7 92,7 78,0 75,0 75,9 74,0 74,0 84,8 91,3
I □ regions B motifs
Figure 4.3: Rate of false positives generated by the method combining
human-mouse comparative genomics to motif prediction. Details are as in figure 4.1.
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4.3.2 Flexible combination of motif prediction methods
In an attempt to reduce the number and rate of false positives, clusters of
overlapping motifs were defined and these were used in place of individual motifs.
Categories of motif clusters used to assess identification of cA-elements were derived
based on a minimal number of programs that predicted motifs contained by these
clusters, i.e. clusters made ofmotifs predicted by at least one program, clusters made
of motifs predicted by at least two programs and so on. This approach also aimed to
test whether using regions overlapped by motifs predicted by at least a certain
number of methods would be as sensitive, and also more specific than the approach
based on individual prediction methods.
Figure 4.1 shows the proportion of functional c/5-element identified by
predictions generated by combinations of at least a certain number of prediction
programs, e.g. 'combi_2+' for the proportion of functional m-element identified by
clusters of overlapping predicted motifs from at least two motif prediction programs.
The number of motif clusters containing motifs predicted by at least one method was
similar to that obtained with AlignACE alone. Sensitivity obtained with clusters of
motifs predicted by at least one method was 7% for functional regions and 10% for
functional motifs (Figure 4.1). As expected, the percentage of functional regions and
motifs identified decreased as the minimum number of methods in the combination
increased. With clusters of predicted motifs from all five programs, sensitivity
dropped to 4% for functional regions and to 5% for functional motifs, respectively.
The number of false positives also decreased as the minimum number of programs
represented in these clusters increased (Figure 4.2). However, the rate of false
positives for any flexible combination was still higher than 70% (Figure 4.3).
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4.4 Discussion
A computational protocol was designed to predict putative regulatory sites in
non-coding regions upstream of genes. It combined the comparative genomics
approach applied to non-coding sequences upstream of human and mouse genes, and
the prediction of known TFBS and novel over-represented motifs. The accuracy of
this protocol was benchmarked against a set of regions upstream of human gene
known to contain functional chs-elements and which were available publicly
(Dermitzakis and Clark, 2002). These human sequences were masked for repeats and
aligned to repeat-masked 2 Kb non-coding sequences upstream of the transcription
start site of Ensembl known genes in mouse. Conserved human sequences were
selected on their length and degree of similarity to the mouse sequences. These non-
coding conserved upstream sequences were used to predict known TFBS and to
identify over-represented motifs. The accuracy of the prediction was assessed by
comparing the location of the known functional cfv-elements with that of the motifs
predicted. Selecting conserved regions showing similarity higher than 65% over at
least 50 bp, 79 out of 100 functional sites were conserved between human and
mouse. This is consistent with the observation that a third of the human functional
sites are not functional in rodents (Dermitzakis and Clark, 2002).
The accuracy of the prediction of known and over-represented motifs varied
between programs. The highest number of cA-elements identified was obtained by
searching TRANSFAC in sub-sequences conserved in at least one mouse upstream
region. However, 42% of the functional sites were not identified by predicted known
motifs. This might be due to the absence of some of these functional sites in
TRANSFAC, and the use of tfscan, which is based on consensus sequences of TFBS,
and was run without allowing mismatches. Prediction of known TFBS may have
been more sensitive based on position weight matrices (PWMs). It may therefore
prove valuable to use programs based on PWMs to identify matches to known TFBS,
such as MATCH (Kel et al., 2003) or Matlnspector (Quandt et ah, 1995). However,
the use of PWMs requires the choice of a score threshold to select meaningful
matches. Unfortunately such threshold can rarely be defined based on experimental
data because there is not enough information so far to do so systematically. Score
thresholds are therefore usually arbitrary (Werner, 2000). Although sensitivity may
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be increased by using PWMs, the rate of false positives would likely remain
relatively high. The lower sensitivity of programs that identify over-represented
motifs may be due to the fact that the number of occurrences of functional sites in the
set of sequences may be insufficient for these motifs to be identified as over-
represented. The number of motifs predicted varied between motif prediction
programs. This variation in the number of motifs predicted may reflect the type of
motifs modelled by different programs, and the options used to run these programs.
For example, the number of motifs predicted by dyad-analysis was high because it
predicted tri-nucleotide pairs separated by a spacer of length varying between 1 and
20. Oligo-analysis was run to predict oligomers of 6 bp only. Running oligo-analysis
to predict motifs of varying size would not necessarily improve sensitivity but would
likely result in more false positives. Also, as the highest scoring motifs predicted by
any methods are not necessarily motifs with a biological meaning (Werner, 2000),
selecting the top-scoring motifs predicted in each set of conserved sequences may
reduce the number of motifs considered but also decrease sensitivity. In addition, the
high rates of false positives observed are higher than those reported by studies using
these programs (Werner, 2000), indicating that the approach applied to this set of
sequences may not be optimal.
In order to limit the number of predicted motifs, overlapping predicted motifs
were grouped into clusters containing motifs predicted by different methods. This
approach proved efficient in eliminating the redundancy of overlapping motifs. In
addition, classifying these clusters according to the number of methods that
generated motifs making up the clusters addressed two questions. First, would
selection of predictions corresponding to a flexible combination of motif prediction
programs maintain sensitivity despite setting more stringent criteria, or increase
sensitivity by joining motifs from different programs into a motif larger than the
initial single ones? Second, would it also increase specificity, by giving more weight
to regions matched by several predictions. The number of functional cA-elements
identified by cluster containing predictions of at least one method was the same as
that identified by motifs predicted by AlignACE. Sensitivity obtained by selecting
clusters of predictions generated by more programs decreased as the required number
of programs increased. Although the number of false positives reduced by
130
Chapter 4 Evaluation of in silico identification of cw-regulatory sequences
considering flexible combination of methods, the rate of false positives was as high
as that obtained by considering motif prediction programs separately.
The protocol tested aimed to annotate putative functional cA-elements in non-
coding regions upstream of genes in a region linked to psychosis. It was designed to
help characterise these genes and provide clues on nucleotide variation in putative
regulatory sites in promoters. Bench scientists would then test these polymorphisms
for association to the illness. This protocol was tested on a set of promoter regions of
genes containing known functional c/s-elements and proved to be partially
successful. Indeed, up to 60% of the functional sites conserved between human and
mouse could be identified. However, all motifs prediction programs generated very
high rates of false positives. Flexible combinations of programs were used in place of
individual, redundant predicted motifs to try and maintain the same sensitivity and
increase specificity. Although this approach reduced the number of false positives,
the rate of false positives was not reduced to a satisfactory level. In addition,
sensitivity was reduced by half in the most flexible case (clusters of predictions from
at least two programs). The protocol tested here was therefore not suitable for
predicting czT-elements to help characterise genes in the 4p region linked to
psychosis. These results also showed that another approach was necessary. Multi-
species comparative genomics has been reported to help address the problem of
annotating putative functional sequences (Thomas et al., 2003). Non-coding regions
conserved between several species representing a range of evolutionary distances are
indeed more likely to be functional than regions conserved between human and
mouse, as the latter contain functional and neutral sequences. The approach used to
annotate putative functional sites in non-coding regions conserved across several
species is the subject of the next chapter.
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5 Evaluation of scoring schemes for comparative
genomicswith vertebrate species
5.1 Introduction
Comparative genomics of the human and mouse sequences has been reported
to be an efficient tool to identify coding sequences and functional non-coding regions
such as gene regulatory elements (Tagle et al, 1988; Pennacchio and Rubin, 2001).
Chapter 4 reported results of the application of this approach, which was combined
to the prediction of known and novel motifs, to a test set of known functional cis-
regulatory elements. The protocol designed generated a number of false positives too
high to provide a limited number of sequences to bench scientists to guide them in
the identification of putative non-coding disease-associated polymorphisms.
Comparing genomic sequences from more than two species has the advantage over
studying two species of reducing the amount of conserved neutral sequences, as
divergence eliminates these sequences differently in each species and lineage (Duret
and Bucher, 1997; Thomas et al., 2003). The present chapter aims to assess the
ability of comparative genomics applied to the currently available whole-genome
sequences from vertebrate species of detecting non-coding functional sequences.
Four multiple alignment scoring schemes, which are described in chapter 2, were
benchmarked against a publicly available set of experimentally verified functional
regulatory regions (Elnitski et al., 2003), identifying the most useful scoring scheme.
The first system was the simple mean of the non-human species' pairwise
percentage of identity to the human sequence. The second and third systems involved
weighting the pairwise percentage of identity to the human sequence. The second
system was based on a simple weight reflecting the relative evolutionary distances
between human and the other species, that is l for the rodent sequences, 3 for the
chicken sequences and 4.5 for the fish sequences, since the evolutionary distance
between human and rodent is approximately 100 millions years, that between human
and chicken is approximately 300 millions years and that between human and fish is
approximately 450 millions years. For the third measure, the weight was the estimate
of synonymous substitutions, dS, for each species, or l if dS was greater than l. The
fourth scoring system is derived from the probability of observing the measured
amount of conservation given the estimate of the rate of neutral evolution, dS, of the
gene in the species being compared to human.
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5.2 Sequence conservation in rodents, chicken and fish
Four sets of genes with one or more experimentally verified regulatory region
were considered based on the species in which an ortholog of the human gene was
identified: i) 'HMR' (human, mouse and rat), 'HMRC' (human, mouse, rat and
chicken), 'HMRZF' (human, mouse, rat, zebrafish and Fugu), 'HMRCZF' (human,
mouse, rat, chicken, zebrafish and Fugu). Pairwise rate of synonymous substitution
dS was estimated for each species compared with human. In mouse and rat, 20% of
the genes are saturated with synonymous substitutions (Appendix 9.1.1). All genes in
the chicken and in the fish show saturation, as expected. Figure 5.1 shows the
average level of conservation of known functional elements and sequences with no
known function for each set. As expected, coding sequences appear to be more
conserved on average than any other feature, while UTRs show an intermediate level
of conservation, lower than that of the coding region, but higher than that of the
untranscribed sequences. These trends are observed in all four sets (Figure 5.1).
Levels of conservation obtained with the HMR set for the various annotation features
are all higher than those obtained with the other sets as expected. Also, it should be
noted that the average level of conservation of each type of annotation feature is
highly variable. Figure 5.2 shows the distribution of the averaged percentage of
identity and of the score based on the binomial probability as measured for a window
sliding along the multiple alignments for the HMRC set. For all sets, the distribution
of the window scores obtained with the scoring scheme based on the binomial
probability, for the coding sequences, the regulatory regions and the non-coding
sequences with no known function spreads across the range of possible values. It is
skewed towards low values for the non-coding sequences and regulatory regions and
towards high values for the coding sequences. This difference in the shape of the
distributions is accentuated when chicken and fish sequences are considered (data not
shown). The distribution for the regulatory regions has a similar shape to that of the
non-coding region and is slightly shifted to higher values, reflecting a better
conservation of the regulatory regions compared to the whole of the non-coding
sequences. Also, its distribution overlaps that observed for the coding sequences,
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Figure 5.2: Distribution of window scores. The charts show the distribution of
the average percentage of identity (a) and of the score based on the binomial
probability (b) obtained for a 40 bp window sliding along the alignment of sequences
from human, mouse, rat and chicken by 20 bp at time, for the known coding and
regulatory regions, and the sequences with no known function.
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5.3 Accuracy of detection of functional sequences
Table 5.1 shows the number and length of conserved sequences identified by
each scoring scheme in each set of genes. Accuracy of detection of known functional
sequences was similar for all four scoring systems, with all four sets (Table 5.2 and
Table S2-S4 in Appendix 9.1.2). Accuracy obtained with the binomial score was
slightly higher than that observed with simple scoring schemes when the sequences
from fish were added. In spite of the similarity of accuracy between the scoring
systems, the score based on the binomial probability was as good as or better than the
other scoring systems across the data sets. Based on these data, the system of choice
would therefore be the score based on the binomial probability. With the HMR set,
using a window length of 40 bp and selecting regions that make up the percentage of
the human sequence represented by coding sequences, 31 genes out of 40 (78%)
contained regulatory regions that were detected. At the nucleotide level, the average
sensitivity was 78% for the coding sequences and 34% for the regulatory regions
(range 7-78%), considering only the genes for which the regulatory region was
detected. The average specificity was 97% (range 89-100%). The sensitivity,
specificity and positive predictive value of detection of sequence with a known
function, that is coding and regulatory regions, were 60%, 97% and 75%,
respectively. Accuracy was similar with the other sets (Table 5.2), although it is
worth noting that fewer genes were analysed as orthologs could not be readily
identified in chicken and fish for all human genes in the HMR set. It is noteworthy
that regulatory regions could be identified in the majority of the genes. The inclusion
of the chicken and fish sequences resulted in a slight increase in the sensitivity of
detection of coding sequences (82% on average) and a slight decrease of the
sensitivity of detection of regulatory regions (26% on average). Using a smaller
window length of 20 bp resulted in identifying regulatory regions in up to four more
genes, although the overall sensitivity and positive predictive probability were lower
than with a 40 bp window, for coding and regulatory regions (Table 5.3). Using a
100 bp window resulted in the identification of fewer regulatory regions (Table 5.3).
Figure 5.3 shows the conservation of the human G6PC gene sequence, the known
annotation and the selected conserved regions.
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Table 5.1: Selected conserved sequences. The number and average length of
selected conserved sequences obtained for three window lengths (20 bp, sliding by
10 bp, and 40 and 100 bp, sliding by 20 bp) are given for each set and each scoring
system. Names of sets are as in the text, 'score': scoring system; 'count': number of
selected conserved sequences; 'length': average length of selected conserved
sequences across all genes in each set; 'bino': binomial score; 'diverg' score based
on dS estimate, 'disty': score based on the distance in years between species; 'pid':
score defined as the average percentage of identity.
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length set score sensitivity specificity ppv
rr cds fct rr cds fct rr cds fct
bino 30 70 57 96 96 96 26 66 69
HMR diverg 30 70 57 96 96 96 26 66 69
disty 30 71 58 96 96 96 26 66 69
pid 30 71 58 96 96 96 26 66 69






















21 81 60 98 98 98 32 75 77
bino 22 79 65 97 98 98 28 78 80
HMRZF diverg 22 78 63 97 97 97 29 75 77
disty 21 76 62 96 97 97 27 73 75
pid 22 80 65 97 97 97 27 76 78
bino 26 81 66 98 98 98 40 78 81
HMRCZF divcrg 22 79 63 98 98 98 35 75 78
disty 19 77 61 97 98 98 29 73 76
pid 25 80 65 98 98 98 37 76 79
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Table 5.2: Accuracy of detection of functional sequences. Accuracy of
detection was assessed at the nucleotide level for three window lengths: 20 bp,
sliding by 10 bp, and 40 and 100 bp, sliding by 20 bp. Values shown are averages
over all genes in each set. Names of sets are as in the text. Values displayed for
windows of 40 and 100 bp are the difference between the values obtained with these
windows and that obtained with the 20 bp window, 'bino': binomial score; 'diverg'
score based on dS estimate, 'disty': score based on the distance in years between
species; 'pid': score defined as the average percentage of identity; 'rr': regulatory
region; 'cds': coding sequence; 'fct': functional sequence (i.e. 'rr' or 'cds'); ppv:
positive predictive value.
139
Chapter 5 Evaluation of scoring schemes for comparative genomics with vertebrate species
20 bp 40 bp 100 bp

































































Table 5.3: Accuracy of detection of regulatory regions. The number of genes tested is
shown for each set, together with the number and percentage of genes for which the
regulatory region were detected, 'nrg' : number of human genes in the set; 'nrpg'
number of genes for which the regulatory region was detected (i. e. 'positive
genes'); '%pg' : percentage of genes for which the regulatory region was detected.
Names of sets and scores are as in Table 5.2.
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Figure 5.3: Percentage of identity plot of the genomic sequences of the
human G6PC and vertebrate orthologs. The picture shows the multiple alignment of
the G6PC gene sequences from human, mouse, rat, chicken, zebrafish and Fugu.
Each pairwise alignment was derived from the multiple alignment of the sequences
from the six species. Arrows on top on the graph indicate known genomic features on
the sequence (G6PC gene, arrow 'G6PC', and the regulatory region, arrow 'REG')
as well as the seven regions selected based on their level of conservation as measured
by the probability of observing the calculated percentage of identity given the
estimate of the rate of neutral evolution ('C' stands for conserved sequence).
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5.4 Sequence conservation in dog, opossum and frog
To assess the reliability of the predictions, the sequences derived from the
analysis of the HMR set were searched against the recently available draft genomic
sequence of three vertebrates: Canis familiaris (dog), Monodelphis domestica
(opossum), and Xenopus tropicalis (frog). As the available genomic sequence data
for these species was whole genome shotgun reads, human repeat-masked sequences
were searched against them using BLASTN (Altschul et ah, 1990). Five types of
human sequences were considered: i) known functional sequences, such as coding
sequences and regulatory regions, ii) known regulatory regions alone, iii) putative
novel functional sequences identified here ('novel' hereafter), iv) sequences with no
known function and which were not selected by the HMR set analysis ('unknown'
hereafter), v) randomly shuffled versions of the unknown sequences (with the
exception of masked repeats, 'shuffled' hereafter). Only sequences larger than 40 bp
were considered. Table 5.4 shows that only a single conserved sub-sequence was
found in the shuffled sequences. Known functional sequences were most frequently
conserved and a greater proportion of their length was conserved compared to the
other sequences. The percentage of novel sequences that were conserved was lower
than that for the known regulatory regions. However, the proportion of the length of
sequence conserved was similar. Thirty two genes out of the 40 control genes (80%)
contained known regulatory sequences with sub-sequences conserved in at least one
species and 19 out of the 36 genes (53%) with novel sequences contained 'novel'
sequences conserved in at least one species. Over these 19 genes, on average, 52% of
the total length of the 'novel' sequences was conserved. Also, 95% of the genes
contained 'unknown' sequences conserved in at least one species. Figure 5.4 shows
that the quality of the conservation of novel sequences was higher than that of known
functional sequences, in turn similar though slightly higher than that of 'unknown'
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score density
■ Regulatory G3 KnownFunc □ Novel □ UnKnownFunc
Figure 5.4: Score density of the sub-sequences conserved in dog, opossum, or
frog. Distribution of the score density of sub-sequences conserved in at least one of
the following species: dog, opossum and frog (score density = score / length).
'Regulatory': sequences with a known regulatory function; 'KnownFunc': sequences
with a known function; 'Novel': sequences with no known function and selected by
the analysis of the HMR set using the 'binomial' scoring system; 'UnKnownFunc':
sequences with no known function and not selected by the analysis of the HMR set
using the 'binomial' scoring system.
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5.5 Discussion
Simple scoring systems based on weighting the average percentage of identity
across a window scanning the multiple alignments showed a modest sensitivity and
high specificity in detecting coding and regulatory regions. The scoring system based
on the binomial probability of the amount of the observed conservation, given the
rate of synonymous substitution (Thomas et ah, 2003), was more accurate than the
simpler scoring schemes in the conditions used here, as it was at least as sensitive as
and as specific as the simpler scoring schemes. The computation of the binomial
score partly relies on the estimation of dS. The use of more elaborate models of
molecular evolution may however bring little improvement, as more complex models
generally harbour higher variances than simpler, less realistic models (Nei and
Kumar, 2000). In addition, an accurate estimation of dS appears not to be crucial as
the sets of orthologs contained sequences from chicken and fish, which are saturated
with synonymous substitutions. In any case, just as Margulies et al. (Margulies et ah,
2003) demonstrated the value of a scoring system based on the rate of neutral
evolution and binomial probability with a spectrum of mammalian species, this work
shows here that a similar scoring system can perform well with a set of few distantly
related species. The spread of the distribution of the average percentage of identity of
the coding sequence in the sets containing chicken and fish sequences is wider than
that in the HMR set, reflecting the fact that the use of distantly related species can
blur the distinction between the non-coding and coding sequences in terms of
average percentage of identity (Thomas et al., 2003). The inclusion of the chicken
and fish sequences in the analysis reduced the number of genes analysed and had a
slight detrimental effect on the accuracy of detection of regulatory regions, for all
scoring methods. The high proportion of genes for which the regulatory region was
identified using the chicken and fish sequences is likely due to the fact that where
orthologs of the human gene could be identified in these species, the relevant genes
where highly conserved.
Accuracy measured in terms of bases was on average lower with windows of
20 bp than with windows of 40 bp, while regulatory regions were detected in up to
four more genes with the small windows compared to the 40 bp windows. This might
be explained by the fact that gene transcription is mainly regulated by modules of
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transcription factor binding sites, but not individual sites themselves (Yuh et al.,
1998). The 40 bp window size may thus provide a better indication of functional
conservation. The number of genes for which regulatory regions were detected using
a 100 bp window was half that for shorter windows. This may suggest that conserved
regions are shorter than 100 bp. While specificity is high for all genes, sensitivity
varies widely among genes, reflecting the lack of conservation of all regulatory
regions across all species for some genes (Yuh et al., 1998; Dermitzakis and Clark,
2002), and indicating that the approach is more appropriate and accurate for some
genes than for others. Overall, the use of a threshold based on the proportion of
coding region in the reference sequence analysed and on the proportion of the length
of the human sequence selected (see Chapter 2) generated very high specificity and
modest sensitivity, in spite of being conservative. The analysis of the mouse genome
suggested that coding sequences represent only half of the functional genomic
sequences (Waterston et al., 2002). Sensitivity might therefore be increased with a
less stringent selection of conserved windows by using a threshold twice that of the
proportion of coding regions in the human sequence. Such a threshold may however
not be appropriate as it implies the assumption that functional sequences are evenly
distributed and conserved across the genome, whereas the amount of sequence under
selective constraint varies across the genome (Waterston et al., 2002).
As the set of known regulatory sequences available to date is limited, it may
not be representative of all regulatory regions in the genome. This limitation is
inherent to the current state of the knowledge and should diminish progressively with
increased experimental verification of putative regulatory region function. It is
noteworthy that these scoring schemes generated reliable results despite the
necessarily imperfect annotation of gene structures provided automatically by
Ensembl.
The reliability of these predictions was further assessed by studying the
sequence conservation in other vertebrates where a considerable amount of genomic
sequence is available. Novel sequences selected in the analysis which have no known
function are more likely to be functional if conserved in these additional species.
Results showed that 49 % of such sequences are conserved in at least one additional
species and 30 % are conserved in at least two. Depending on the species involved,
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these sequences may be either functional or part of the core neutral eutherian genome
(Rat Genome Sequencing Project Consortium, 2004). Based on the data from
opossum, at least 30 % of these sequences are likely to be functional. Finally, many
conserved sub-sequences in 'unknown' sequences would probably be classified as
'novel' with a less stringent threshold on the total length of sequence to be selected.
The protocol tested here allowed for predictions of the functional potential of
non-coding DNA to be sufficiently reliable to suggest a limited number of putative
functional regions for experimental verification with an acceptable and conservative
measure of the false positive rate. This approach was therefore applied to genes in
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6 COMPARATIVE ANALYSIS OF GENES IN A
CANDIDATE REGION FOR PSYCHOSIS
6.1 Introduction
Bipolar Affective Disorder (BPAD), also named manic depression, and
schizophrenia are two major psychiatric illnesses, each affecting 1% of the
population during their lifetime (Weissman et ah, 1988). The molecular and cellular
bases of these diseases are not well understood, due to their heterogeneity, lack of
animal model, and general incomplete knowledge of normal brain function (Owen
and Cardno, 1999). However, genetic susceptibility is an important factor, as
indicated by family, twin and adoption studies (Owen and Cardno, 1999). A region
on chromosome 4p was identified by our laboratory by a genome-wide linkage
analysis of a large pedigree, F22, affected by affective disorders such as BPAD and
recurrent unipolar depression (UP) (Blackwood et ah, 1996). This finding was
subsequently confirmed by other groups that also reported linkage to schizo-affective
disorder and schizophrenia (Asherson et ah, 1998). The group followed this work by
constructing a contig encompassing 6.9 Mb of the 4p 15-16 region (Evans et ah,
2001; Le Hellard et ah, 2001), including an 11 cM D4S394-D4S403 (5.8 Mb) critical
region for BPAD and a single remaining -300 Kb gap. The region was further
characterised by a computational study of transcripts mapped to the contig (Semple
et ah, 2000; Evans et ah, 2001). Access to three other linked families: F59, CF50 and
F48 was obtained through collaboration (Williams et ah, 1999; Detera-Wadleigh et
ah, 1999). Haplotype analysis performed by the group in these four families allowed
the determination of the haplotype that segregates with the disease in each of them.
The largest candidate region is bound by the recombination breakpoints in
F22 and recombination breakpoints in the other families delineate four sub-regions.
Two of these regions can be prioritised for candidate gene analysis by the strength of
evidence provided by the different families. Figure 6.1 represents the 4p 15-16
candidate region and shows the location of the two high-priority sub-regions referred
to as 'region B' and 'region D' hereafter. The key activity of the group now consists
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in carrying out case-control association studies of single markers and haplotypes in
large control, BPAD and schizophrenia samples. SNPs used in these studies are
either retrieved from public resources, such as dbSNP (Smigielski et ah, 2000), or
detected in-house in tested samples. SNPs that have been analysed so far were
mainly located in the coding sequences of the genes in these two regions. However,
evidence for the crucial role of regulatory polymorphisms in normal function of the
cell and, and hence diseases, is now increasing (Wray et al., 2003). Identification of
the causal variants in the 4p region therefore also relies upon the testing of SNPs in
non-coding sequences. The large size of the candidate region, which spans
approximately 8 Mb in total for both high-priority regions, underlines the necessity
of narrowing the number of markers to test to a manageable number. Detection of
non-coding sequences with a high potential for function is therefore indispensable to
association studies. The work presented in this chapter aimed to apply the most
successful protocol described in the previous chapter to identify a limited number of
non-coding sequences to be screened for SNPs.
Figure 6.1: Candidate region for psychosis on chromosome 4p. The schema
represents the 4p 15-16 region linked to psychosis, together with the extent of the
haplotypes that segregate with the diseases in the four families. The overlaps of these
haplotypes and the strength of evidence define two high-priority sub regions D and B
(vertical boxes), then C and A. 'AFD': major affective disorder; 'SCZAFF': schizo¬
affective disorder and schizophrenia; 'SCZ': schizophrenia.
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The analysis reported in this chapter focused on regions B and D and
specifically on the known genes and well-supported predicted genes. In human,
regions B and D contained 9 and 17 such genes, respectively, as provided by
Ensembl in April 2004. The data set analysed comprised all 26 human genes. For
each of these genes, the orthologs in mouse, rat, chicken, zebrafish and the pufferfish
T. rubripes were primarily identified using resources from Ensembl (similarity
relationship, online BLAST facility) (Clamp et al., 2003), but also from the NCBI
(including Homologene, http://www.ncbi.nlm.mh.gov/entrez/queiy.fcgi7dtHiomologene)
and the UCSC Genome Bioinformatics site (Kent et al., 2002). Inspection of the
conservation of synteny in this region was carried out to resolve conflicting data
often due to the presence of paralogs and incorrect annotation. Genomic sequences of
the genes identified and their 10 Kb flanking regions were retrieved from Ensembl.
For each human gene, a multiple alignment of its sequence and those of its orthologs
was built using MLAGAN (Brudno et al., 2003). A 40 bp window for which the
'binomial' score was computed then scanned the alignment. Top-scoring windows
were then selected and sequences with high potential for function were derived (see
chapter 5).
6.2 Sequence conservation in rodents, chicken and fish
6.2.1 Identification of orthologs
Orthologs of human genes in mouse, rat, chicken, zebrafish and pufferfish
were identified using the similarity relationships provided by Ensembl, based on best
reciprocal hits. Many cases were observed where the orthologs could not be
identified readily, due to conflicting data regarding the available sequence assembly
or annotation and regarding the suggested orthology relationships. Although these
problems are related to one another, cases observed were classified into three types:
i) sequence annotation and assembly, ii) sequence availability, and iii) orthology
relationships, each sub-divided into several categories, as shown in Table 6.1. Out of
the seven mis-assemblies observed five where found in the mouse (assembly
NCBI32), of which four were not present in the NCBI30 assembly of the mouse
genome. Evidence for the incorrect prediction of first exons was observed for 16
genes, based on EST data and truncated open reading frames. Inspection of the
conservation of synteny led to the exclusion of one ortholog reported in rat, eight
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reported in zebrafish, and five reported in pufferfish. For six human genes, while no
ortholog was reported, inspection of synteny of the flanking genes in the species of
interest allowed the identification of the putative ortholog in that species. However,
in seven additional cases, synteny of the flanking genes was conserved in the species
but the ortholog could not be identified, due to the presence of a gap in the sequence,






annl Mis-assembly: the predicted structure of the gene was spurious, based
on the annotation and structure of close orthologs (mouse); or the















ann3 Missed 5* end: The structure of the Ensembl gene differed from that of
the NCBI gene, and/or ESTs and promoter predictions by FirstEF and
Eponine suggested an alternative start of the gene at a position further
upstream than that predicted. This derived gene structure was further
supported by an ortholog of the gene.
<D
O
seql Truncated gene: The sequence of the reported ortholog seems to be





seq2 Truncated flanking sequence: the reported ortholog was located in a
sequence such that the flanking region available was shorter than 10
Kb.
ortl Spurious ortholog: conservation of synteny of the reported ortholog
and its flanking gene(s) i) could not be assessed, due to missing
sequence or lack of convincing evidence for homology to any other
gene, ii) suggested that the reported genes was in fact the ortholog of a
different human gene, or iii) provided no or weak support for the
orthology relationship reported.
jo
ort2 Too many orthologs: several orthologs were reported, and synteny




Ort3 Not reported but suggested: no ortholog was reported but
conservation of synteny of the genes flanking the human gene, in the
species of interest suggested that the ortholog may exist but could not
be found, because of a gap in the sequence, or a putative mis-assembly.
Ort4 Not reported but detected: no ortholog was reported but conservation
of synteny of the genes flanking the human gene, in the species of
interest suggested the presence of the ortholog, which was further
supported by expression data and gene prediction.
Table 6.1: Categories of problems observed in the identification of vertebrate
orthologs of known human genes in the two chromosome 4 candidate regions. 'Key':
names of categories used in Table 6.2; 'Description': description of the problem.
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mis-assembly 7 DKFZp761I3107 mouse (NCBI30)
KIAA0746 chicken
>x RBPSUH chicken














< HS3ST1 rat, chicken, zebrafish, pufferfish














p GBA3 chicken, pufferfish
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not reported but suggested 7 KIAA0746 zebrafish
LOC389203 chicken
RBPSUH ratj pufferfish
GBA3 mouse, chicken, zebrafish




Table 6.2: List of problems observed in the identification of vertebrate
orthologs of known human genes in the two chromosome 4 candidate regions. 'Nr'
number of cases observed; '(NCBI30)': The sequence used was retrieved from the
NCBI30 assembly of the mouse genome.
153
Chapter 6 Comparative analysis of genes in a candidate region for psychosis
After inspection of the availability and quality of the annotation of the
sequences in the six species, all 26 known human genes originally considered were
included in the analysis. The number and total length of exons in the human
sequences are displayed in Table 6.3. The genes included in the analysis are listed for
each species in Table 6.4.




































Table 6.3: Genomic sequence features in well-characterised genes in the two
candidate regions. Table showing the number and total length of coding sequences,
5'UTRs, coding sequences, 3'UTRs, introns and flanking regions, summed over all
genes in the HMR set (column 'Set of genes'), and averaged over these genes
(column 'Gene Average').
6.2.2 Conservation of synteny
Conservation of synteny of human genes in regions B and D was inspected in
mouse, rat, chicken, zebrafish and pufferfish. Analysis of region B suggests the
presence of important rearrangements, or errors in the assembly of this region in the
mouse, rat and chicken genomes, as suggested by differences in the order of some
genes, absence of some genes, and a large insertion within one gene (Figure 6.2).
Evidence for conservation of synteny for four genes was found in zebrafish and
pufferfish (Figure 6.2). Synteny of the nine genes studied in region D, separated in
two blocks, was conserved in mouse, rat and chicken, but not in fish.
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6.3 Highly conserved genomic sequences
Three sets of sequences were studied. First, the 'HMR' set consisted of each
human gene and its orthologs in mouse and rat and contained 25 such groups of
orthologs. Second, the 'HMRC' set consisted of the human genes and their orthologs
in rodents and in chicken and contained 23 groups of orthologs. Third, the
'HMRCZF' set consisted of the human genes and their orthologs in rodents, chicken,
zebrafish and Fugu. This set contains 20 sets of orthologs.
Results of the analysis are summarised in Table 6.5 and Table 6.6. The total
length of human sequence analysed was 2.1 Mb, 1.9 Mb and 1.4 Mb for the HMR,
HMRC and HMRCZF sets, respectively. The total length of sequence selected for a
high potential for function represented 2.5, 2.6 and 3.0% of the sequence tested with
the HMR, HMRC and HMRCZF sets, respectively. Over all genes, the total length of
selected sequence was: 54.2 Kb, 47.7 Kb and 40.9 Kb for the HMR, HMRC and
HMRCZF sets, respectively, in a total of 646, 534 and 469 conserved sub-sequences.
On average, between 22 and 26 conserved sequences were identified in each gene
(Table 6.5). Out of the 646 conserved sub-sequences selected based on comparison
between human, mouse and rat, HMR set, 263 (40%) overlapped coding sequences.
The proportion of conserved sub-sequences overlapping coding sequences was
higher when chicken was included (HMRC set), 45% (240/534), or when fish
sequences were considered (HMRCZF set): 49% (230/469). The proportion of base
pairs in coding sequences overlapped by selected conserved sub-sequences was:
58%, 73% and 74% for the HMR, HMRC and HMRCZF sets respectively. With the
HMR set, three conserved sub-sequences were identified in 5'UTRs and did not
overlap coding sequences, whereas 24 conserved sub-sequences were found to be
located in 3'UTR without overlapping coding sequences. This difference was also
observed with the other sets (Table 6.5). As shown in Table 6.3, over all genes in the
HMR set, 5'UTRs cover 6.7 Kb, whereas 3'UTRs cover 24.3 Kb. The 4-fold
difference in the number of conserved sub-sequences in 3'UTRs compared to
5'UTRs may therefore be partly accounted for by the difference in length of these
sequences, and hence maybe in the quality of the annotation of UTRs in the
sequences, rather than by a higher sequence conservation in 3'UTRs than in 5'UTRs.
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HMR HMRC HMRCZF
Sum Average Sum Average Sum Average
Total number 646 26 534 22 469 23
Coding sequences 263 11 240 10 230 1
Non-coding sequences 383 15 294 12 239 12
5'UTR 3 0 2 0 2 0
3'UTR 24 1 23 1 23 1
Introns 251 10 183 8 133 7
Flanking 77 3 73 3 70 3
UTRs; Introns; Flanking 28 1 13 1 11 1
Percentage Novel (%) 60 55 52
Table 6.5: Repartition of selected genomic sequences conserved in
vertebrates. Results are displayed for the sets HMR, HMRC and HMRCZF. For each
set, values in the columns 'Sum' show results summed over genes in the set, and
values in columns 'Average' show results averaged over genes in the set. 'Total
number': total number of conserved sub-sequences selected; 'coding sequences':
number of conserved sub-sequences (CSSs) in coding sequences; 'Non-coding
sequences': number of CSSs not in coding sequences; 5'UTR, 3'UTR, 'Introns' and
'Flanking': number of CSSs entirely within each type of sequence; 'UTRs; Introns;
Flanking': number of CSSs overlapping each type of non-coding sequences;
'Percentage novel (%)' : Percentage CSSs that did not overlap a coding sequence.
Out of all selected conserved sub-sequences in the HMR set, 58% (383/646)
did not overlap any coding sequence. These sequences will therefore be referred to as
'conserved non-coding sequences' hereafter. The percentage of such sequences
identified when chicken sequences are included decreased to 55% (294/534, HMRC
set), and to 52% (239/469, HMRCZF set) when fish sequence were considered. The
average number of conserved non-coding sequences identified per gene was 15, 12
and 12 for the HMR, HMRC and HMRCZF sets, respectively.
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The number of conserved non-coding sequences observed within 10 Kb
upstream of the first exon of genes was 43, 53 and 54 for the HMR, HMRC and
HMRCZF sets, respectively. Out of these sequences, 23 (53%), 20 (38%) and 16
(30%) were located within 2 Kb immediately upstream of the start location of the
genes.
HMR HMRC HMRCZF
Sum Average Sum Average Sum Average
Total ali. length (bp) 2 787 152 111 486 3 044 204 126 842 2 654 205 132 710
Total seq. length (bp) 2 104 892 84 196 1 905 385 79 391 1 369 254 68 463
Total pred. length (bp) 54 240 2 170 47 680 1 987 40 859 2 043
Percentage selected (%) 2.6 2.6 2.5 2.5 3.0 3.0
Coding bp selected (%) 58 73 74
Non-coding bp in CSS (%) 52 42 38
N coding bp selected 26 223 1049 27 862 1 160 25 335 1 268
N coding bp discarded 14 925 596 10 197 425 8 123 406
N non-coding bp selected 28 017 1121 19 818 825 15 524 776
N non-coding bp discarded 2 035 727 81 429 1 847 508 76 980 1 320 272 66 014
Table 6.6: Amount of selected genomic sequence conserved in vertebrates.
Columns are as in Table 6.5. 'Total ali. length': total length of the aligned human
sequence; 'Total seq. Length': total length of the original human sequence, 'Total
pred. Length': total length of conserved sub-sequences; 'Percentage selected':
percentage of base pairs in the human sequence selected as highly-conserved;
'Coding bp selected': percentage of coding base pairs selected; 'Non-coding bp in
CSS': percentage of selected base pairs in non-coding sequences; 'N coding
selected': number of base pairs in coding sequences selected; 'N coding discarded' :
number of base pairs in coding sequences not selected, i.e. discarded; 'N non-coding
selected': number of base pairs in non-coding sequences selected; 'N non-coding
discarded': number of base pairs in non-coding sequences discarded'.
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6.4 Polymorphisms in highly conserved genomic regions
Table 6.7 shows that 5 703 SNPs were identified in the genes in the HMR set,
and 5 448 and 3 773 in the sets HMRC and HMRCZF, respectively. Out of these,
155, 123 and 107 were located in conserved sequences, representing approximately 2
to 3 % of the total number. These 'conserved SNPs' were classified according to
whether the conserved regions overlapped a coding sequence or not. Within the
HMR set, 41 out of the 155 conserved SNPs (26%) were located in conserved non-




Total Number Coding Non-coding
HMR 5703 155 114 41
HMRC 5448 123 80 43
HMRCZF 3573 107 76 31
Table 6.7: Number of single nucleotide polymorphisms in selected regions
conserved in vertebrates. Names of sets are as in text.
6.5 Examples of highly conserved genomic regions
6.5.1 Anaphase promoting complex subunit 4, ANAPC4
Figure 6.3 illustrates results obtained for the analysis of the human 'anaphase
promoting complex subunit 4' (ANAPC4) gene in region D, which mediates
metaphase-anaphase transition (Yu et al., 1998). Using sequences from six species,
the 28 exons of this gene were all identified, by 29 CSSs (indicated by arrows heads
in Figure 6.3). Out of the 12 remaining non-coding CSSs, 5 were located in introns, 2
in 3'UTRs, and 5 in the flanking regions. Three non-coding CSSs contained a SNP
reported in dbSNP, and one also contained a putative binding site for the LIM
Homeobox 3 (LXH3) transcription factor. Figure 6.4 shows the aligned sequences
for these three CSSs and the information content at each position.
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Figure 6.4b shows the level of conservation observed for a CSS in the last
intron of the ZCCHC4 gene, at position 1.5 Kb in figure 6.4a. Figure 6.4b contains
two parts: i) the aligned sequences, at the bottom, with identical letters in red and
embedded in boxes, and ii) the corresponding plot of the information content, above
the alignment, which illustrates the importance of individual sites in the alignment.
The explanation of information content in this context is as follows. At a given
column, one is uncertain of the bases in each sequence prior to reading them. While
each base is read, the uncertainty decreases as some information is received. The
measure of uncertainty is the base 2 logarithm of the number of symbols that can be
found and is expressed in bits. If only one symbol is possible, uncertainty is zero, but
with four equally possible symbols, such as nucleotides in a DNA sequence where
gaps are discarded, maximum uncertainty is achieved as 2 bits. The information
content is derived from the maximum uncertainty (i.e. before reading bases in the
column) from which is subtracted the uncertainty after reading bases (i.e. accounting
for the information received by reading bases) and a factor to account for the fact that
a finite number of sequences have been used. In the ideal case of a high number of
sequences and equiprobable nucleotides, a site with a base perfectly conserved has an
information content of 2.
Although analysis of the ANAPC4 gene included sequences from six species,
human, mouse, rat, chicken, zebrafish and pufferfish, in the alignment shown in
Figure 6.4b, sequences from mouse and zebrafish were discarded because they did
not appear to contain the CSS. In Figure 6.4b, the T bases at positions 26 and 27 are
conserved in the four sequences shown, and this is illustrated by a tall letter.
Similarly, the neighbouring T and Gs at positions 28-30, are conserved in human, rat
and zebrafish, but not chicken where these bases seem to be deleted. These positions
are represented by a tall letter, since the sequence with the gap is ignored and only
three sequences are considered, but the height of this letter is slightly smaller than for
the T's present in all four species, reflecting the effect of the change in the number of
sequences included. Similarly, position 25 contains three As but also a C, and is
represented by much smaller letter A, reflecting the bigger effect of a substitution on
the information content than that of a gap, as well as an even smaller letter C to
indicate the substituted base. The information plot shown here is used to help read
the alignment below it. This plot contains 80 positions in total, of which 9 harbour a
tall letter representing the base conserved in four species, 41 smaller letters at
positions where the represented base differs in one species. The region of the plot in
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the box indicating the position of a putative LHX3, shows that out of the 8 positions
in the motif, the 1st, 3rd, 4th and 6th columns have a base shared by three species. The
total length of sequence shown for the 80 bp CSS (Figure 6.4b), 40 bp CSS (Figure
6.4c), and 60 bp CSS (Figure 6.4d, mouse sequence excluded) is 180 bp. Out of these
180 columns, 127 contained a nucleotide conserved in at least three species: 1 in all 6
species, 11 in 5 species, 46 in four species and 69 in three species. This illustrates the
high conservation of these sequences, despite the presence of numerous, scattered
substitutions in each sequence, shown in the seemingly unclear alignments but
summarised in the information content plots. Region D contains two promising
functional candidate genes: cholecystokinin (CCK) A receptor (CCKAR) and
phophatidylinositol 4-kinase type-II ji (PI4K2B).
6.5.2 Cholecystokinin (CCK) A receptor, CCKAR
The plot of the percentage of identity of the annotated sequence of the human
CCKAR gene with the sequence of its ortholog in mouse, chicken, zebrafish and
Fugu is shown in Figure 6.5. All five exons contained at least one CSS and several
CSSs were detected in non-coding sequences: five in the 10 Kb upstream region, one
in the 5'UTR, seven in introns, and two in the 10 Kb downstream region.
Details of four of the CSSs identified are shown in Figure 6.6: one CSS in a
coding sequence (CDS) (Figure 6.6b), two in intron 2 (Figures 6.6c and 6.6d) and
one in intron 3 (Figure 6.6e). In Figure 6.6b, the alignment of the 40 bp CSS in the
second exon, at position 18 Kb in figure 6.6a, shows the level of conservation
observed, which is illustrated in the corresponding plot of the information content,
above the alignment. This plot contains 14 positions with a single tall letter
representing the base conserved in all five species, 11 smaller letters at positions
where the represented base differs in one species, and 6 even smaller letters at
positions with 3 identical bases out of five. In comparison, the other three CSSs, in
non-coding sequences, also harbour high levels of conservation with many bases
conserved in all five species, such as in one of the 60 bp CSS in intron 2 (Figure
6.6c) located at 17.4 Kb in Figure 6.6a. Although, this sub-sequence does not seem to
be present in Fugu, as indicated by gaps in the alignment in the bottom half of Figure
6.6c, it contains 9 bases identical in human, mouse, chicken and zebrafish, and 28
bases conserved in three of the four species.
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The alignment of the other 60 bp CSS in intron 2, at 14.7 Kb in Figure 6.6a
and shown in Figure 6.6d, contains 38 columns with a base conserved in at least
three species out of five: 4 columns with perfectly conserved bases, 15 columns
identical in 4 species; and 19 columns with bases shared by 3 species. Gaps in one
species are observed in 31 columns. This CSS also contains a putative binding site
for the LIM Homeobox 3 (LHX3) transcription factor. Out of the 10 bases in this
site, one is identical in all species and eight are conserved in four species.
The 100 bp CSS in intron 3, at 12.7 Kb in Figure 6.6a, is represented in
Figure 6.6d. Ignoring the first seven bases present in human and mouse only, out of
the 93 remaining positions, 45 contains a gap in chicken or Fugu. However, 60 of the
93 columns contain a base conserved in at least three species: one base is identical in
all five species, while 26 columns contain a base conserved in 4 species and another
33 columns contain a nucleotide conserved in three species.
The upstream region of the CCKAR gene also harbours CSSs, including three
that are located within 800 bp of the initiation codon. These three CSSs, 'CCS_4',
'CCS_5', 'CCS_6' and one CSS in the first intron, 'CCS_8' are shown in Figure 6.7a
which displays the annotated sequence spanning 800 bp upstream and 800 bp
downstream of the initiation codon, as well as the location of the CSSs. Alignments
of these four 40 bp CSSs are shown in Figure 6.7b-e. Despite several gaps in these
sequences, out of the 160 bp covered by the four CSSs, 99 bp are conserved in at
least three species: 11 are identical in all five species, 23 are conserved in four
species, and 65 are conserved in three species. Furthermore, out of the remaining 61
positions, 52 contain a nucleotide that is identical in human and mouse. Out of the 10
SNPs observed in this 1.6 Kb region, one lies in CSS_5, 'SNP_71' in Figure 6.7a,
i.e. rs4349588 in Figure 6.7c, and another lies in CSS_6, 'SNP_68' in Figure 6.7a, i.e
rs6448456 Figure 6.7d, at positions -473 and -85 from the initiation codon,
respectively.
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Figure 6.7: Conserved sequences in the 5' end of the human CCKAR gene, a) Plot of
the region spanning 800 bp either side of the initiation codon of the human CCKAR gene, on
the 'transcripts' track (transcript ENST00000295589), and conserved sub-sequences (CSSs)
identified in mouse, chicken, zebrafish and pufferfish Fugu. SNPs are displayed with their
internal name (black label), and their dbSNP name, followed by their position with respect to
the initiation codon (red label). For example, at approximately 0.9 Kb on the scale, lies
SNP 68, named 'rs6448456' and located at -85 with respect to the initiation codon (at 0.8
Kb on the scale). CSSs are labelled in black, and their location with respect to the initiation
codon and length are shown in the red label (start.end:length). Remaining details as in Figure
6.4. b) 'CCS 4' in the upstream region, at 1.35 Kb on the scale; c) 'CSS 5' in the upstream
region, at 1.25 Kb; d) 'CSS 6' in the 5'UTR, at 0.85 Kb; e) 'CSS 8' in intron 1, at 0.5 Kb
on the scale.
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6.5.3 Phophatidylinositol 4-kinase type-ll p , PI4K2B
The percentage of identity plot obtained for the analysis of the PI4K2B gene
in human, mouse, rat, chicken and Fugu is displayed in Figure 6.8. Out of the 28
CSSs identified, 12 were located in the 10 exons of the gene, 1 in the 5'UTR, 4 in the
3'UTR, 8 in introns, and three (11%) overlapped a repeat by more than 20 bp, two in
the upstream region, and one in the downstream region. The latter three CSSs were
each 40 bp and represented 6% of the total length of sequence covered by CSSs
(1980 bp), while repeats represent 64% of the human sequence analysed (41 594 bp
out of 65 061 bp). Across the 18 genes analysed in human, mouse, rat, chicken,
zebrafish and pufferfish, 52 of the 471 CSSs (11%) overlapped a repeat, and for 41
of these, the overlap was longer than 20 bp. Half the CSSs overlapping a repeat by
more than 20 bp were located in three genes: nine in FLJ11082, seven in FLJ35725
and five in GPR78, for which repeats represent 56%, 48% and 24% of the human
sequence analysed, respectively.
Details of four CSSs in non-coding regions of the PI4K2B gene sequence and
10 Kb flanking sequences are given in Figure 6.9, which also shows the entire
annotated human PI4K2B gene sequence, and the position of CSSs (Figure 6.9a).
The four examples shown are located on this sequence in intron 6 (Figure 6.9b), in
intron 9 (Figure 6.9c) and in the 3'UTR (Figures 6.9d and 6.9e). The alignment of
the CSS in intron 9 (Figure 6.9c) was manually edited by removing the sequence of
the chicken because it did not contain the CSS and by adding a gap in the sequence
of the zebrafish at position 20 and a gap in the other sequences at position 27. Out of
the 181 bp covered by these four CSSs, 150 were conserved in at least three species:
32 were perfectly conserved, 58 were conserved in four species and 60 were
conserved in three species. One of the CSSs in the 3'UTR contains two sub¬
sequences 'TTGTATTTTT', at positions 20-29 and 39-47 in the alignment shown in
Figure 6.9e, both conserved in human, mouse and rat, with the first sub-sequence
being conserved in chicken, too.
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6.5.4 DEAH (Asp-Glu-Ala-His) box polypeptide 15 , DHX15
CSSs shown above show high conservation in several species, and CSSs in
non-coding sequences are usually 40 bp to 80 bp. In contrast, some genes contain
large non-coding CSSs, such as the DEAH (Asp-Glu-Ala-His) box polypeptide 15
(DHX15) gene in region D, at 24.2 Mb on chromosome 4. As shown in Figure 6.10,
the DHX15 gene contains a 240 bp CSS in intron 4, immediately downstream of
exon 4 (Figure 6.10b), and a 140 bp CSS in intron 9, immediately downstream from
exon 9 (Figure 6.10c).
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Figure 6.10: Conserved sequences in the human DHX15 gene. Plot of the
sequence of the human DHX15 gene, on the 'transcripts' track and 10 kb flanking
regions (a), and alignments of two intronic CSSs (b and c). Details as in Figure 6.4.
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Alignments of the non-coding CSSs shown here for four genes appear to
contain more gaps, and fewer positions where bases are conserved in all species than
CSSs in coding sequences. Nonetheless, these four examples illustrate that these
genes contain non-coding sequences of 40 bp to 240 bp that are conserved in
vertebrates as distantly related to Mammals as bird and fish. Several CSSs contain
SNPs and two of them also contain a putative binding site for the LIM Homeobox 3
(LXH3) transcription factor (Figure 6.4a and 6.6d).
6.6 Discussion
Comparative genomics has been reported to be an efficient tool to detect
functional genomic sequences (Wasserman et al., 2000; Pennacchio and Rubin,
2001; Chapman et al., 2004). This chapter reports the identification of known and
putative functional sequences in the human chromosomal region 4p 15-16 linked to
psychosis (Blackwood et al., 1996), by comparing the human sequence to sequences
from five vertebrate species for which the genome sequence was publicly available.
Results presented here were obtained by applying the protocol described in the
previous chapter to genes with known function and genes with unknown function but
supported by convincing evidence from gene prediction and expression data. This
method aimed to detect sequences conserved to a greater extent than would be
expected according to the rate of synonymous substitution measured for this gene.
The protocol used can be briefly summarised as follows. First, orthologs of the
human gene were sought in mouse, rat, chicken, zebrafish and pufferfish. Second, the
protein sequences encoded by the human gene and by the orthologs identified in
these species were aligned to estimate the rate of synonymous substitution at four¬
fold degenerate positions. A global multiple alignment of the genomic sequences for
the gene and its flanking regions from each species was then built. Aligned
sequences were subsequently scanned using a sliding window to identify regions
showing higher conservation among the species considered than expected from the
estimated rate of synonymous substitutions. Finally, SNPs in the conserved
sequences detected were identified.
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As for the genes used to benchmark the protocol described in the previous
chapter, identification of orthologs of the human genes analysed here was
cumbersome. Prior to the 'pre-release' of the chicken genome sequence by Ensembl,
attempts were made to identify orthologs by developing a script to consult the
Ensembl SQL database (version 15), analyse the reported best reciprocal hits and
identify genes in mouse, rat, zebrafish and pufferfish that were each the best
reciprocal hit in the other four species. This generated helpful information but
manual inspection of the reported putative orthologs in each species remained
necessary. In the easiest cases, problems were related to the structure of genes
provided by Ensembl. Most discrepancies were resolved by inspecting annotation of
the sequences in detail. This was possible for the genomes of the mouse, rat and
chicken, although some orthologs, in rat and chicken in particular, were discarded
due to errors in the fragmented genomic assemblies. Other problems related to the
identification of the orthologs themselves, especially when no ortholog or several
orthologs were suggested. Several problems of this type were resolved by searching
the protein and genomic sequences from the different species with the homologous
sequence in an attempt to identify the ortholog manually, and by inspecting synteny
of the genes in all six species. Several problems could however not be deciphered,
such as in the case of genes from large families, and in particular in the identification
of orthologs in fish. In most cases, this most likely reflected the lack of sequence
data, resulting in the fragmented assembly of these genomes, and also the presence of
paralogs in these species.
Results obtained by comparing sequences from human, mouse, rat, chicken,
zebrafish and pufferfish were overall similar to that obtained when fish sequences are
not considered. However, fewer genes were included in the analysis using sequences
from all six species as orthologs in fish could not be identified for six human genes.
Conservation in fish of a sequence conserved in human, mouse, rat and chicken
further supports the assumption that this sequence is functional. However,
conservation of a sequence in rodent and chicken alone is strong evidence for
putative function. Since the recent release of the assembly of the chicken genome,
the labour required to identify orthologs in fish therefore seems to outweigh the
additional knowledge provided by their analysis, at least until the quality of the
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sequence data in these species improves greatly. Furthermore, genomes from several
mammalian species, which are more closely related to human and therefore more
appropriate for the analysis of human genes than chicken and fish, are being
sequenced, such as the dog, of which the genome assembly is due to be published in
the near future (http://www.nhgri.nih.gov). Sequences from these mammalian
species will prove valuable as many functional genomic sequences required for
biological processes specific to mammals, perhaps including brain functions
involved in psychosis, may not be present in the genome of vertebrate species such
as chicken or fish.
Several CSSs selected in this analysis overlap partially or entirely known
interspersed repeats. It is possible that other CSSs overlap repeats not identified by
RepeatMasker. However, RepeatMasker identifies known repeats reliably
(http://www.repeatmasker.org) and it is therefore unlikely that known repeats exist in
the sequences analysed but have not been detected. On the other hand, if some
repeats were not identified, they would most likely belong to unknown classes of
interspersed repeats. Such classes are expected to be rare since interspersed repeats in
the human, mouse and rat genomes are well studied (International Human Genome
Sequencing Consortium, 2001; Waterston et al., 2002; Gibbs et al., 2004).
Furthermore, out of the 26 known human genes in the two candidate regions B and
D, orthologous genes were identified in chicken and/or fish for 25 genes. Almost all
CSSs identified are therefore shared between human and at least one distantly related
species. The presence of interspersed repeats in these CSSs is unlikely because
interspersed repeats are expected to accumulate mutations at a neutral rate
(International Human Genome Sequencing Consortium, 2001; Waterston et al.,
2002; Elnitski et al., 2003; Kolbe et al., 2004; Gibbs et al., 2004). As for CSSs
detected here that overlap interspersed repeats, they may merely be due to the
presence of sub-sequences within interspersed repeats that are conserved in
vertebrates (Furano, 2000; Ogiwara et al., 2002). It is however noteworthy that
certain classes of interspersed repeats are functional in eukaryotes such as
Drosophila, sea urchin, mouse and human (Britten, 1997). These interspersed repeats
may therefore be under selective constraint and presumably demonstrate higher
conservation than expected. In primates, for instance, Alu repeats may be under
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selective constraint related to their role in regulation of gene expression, rather than
to the maintenance of their capacity to replicate in the genome (Britten, 1994).
Although most interspersed repeats are inactive in human, some are still
active (Smit, 1996; International Human Genome Sequencing Consortium, 2001),
and polymorphic insertions have been reported for several types of interspersed
repeats (Carroll et al., 2001; Myers et al., 2002; Buzdin et ah, 2003; Watkins et ah,
2003). Some interspersed repeats insert within genes, disrupting their function and
causing diseases (Druker and Whitelaw, 2004). For instance, insertion of a truncated
element of the LI subfamily of long interspersed nuclear elements (LINEs) into an
exon of the factor VIII gene was detected in patients with haemophilia and proved to
cause the disease (Kazazian et ah, 1988). Interspersed repeats can also have a
regulatory role when they insert in or near promoters and in enhancers of genes, as
observed in human and mouse (Ostertag and Kazazian, Jr., 2001; Druker et ah,
2004). Insertion of the 3'UTR segment of a LI element in an enhancer 15 Kb
upstream of the growth hormone gene cluster resulted in the expression of these
genes (Shewchuk et ah, 2001). Similarly, insertion of a LI element in an enhancer
situated 20 Kb upstream of the promoter of the apolipoprotein A gene, was shown to
be responsible for a 10-fold increase in transcriptional activity of the gene (Yang et
ah, 1998). This appears to be due to the presence binding sites for the Spl and Ets
transcription factors in the 5'UTR of LI repeats (Yang et ah, 1998). In addition, the
5'UTR of LI elements also contains an antisense promoter that can drive
transcription in the opposite direction from that of the internal LI, resulting in the
production of transcripts with the adjacent flanking region (Speek, 2001). Because
the human genome contains approximately 4000-5000 full-lengths LI copies, it is
possible that many of these elements influence the expression of genes nearby
(Nigumann et ah, 2002; Druker and Whitelaw, 2004). It is noteworthy that
chromosome 4 appears to be much more permissive to insertions of the youngest
type of LI elements in human, specifically, than any other chromosomes, and than
would be expected from its length or gene density, although the significance of this
findings is not clear (Boissinot et ah, 2004).
Short interspersed nuclear elements (SINEs) also contain a promoter region
but no protein-coding sequence (Okada, 1991; Druker and Whitelaw, 2004). The
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most prominent form of SINEs comprises Alu elements, which are the only SINEs
still active in the human genome (International Eluman Genome Sequencing
Consortium, 2001). Increasing evidence suggest that Alu repeats are implicated in
transcription, translation, response to stress, nucleosome positioning and imprinting,
and might have be involved in the evolution of regulatory networks in the primate
lineage (Britten, 1994; Shankar et ah, 2004). Several Alu insertions are thought to
cause human diseases, including insertions occurring in coding sequences or close to
exon boundaries, where they may affect splicing (Deininger and Batzer, 1999;
Deininger and Batzer, 2002). For instance, an alternatively splice variant of
neuregulin 1, one of the strong candidate genes for schizophrenia, contain an in-
frame Alu-sequence in the coding sequence, but the biological relevance of this
insertion is not known (Stefansson et al., 2004). Alu repeats also affect gene
expression at the level of transcription, via insertions in or near promoter and
enhancer regions (Britten, 1996), such as in an enhancer in the last intron of CD8A
gene encoding the CD8 antigen, alpha polypeptide (p32) (Hambor et al., 1993), or in
the promoter of the gene encoding the nicotinic acetylcholine receptor a6 subunit
(CHRNA6) (Ebihara et al., 2002). Antisense transcription from the promoter of
SINEs has also been observed in mouse (Ferrigno et al., 2001). In addition, Alu
repeats are also involved in mRNA editing (Kreahling and Graveley, 2004),
including mRNAs in the human brain (Blow et al., 2004). The functional
significance of Alu repeats is consistent with the possibility of positive selection of
these repeats in gene-rich regions of the human genome (International Human
Genome Sequencing Consortium, 2001).
In addition, endogenous retroviruses (ERVs), the only long-terminal repeat
(LTR) retrotransposons still active in the mammalian genome, cause several diseases
(Druker and Whitelaw, 2004) and human endogenous retroviruses (HERVs) have
been reported to influence the expression of some human genes (Britten, 1996), such
as amylase genes (Samuelson et al., 1990; Ting et al., 1992). Interestingly, a type of
HERV might be involved in the aetiology of schizophrenia, although the role of such
inserts remains undefined (Deb-Rinker et al., 1999; Yolken et al., 2000; Karlsson et
al., 2001; Deb-Rinker et al., 2002).
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Some interspersed repeats in the upstream region of human genes are
conserved in the upstream sequences of othologous genes in rodents and appear to be
responsible for the expression of these genes, such as the essential frataxin gene
implicated in ataxia (Greene et ah, 2005). Although the promoter of the human
frataxin gene contains the mammalian initiator region and another regulatory
element, expression of the gene seems to be mainly driven by interspersed repeats in
its promoter under the conditions of experimental tests. Reporter gene assays carried
out with constructs lacking these repeats, one LINE and one SINE, showed a 40%
reduction in expression compared to that observed with the full length construct
(Greene et ah, 2005). Surprisingly, the region upstream of the transcription start site
is poorly conserved in rodents and similarities between the 1.2 Kb sequences
upstream of the initiation codon in human and rodents are restricted to only two
small regions located in the 220 bp 5'UTR. It is interesting that the first region, 46 bp
long only, overlaps an ancient LINE element. Moreover, deletion of this region in
reporter gene assays, in addition to the repeats mentioned above, resulted in a
reduction of expression by another 40%, from 60% to 20%. Finally, electrophoretic
mobility shift assays allowed the identification of two sequences of approximately 30
bp, each located in one of the two conserved regions, and none of these sequence
contained known transcription factor binding sites (Greene et al., 2005).
Thus, it is unlikely that CSSs identified in the set of known genes in the two
candidate regions for psychosis on chromosome 4 overlap unknown interspersed
repeats, while the few CSSs overlapping known repeats might be functional, in
particular because they appear to have been conserved over at least 300 million
years.
Conserved non-coding sequences identified in the candidate regions have a
high potential for function and could represent yet unidentified exons or regulatory
regions. These sequences are therefore targets for experiments aiming to map
transcripts and investigate their transcriptional regulation. These sequences are also
targets for SNP detection and some were found to contain SNPs to prioritise in allelic
association studies performed by the laboratory to identify variants associated with
psychosis. In addition to genes encoding receptor for dopamine receptor D5 (DRD5),
and other G protein-coupled receptors such as GPR78 and GPR125, the two minimal
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regions contain other candidate genes, such as cholecystokinin (CCK) A receptor
('CCKAR) and phophatidylinositol 4-kinase type-11 /3 (.PI4K2B) for which details of
some CSSs were given above.
Cholecystokinin (CCK) is a neurotransmitter in intestinal and central
neurones which inhibits food intake in a dose-dependent manner (Gibbs et ah, 1973;
Degen et ah, 2001). CCK is secreted from intestinal cells in response to food intake
and is important in the regulation of energy balance as a post-prandial satiety signal
maybe mediated by CCKAR (Noble et ah, 1999; Hillebrand et al., 2002). The
CCKAR gene may contribute to susceptibility to diabetes (Marchal-Victorion et al.,
2002), severe obesity (Miller et al., 1995; Funakoshi et al., 2000) and bulimia
nervosa (Geracioti and Liddle, 1988; Klein and Walsh, 2004). CCK also plays an
important role in the function of the central nervous system via its interaction with
dopamine and other neurotransmitters such as serotonin and gamma-aminobutyric
acid (Rehfeld, 2004). CCK is one of the most abundant neuropeptide in the human
brain, in particular in cortical areas (Larsson and Rehfeld, 1979; Noble et al., 1999;
Hillebrand et al., 2002). Furthermore, a transition in a transcription factor binding
site in the promoter of the CCK gene may be associated with smoking (Comings et
al., 2001), alcoholism (Harada et al., 1998), delirium tremens (Okubo et al., 2002),
hallucinations in patients with Parkinson's disease (Wang et al., 2003), anxiety and
panic disorder (Wang et al., 1998; Hattori et al., 2001; Rotzinger and Vaccarino,
2003), and schizophrenia (Wang et al., 2002). In addition, regulation of the
expression of the CCK gene seems to involve glygogen synthase kinase 3 (3
(GSK3B) (Hansen et al., 2004). This is noteworthy since this enzyme mediates the
action of mood stabilisers (Klein and Melton, 1996; Stambolic et al., 1996) and has
been associated with affective disorders (Barrett et al., 2003; Benedetti et al., 2004a;
Benedetti et al., 2004b; Benedetti et al., 2005). Despite a study reporting that a
microsatellite in the upstream region of the CCK gene does not seem to be associated
with mood disorders in Japanese (Hattori et al., 2002), these findings strongly
suggest that the cholecystokinin system may be involved in psychiatric diseases.
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Two CCK receptors have been identified (Kopin et al., 1992; Wank et al.,
1992). CCKAR and CCKBR are receptor-coupled G proteins involved in
phosphoinositids (Pis) break down and intracellular calcium mobilisation, and
distinguished by their affinities to various forms of the CCK peptide (Kopin et ah,
1992; Pisegna et al., 1992). Both receptors control CCK-induced release of dopamine
in different brain areas (Crawley, 1991; Wang et al., 2003). CCKAR has also been
found in dopaminergic neurones in areas of the brain implicated with schizophrenia
(Hokfelt et al., 1980).
Association between polymorphisms in the upstream region, including
rs6448456, in the 5'UTR of the human CCKAR gene at position -85 numbered from
initiation codon ('SNP_68' in Figure 6.7a), have been associated with hallucinations
during withdrawal in Japanese alcohol dependent men (Okubo et al., 2002), auditory
hallucinations and other positive symptoms in SCZ (Wei and Hemmings, 1999;
Tachikawa et al., 2000; Zhang et al., 2000) and SCZ (Tachikawa et al., 2001).
Another variant, in intron 1, has been suggested to interact with a variant in the
promoter of the CCK gene in visual hallucinations experienced by patients with
Parkinson's disease (Wang et ah, 2003). These variants were shown in Figure 6.7
and include rsl800857 (SNP_62), rsl800855 (SNP_63), rs6448456 (SNP_68),
rsl799723 (SNP_69), rsl800908 (SNP_70). These associations need further
examination as no major role for CCK related polymorphisms have been reported in
some populations with panic disorder (Hamilton et ah, 2001), SCZ (Bowen et ah,
1998), and alcoholism (Ishiguro et ah, 1999; Vanakoski et ah, 2001). Although, none
of the polymorphisms in the CCKAR gene have been reported to be functional, it is
interesting that two of them, rs4349588 and rs6448456 lie in conserved sub¬
sequences identified here in species as distantly related to human, mouse and rat, as
chicken, zebrafish and Fugu (Figure 6.7c and Figure 6.7d). Assuming that
evolutionary constraints that retained these sequences reflect their function, it may be
possible that the effect of the polymorphisms in these sequences were not detected by
the analyses carried out, and thus would have small effect on gene expression.
Alternatively, functional variants in close vicinity of these loci may exist but have
not been identified yet.
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PI4K2B is an enzyme involved in phospholipid metabolism (Minogue et al.,
2001; Barylko et al., 2001; Balla et al., 2002). Lipid synthesis and degradation are
involved in two cellular processes. First, phosphoinositids (Pis) play roles in
cytoskeletal organisation and in the interactions between the membrane and protein
machinery involved in vesicle budding and traffic (Rohrbough and Broadie, 2005).
Second, Pis serve as intracellular second messengers mediating signal transduction
by hormones and neurotransmitters into the cell (Rohrbough and Broadie, 2005).
Cellular signalling and intracellular trafficking are activated independently and this
requires spatial and temporal control of PI metabolism. This is mediated partly by PI
kinases, which phosphorylates Pis in specific compartments of the cell, including the
plasma membrane, endosomes, secretory granules, and the Golgi complex. The
various functions of Pis are governed by various combinations of phosphorylation of
the 3', 4' and 5' positions of the inositol head group (Rohrbough and Broadie, 2005).
Phosphorylation of the 4' position of the inositol ring by PI 4-kinases, generating
PI(4)P, seems to be the rate limiting step in the production of higher phosphorylated
second messengers such as dyacylglycerol (DAG), and phosphorylated inositol
derivatives such as inositol 1,4,5-triphosphate (IP3) or PI(4,5)P2, which is able to
anchor signalling complexes to membranes. The regulated production and
distribution of PI(4)P is highly complex and dynamic, and variation in the
distribution of PI(4)P varies with the cell type (Rohrbough and Broadie, 2005;
Weixel et al., 2005).
Several genes involved in the synthesis or dephosphorylation of PI(4,5)P2 lie
in regions linked to BPAD, including lOp, 18q, 21 q and 22q (Baron, 1997; Sklar,
2002). Some of these regions are also linked to SCZ, such as lOp, 18q and 22q
(Lewis et al., 2003). A member of the PI 4-kinase family, PI 4-kinase type III a
(PI4KCA), on 22ql 1 linked to BPAD and SCZ (Baron, 1997; Sklar, 2002; Lewis et
al., 2003), contains a polymorphism at position -31 showing a trend for association
to BPAD (Saito et al., 2003). Similarly, the promoter of PI 3-kinase class 3
(PIK3C3), on 18q also linked to BPAD and SCZ (Baron, 1997; Sklar, 2002; Lewis et
al., 2003), contains a SNP at -432 which affects binding of a transcription factor and
has been associated with both BPAD and SCZ (Stopkova et al., 2004a; Duan et al.,
2005). In addition, a microsatellite close to the exon 9-intron 9 splice donor site of a
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member of the PI(4)P 5-kinase family, PIP5K2A, may also to be involved in BPAD
and SCZ (Stopkova et al., 2003). Finally, mood stabilisers such as lithium and
valproic acid target the glycogen synthase kinase 3-(3 (GSK3B) (Klein and Melton,
1996; Stambolic et al., 1996). Polymorphisms in this gene, including a SNP in its
promoter, have also been associated with affective disorders (Barrett et al., 2003;
Benedetti et al., 2004a; Benedetti et al., 2004b) and long-term response to lithium in
BPAD (Benedetti et al., 2005).
The type II family of PI 4-kinases, comprising PI 4-kinase type II a
(PI4K2A) and PI 4-kinase type II (3 (PI4K2B), have been isolated recently (Barylko
et al., 2001; Minogue et al., 2001). PI4K2A and PI4K2B harbour little similarity to
other protein or lipid kinases and represent a novel and distinct branch of the PI 4-
kinase family (Barylko et al., 2001; Minogue et al., 2001). Rates of activity and
kinetics of the two membrane-bound isoforms are identical, and the two enzymes
have been suggested to have overlapping but not identical functions (Wei et al.,
2002). PI4K2A appears to be an integral protein, while PI4K2B acts as a peripheral
protein (Wei et al., 2002). Both enzymes have been reported to localise primarily to
intracellular membranes in the endoplasmic reticulum, Golgi complex and in plasma
membrane rafts (Wei et al., 2002; Waugh et al., 2003). PI4K2B is primarily cytosolic
and associates with plasma membrane in higher levels than PI4K2A, while PI4K2A
was also found in synaptic vesicles of neurones in the brain (Wei et al., 2002).
PI4K2B seems to be involved in the endocytotic pathway in the cytoplasm
and in the production of second messengers when it is recruited to the plasma
membrane (Heilmeyer et al., 2003). PI4K2B may contribute to the transmission of
signals from some growth factors when it is recruited to the membrane and activated
by AKT1 ('v-akt murine thymona viral oncogene homolog 1') (Wei et al., 2002).
Interestingly, recent studies in human and mouse suggest that AKT1 may play a role
in the aetiology of SCZ (Emamian et al., 2004; Ikeda et al., 2004). Furthermore, in
response to neurotrophins, AKT1 inactivates GSK3B and may thereby promote axon
outgrowth (Yoshimura et al., 2005). The GSK3B gene has also been associated with
affective disorders (Barrett et al., 2003; Benedetti et al., 2004a; Benedetti et al.,
2004b; Benedetti et al., 2005).
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Type II PI 4-kinases colocalise in membrane lipid rafts with some growth
factor receptors and may contribute to their endocytosis and processing (Minogue et
ah, 2001; Waugh et ah, 2001). Lipid rafts are membrane microdomains rich in
cholesterol and PI(4,5)P2 that may serve as platforms for a range of cellular
signalling complexes (Tsui-Pierchala et ah, 2002). In neurones, lipid rafts are
important for cell adhesion, axon guidance and synaptic transmission (Tsui-Pierchala
et al., 2002). For example, the translocation of protein tyrosine kinases to lipid rafts
is necessary for signalling and regulation of synaptic plasticity by neuregulin (Yang
et al., 2004), which is implicated in SCZ (Stefansson et al., 2002). It is not known
whether PI4K2B plays a role in neurones, but neuronal PI 4-kinase activity has been
detected (Wiedemann et al., 1998). This seems to be accounted for mainly by
PI4K2A, however, when it associates with synaptic vesicles (Guo et al., 2003).
Nonetheless, PI4K2A activity does not account for the totality of PI 4-kinase activity
(Guo et al., 2003), and it is possible that PI4K2B contributes to the generation of
PI(4)P, hence of PI(4,5)P2, in lipid rafts enabling them to function.
PI4K2B might also play a role in vesicles turn-over. Neurotransmitters are
released in the synaptic space by exocytosis of the synaptic vesicles that contain
them. The membrane of these vesicles then re-enter the cell by endocytosis and are
recycled (Rohrbough and Broadie, 2005). Such transport of vesicles, including
vesicles in synapses, relies on phosphoinositide synthesis and hydrolysis (Cremona
and De Camilli, 2001; Rohrbough and Broadie, 2005). Generation of PI(4,5)P2 to
compensate its degradation during endocytosis is thought to occur on the plasma
membrane via the action of PI(4)P 5-kinase type Iy (PIP5K1C), using PI(4)P as a
substrate (Wenk et al., 2001). Generation of PI(4)P itself is due to PI 4-kinase
activity, which has been observed on synaptic vesicle (Wiedemann et al., 1998). The
family of type II PI 4-kinases has been reported to account for an important
proportion of PI 4-kinase activity, including activity on membranes, in various
tissues (Barylko et al., 2001; Minogue et al., 2001). PI4K2A is present in neurones
and is thought to account for the majority of the synaptic vesicle membrane-bound PI
4-kinase activity (Hinshaw, 2000; Guo et al., 2003). PI4K2A may contribute to
synaptic vesicle cycle by generating PI(4)P from PI, thereby enabling creation of
PI(4,5)P2 in synaptic vesicles after its degradation by polyphosphoinositide
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phosphatase synaptojanin 1 (SYNJ1), required for fusion of vesicles with the
membrane (Guo et ah, 2003). Although the major form of PI kinase activity in the
brain seems to be PI 4-kinase activity and mediated by PI4K2A, it is possible that
other PI 4-kinases play important roles in the brain upon activation (Zhao et ah,
2001). Because PI4K2A and PI4K2B have very similar activities, PI4K2B may
account for some of the PI 4-kinase activity observed in the brain. Interestingly, the
SYNJ1 gene lies on 21q22 linked to BPAD (Baron, 1997; Sklar, 2002) and two
studies have reported trends of association of the gene with BPAD (Saito et ah, 2001;
Stopkova et ah, 2004b). Evidence suggesting a potential role of type II PI 4-kinases
in neuropsychiatric disease is also provided by a study reporting that activity of
plasma membrane-bound type II PI 4-kinase activity in rat is inhibited directly and
reversibly by pathophysiological concentrations of amyloid (3 proteins, and that type
II PI 4-kinases may therefore be implicated in the pathogenesis of Alzheimer's
disease (Wu et ah, 2004).
The role of the recently identified PI4K2B gene in the PI metabolism is
unclear at present. Because the type II PI 4-kinase family has recently been
identified, the tissue and cellular distributions and the functions of both isoforms are
not certain. Although it is not clear whether PI4K2B occurs in the brain, and in
particular in neurones, it seems possible that this enzyme, like PI4K2A, is involved
in the turn-over of synaptic vesicles. The function of PI4K2B may indeed be elusive
in the cell types and conditions tested since PI4K2B appears to be mainly cytosolic
and inactive, but activated upon recruitment to the plasma membrane. It is
noteworthy that the PI4K2B gene lies on 4pl5, linked to psychosis, and is involved
in PI metabolism, a situation reminiscent of other genes encoding PI kinases that are
located on chromosomal regions linked to BPAD and SCZ, and that have been
associated with either or both of these illnesses, such as another PI 4-kinase, PI4KCA
(Saito et ah, 2003). PI4K2B thus appears to be another strong candidate gene in the
4p 15 region. Regions identified in this gene that are conserved in distantly related
species and were described above are likely to contribute to the function of PI4K2B
and may be involved in susceptibility to BPAD and SCZ.
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The examples shown here illustrate that genes in the candidate region,
including strong candidate genes, contain non-coding sequences of 40 bp to 240 bp
that are conserved in vertebrates as distantly related to mammals as bird and fish.
Several conserved non-coding sequences contain SNPs, some ofwhich were reported
to be associated with neuropsychiatric diseases such as SCZ, and two of them also
contain a putative binding site for the LIM Homeobox 3 (LXH3) transcription factor.
These findings confirm the view that comparative analysis is a powerful tool for the
identification of potentially functional non-coding regions, and can be applied to
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7 Final conclusions
7.1 Summary
Affective disorders and schizophrenia are common and major psychiatric
diseases that involve mood-related symptoms and disturbed thinking, respectively
(Gelder et al., 2000). In addition to impairing the patient's life, these illnesses
represent an important burden placed upon the patient's family, social and health
services, and account for an substantial amount of the total NHS spending (Gelder et
ah, 2000). Although causes of these diseases are uncertain, they include genetic
factors and seem to involve the serotonergic, dopaminergic and glutamatergic
pathways (Baron, 1997; Harrison and Weinberger, 2005; Kato, 2001). Furthermore,
treatment of these disorders through medication is often palliative and response to
treatment varies widely between patients (Malhotra et al., 2004). Unravelling the
aetiology of these diseases is therefore the focus of many academic research groups
and pharmaceutical companies. Several candidate regions for bipolar affective
disorder (BPAD) and schizophrenia (SCZ) have been identified by linkage studies
(Owen and Cardno, 1999; Potash and DePaulo, 2000; Sklar, 2002). One of these
regions was identified by the group on 4p 15-16 (Blackwood et al., 1996). The group
also set up an ACeDB database to manage the annotated genomic sequence of this
region. The key activity of the group now consists in carrying out case-control
association studies of single markers and haplotypes in large samples of control,
unipolar (UP), BPAD and SCZ DNA. SNPs used in these studies are either retrieved
from public resources, such as dbSNP (Smigielski et al., 2000), or detected in-house
in tested samples. Due to the large number of markers to test and the large size of the
case and control samples required to achieve statistical significance, DNA pooling is
used in a fast, cost-effective initial screen of these markers. SNPs retained are then
tested using classical association studies based on individual genotypes and
haplotypes.
187
Chapter 7 Final conclusions
The first aim of this thesis was to develop a computational tool to assist
ongoing laboratory work by allowing association data management and analysis.
This was achieved by creating an extension of the ACeDB database and a CGI front-
end to allow for the submission and analysis of allelic association data. Specifically,
these two tools allow: i) storage of information relevant to genotyping assays
(experimental conditions and results) and to DNA pool construction, ii) creation of
meta data sets, and iii) test of allelic association with disease based on single DNA
pools, single sets of individual samples in a population, or merged data sets, and
storage of results of these tests. Since their development, these tools have been used
successfully by experimental scientists with little knowledge of the intricacies of
ACeDB, demonstrating their usefulness.
The goal of an association study is to detect differences in allele frequencies
between affected and unaffected people that are expected to indicate differences in
the function of genomic sequence variants at the loci studied. Markers tested by the
group so far were located in coding sequences of genes in the two high-priority
candidate regions B and D. Evidence is however accumulating that polymorphisms
in non-coding sequences, in particular regulatory regions of genes, may play a role in
the aetiology of complex disorders as important as those in coding sequences
(Knight, 2005; Wray et al., 2003). Annotation of both coding and non-coding
sequences of the candidate 4p region with functional elements, either known or
novel, is therefore key to the identification of polymorphisms contributing to the
diseases directly, or located close to causal variants. As coding sequences are
estimated to represent only 2% of the mammalian genome (Rat Genome Sequencing
Project Consortium, 2004), functional elements in non-coding sequences must be
identified among a vast amount of sequence. Following the development of the
database extension and CGI front-end to manage and analyse data generated by
ongoing work, this thesis therefore set out to develop computational tools to identify
functional elements in non-coding sequences.
Little is known about the types and quantities of functional elements in non-
coding sequences, referred to until recently as 'junk' DNA. Regulatory regions of
genes, which are located immediately upstream of genes, such as promoters, or
within introns, or many kilobases away from the gene regulated, play a crucial role in
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gene transcription regulation and have therefore been the focus of many studies of
non-coding functional elements (Orphanides and Reinberg, 2002; Kadonaga, 2004;
Svejstrup, 2004). These regions contain transcription factor binding sites (TFBSs)
that are represented by small, between 6 and 20 bp, and often degenerate sequence
motifs. Searching a sequence for these motifs typically generate a high number of
false positives as the motifs are so small that they can occur by chance alone (Duret
and Bucher, 1997). Restricting the search to sequences conserved between human
and mouse can help address this problem (Tagle et al., 1988; Wasserman et ah, 2000;
Pennacchio and Rubin, 2001). The first method tested in this project aimed to
identify putative regulatory regions by combining comparative genomics of upstream
regions of genes in human and mouse with prediction of known transcription factor
binding sites and detection of novel motifs in sequences conserved in the two species
(Chapter 4). This approach was not sensitive enough and predicted too high a
number of false positives to guide experimental work in the laboratory.
Most methods used to identify conserved human genomic sequences have
compared human and mouse sequences and identified sub-sequences with a given
minimum length and minimum percentage identity (Loots et ah, 2000; Wasserman et
ah, 2000). Analysis of sequences from additional species reduced the amount of
conserved neutral sequences, as divergence eliminates these sequences differently in
each species and lineage (Duret and Bucher, 1997; Thomas et ah, 2003). Most of
these studies considered a limited number of genes within the same narrow
chromosomal region (Gottgens et al., 2002; Thomas et al., 2003). For example, a
study using sequences from 12 species and the scoring scheme based on the
probability of the amount of conservation measured, given an estimated rate of
neutral substitution, reported results for a 1.8 Mb region around the CFTR gene only,
and relied on a broad estimate of the quantity of functional sequence in the entire
human genome (Thomas et al., 2003). This study was difficult to compare with
others because it included sequences from many species, contrasting with the
majority of studies based two or three species only (Dubchak et al., 2000; Gottgens
et al., 2002; Wasserman et al., 2000; Dubchak and Frazer, 2003). In contrast with the
study of the CFTR region which used the evolutionary depth of the sequences
analysed to distinguish between functional and neutral sequences, Kolbe and co-
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workers (2004) used statistical properties of genomic sequences from human, mouse
and rat of genes at various locations in the human genome and reported high
accuracy with a 80% sensitivity, 85% specificity and 84% positive predictive value.
This 3-way regulatory score has so far been developed for human, mouse and rat
only.
The second approach applied in this project relied on the analysis of
sequences of a human gene and of its orthologs in the five vertebrate species for
which the genome sequence was publicly available at the time (Chapter 5). Four
scoring schemes were benchmarked against a set of genes with known functional
regulatory regions, identifying the most accurate: the score reflecting the probability
of observing the amount of conservation measured, given the rate of synonymous
substitution estimated for the gene studied (the 'binomial score'). Results showed
that this approach was sensitive, since it detected a large proportion of known coding
and regulatory genomic sequences (sensitivity of 78%), was highly specific
(specificity of 97%) and showed a reasonable predictive power (positive predictive
value of 60%). In comparison to the two studies mentioned above by Thomas et al.
(2003) and Kolbe et al. (2004), the binomial score used in this thesis is as accurate
and has the advantages of being applicable and tailored to each gene, or genomic
region, unlike the study of the CFTR region (Thomas et al., 2003), and of including
sequences from all species for which the genome sequence is available, such as
chicken, zebrafish and pufferfish, unlike the 3-way regulatory score (Kolbe et al.,
2004). The binomial score predictions may be regarded as conservative since
positive control regions identified experimentally in the control sequences are likely
to represent only a proportion of regions within these sequences that are actually
involved in the regulation of gene expression in a given cell in different tissues, or
areas of the brain, at different stages of development, or in response to various
environmental stimuli (Werner, 2000). The limited number of conserved sequences
detected using this scoring scheme could therefore realistically form the basis of
experimental work.
The binomial score approach was consequently applied to genes in the 4pl5-
16 candidate region for psychosis. Conserved sequences were detected in 26 known
and predicted genes supported by expression data, and their 10 Kb flanking regions,
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by using orthologs from three sets of species: i) rodents only, ii) rodents and chicken,
and iii) rodents, chicken and fish. Non-coding sequences conserved in the highest
number of species are strongly supported putative functional sequences. Sequences
with a high potential for function are targets for experimental verification of their
function and for SNP detection. SNPs already identified in these regions are markers
to test in allelic association studies using pooled DNA.
Examples of conserved sub-sequences (CSSs) identified in four genes in the
4p region using sequences from mammals, bird and fish, and a conservative set of
parameters, were described in the Chapter 6. All exons in the four genes were at least
partially overlapped by CSSs. In addition, numerous CSSs were identified in non-
coding sequences of these genes. In particular, CSSs in introns and the upstream
region of two candidate genes for psychosis were described in details. The first codes
for a receptor for one of the most abundant neuropeptides in the human brain,
cholecystokinin (CCK) A receptor (CCKAR) (Pisegna et ah, 1992) and the second
encodes an isoform of a type II PI 4-kinase potentially implicated in the synaptic
vesicle cycle, phophatidylinositol 4-kinase type-II |3 (PI4K2B) (Minogue et ah,
2001). In addition to being conserved in vertebrates as distantly related as mammals
and fish, and hence interesting in their own right, some of these non-coding
sequences contain polymorphisms previously reported to be associated with SCZ
(Bowen et al., 1998), panic disorder (Hamilton et al., 2001), alcoholism (Ishiguro et
ah, 1999; Vanakoski et al., 2001), and hallucinations experienced by patients with
Parkinson's disease (Wang et al., 2003).
7.2 Future directions
To continue this project, it would prove valuable to extend the analysis to the
entire candidate region by applying this approach to blocks of conserved synteny
rather than genes and their flanking sequences. The threshold used for the selection
of top-scoring windows would be derived from the total length of known coding
sequences in the human sequence spanned by the block tested. Also, the threshold
used to detect sequences reported here was the exact proportion of coding region in
the human sequence and is likely to be conservative since 5% of the mammalian
genome is estimated to contain functional sequences whereas coding sequences only
191
Chapter 7 Final conclusions
account for half this amount (Rat Genome Sequencing Project Consortium, 2004).
Although conservation of all coding sequences is not expected, a less stringent
threshold could be used, depending on the length of the block, to allow for the
selection of additional sequences with high potential for function. The analysis of
blocks of conserved synteny from human and other species with the method
presented here requires that sequences contain no rearrangement, nor error in the
assembly because sequences were aligned using the global multiple alignment tool
MLAGAN (Brudno et ah, 2003). This issue could be addressed by using a local
multiple alignment tool (Schwartz et ah, 2003). The method presented here relies on
a window scanning the alignment to which a score is given based on the amount of
conservation observed for each species compared to human. It might therefore be
valuable to try and score each column in the alignment, using a scoring scheme based
on its information content, and derive sequences with high potential for function
based on these columns' scores. This work could also serve as a basis for detection
within the non-coding conserved regions of known regulatory motifs, or novel
motifs, either individually or arranged in clusters, using software available to date
(Frith et al. 2003). Identified motifs could then be searched for in the entire candidate
region. It may also prove useful to search the human genome with conserved
sequences identified in the candidate region 4pl5-16, as they may suggest the
presence of genes elsewhere in the genome that share common putative regulatory
regions. It may also be useful to inspect genes located within other susceptibility
regions for BPAD or schizophrenia, identify conserved non-coding sequences in
these regions and compare these to that identified in the 4p 15-16 region. This may
allow the identification of sequence motifs shared by several conserved regions
located in different places in the human genome.
Using the three sets of vertebrate species serves to identify sequences
conserved in distant species such as fish, and also those not conserved in fish but in
more closely related species such as chicken. However, some functional sequences
important for biological functions specific to mammals, such as brain functions, may
not be identified by the analysis including chicken and fish sequences. It follows that,
although putative functional non-coding sequences detected using sequences from
distant vertebrates such as fish or chicken ought to be studied, sequences identified in
human and rodent only will likely enable the identification of non-coding functional
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sequences and polymorphisms within them. On the other hand, a certain proportion
of the sequences conserved in rodents may not be functional, but part of the eutherian
core genome (Rat Genome Sequencing Project Consortium, 2004). It would
therefore be valuable to complement this approach, based solely on comparative
genomics, with sequences not only conserved but also predicted to be functional,
based on sequence conservation in rodent combined with the analysis of the
statistical properties of nucleotides in the aligned sequences to distinguish neutral
sequences from functional ones (Kolbe et ah, 2004). In addition, some of the
conserved sequences might be filtered out by including sequences from additional
mammalian species, such as dog, when the sequence of their genome becomes
available.
Continuing efforts from international genome sequencing projects allow the
regular improvement of the assemblies of the human, mouse and rat genomes and
will result in the release of genomes from other vertebrate species. In particular,
mammalian species are more appropriate than chicken and fish to use for this
research project focusing on a human disease because analysis of several mammalian
species is more informative (Thomas et ah, 2003). The genome of the dog, for
example, is due to be released in the very near future, followed by that of the cat,
cow, pig and horse (http///www.genome.gov). The genome of the short-tail opossum
will soon be released too, and is likely to provide valuable data, because of the
intermediate position of marsupials on the evolutionary tree of species, between
closely related mammals and distantly related vertebrate species such as chicken
(Graves and Westerman, 2002). Also, identifying orthologs of genes from the 4pl5-
16 candidate region in these mammalian species is expected to be easier than in more
distantly related species, and conservation of synteny may span longer regions.
The approach tested here could be extended to the other 30 genes located in
the candidate region. Since these genes are not well characterised, identifying their
orthologs in rodents, chicken and fish may prove difficult and require time-
consuming manual inspection of the data. In any case, analysis of these 30 genes
using the sequences available to date would complement the set of non-coding
putative functional sequences generated here and provide a substantial amount of
reliable reagents for experimental verification and SNP detection for the entire
candidate region.
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Comparative genomics has been shown to be an efficient tool to identify
functional sequences (Thomas et al., 2003). It has however also been shown here that
even though regulatory regions in human show a substantial amount of conservation
in rodents, and species as distantly related as chicken and fish, not all human
regulatory regions are conserved in these species. This is consistent with the fact that
a third of TFBSs in human are not expected to be conserved in mouse (Dermitzakis
and Clark, 2002). This issue could be addressed by comparing sequences from six
primates species (Boffelli et ah, 2003), if sequence data was available for these
species. This is not yet the case however, as chimpanzee is the only primate species
of which the genome sequence has been released (http://www.genome.gov). Until the
moment when sequences from several primates are available publicly, regulatory
motifs in the 4p 15-16 region that are functional in human but not present in rodent
might be identified by detecting shared, over-represented sequence motifs in
upstream regions of genes involved in the same biochemical pathways as genes in
the 4p 15-16, which could be identified using GO annotation terms
(http://www.geneontology.org) or of genes co-regulated with genes in the candidate
genes, identified using expression data.
7.3 Conclusion
To conclude, the development of the extension of the ACeDB database and
the CGI front-end enabled ongoing work by the group by allowing management and
analysis of data generated by allelic association studies based on pooled DNA and
individual genotypes. The development of a protocol using comparative genomics
between vertebrate species generated reliable predictions to guide future laboratory
work and forms the basis for the development of further computational tools to
improve annotation of non-coding sequences in the candidate region. This thesis has
therefore provided essential data for the identification of polymorphisms and
haplotypes, particularly in non-coding sequences, which are associated with
psychosis. Ultimately, this work will also contribute to the unravelling of the
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9.1 Evaluation of scoring schemes for comparative
genomics with vertebrate species
HMR HMRC HMRZF HMRCZF











BIN1 0.5 0.5 0.5 0.5 2.3
CHRND 0.7 0.8 0.7 0.8 3.4
CHRNG 0.7 0.8 0.7 0.8 65.3
CKMT2 0.5 0.7 0.5 0.7 1.6
GNRH1 0.6 0.6 0.6 0.6 43.9
LCP1 0.5 0.5 0.5 0.5 1.4
MB 1.2 1.3 1.2 1.2 6.6
MYL.3 0.6 0.6 0.6 0.6 4.4
NEFL 0.8 0.9 0.8 1.0 2.6
PLAT 1.0 1.0 1.0 1.0 25.5
SLC25A4 0.4 0.4 0.4 0.4 1.5
ACTA1 1.2 1.4 1.2 1.3 2.8 8.6
CHRNB1 0.6 0.7 0.6 0.7 52.1 57.9
CHRNE 1.0 1.0 0.9 1.0 53.0 56.3
CKM 0.8 0.9 0.8 0.9 2.7 2.7
COL1A1 0.3 0.3 0.3 0.3 1.9 3.2
DES 0.6 0.7 0.6 0.7 66.6 31.2
EPO 0.7 0.8 0.9 0.9 1.1 1.7
GP1BA 0.6 0.7 0.9 0.9 3.6 53.0
CFTR 0.6 0.6 0.6 0.6 1.3 0.6 0.6 17.4 26.3 0.6 0.6 1.3 48.1 28.1
CRYAB 0.4 0.3 0.4 0.4 1.6 0.4 0.4 47.5 50.7 0.4 0.4 1.5 46.6 22.4
G6PC 0.7 0.8 0.7 0.7 57.8 0.7 0.7 2.6 4.4 0.7 0.7 56.1 2.4 5.3
HSPA5 0.4 0.4 0.4 0.4 1.3 0.4 0.4 12.8 6.9 0.4 0.4 1.3 13.0 7.7
IGF1 0.6 0.6 0.6 0.6 1.4 0.6 0.6 2.4 4.0 0.6 0.6 1.5 2.5 2.9
IGFALS 1.8 1.9 1.9 2.0 8.9 2.3 2.3 48.5 69.3 2.4 2.4 6.9 48.4 69.4
MYOG 0.5 1.0 0.6 0.8 16.2 0.5 1.0 30.8 70.7 0.6 0.8 14.7 17.0 54.1
PROC 1.1 1.4 1.1 1.4 18.5 1.2 1.6 20.6 4.5 1.2 1.6 18.0 29.1 4.6
RB1 0.4 0.4 0.4 0.4 1.6 0.5 0.6 50.6 20.5 0.5 0.5 1.6 37.5 20 8
STAR 0.9 0.7 0.9 0.7 3.5 0.9 0.7 2.9 2.5 0.9 0.7 3.3 3.3 2.6
TNNC1 0.9 0.8 0.9 0.8 4.7 0.9 0.8 3.0 3.8 0.9 0.8 4.7 3.0 3.7
Table SI: Rates of synonymous substitution. Estimates are given for the four
sets of groups of orthologous genes: HMR: Human, mouse and rat; HMRC: Human,
mouse, rat and chicken; HMRZF: Human, mouse, rat, zebrafish and fugu; HMRCZF:
Human, mouse, rat, chicken, zebrafish and fugu. Each single column indicate the rate




Set Score Seq av sd min Max av sd min max av sd min max
HMR bino rr 30 17 1 69 96 3 89 100 26 16 3 65
HMRC bino rr 21 18 2 61 98 2 91 99 33 21 6 74
HMRZF bino rr 22 15 2 54 97 2 94 100 28 19 1 56
HMRCZF bino rr 26 19 7 59 98 1 96 100 40 22 8 77
HMR diverg rr 30 17 1 69 96 3 88 99 26 16 3 65
HMRC diverg rr 20 18 1 61 98 2 91 99 31 21 5 77
HMRZF diverg rr 22 14 2 50 97 2 93 100 29 16 5 56
HMRCZF diverg rr 22 12 7 45 98 2 94 99 35 19 9 70
HMR disty rr 30 17 1 72 96 3 88 99 26 16 3 65
HMRC disty rr 21 17 2 61 97 3 89 99 30 18 6 54
HMRZF disty rr 21 12 7 45 96 2 92 99 27 17 3 53
HMRCZF disty rr 19 14 7 45 97 2 92 99 29 18 4 52
HMR pid rr 30 17 1 72 96 3 88 99 26 16 3 65
HMRC pid rr 21 18 1 61 98 2 90 99 32 22 5 77
HMRZF pid rr 22 15 2 50 97 2 94 100 27 18 1 51
HMRCZF pid rr 25 14 7 45 98 2 95 99 37 19 13 70
HMR bino cds 70 17 3 93 96 3 89 100 66 18 2 95
HMRC bino cds 81 18 20 99 98 2 91 99 76 18 16 98
HMRZF bino cds 79 12 55 99 98 2 94 100 78 14 41 96
HMRCZF bino cds 81 13 55 93 98 1 96 100 78 16 44 97
HMR diverg cds 70 17 3 93 96 3 88 99 66 18 2 95
HMRC diverg cds 80 18 23 98 98 2 91 99 76 17 18 98
HMRZF diverg cds 78 14 50 99 97 2 93 100 75 16 42 96
HMRCZF diverg cds 79 15 54 93 98 2 94 99 75 17 41 96
HMR disty cds 71 17 8 94 96 3 88 99 66 18 4 95
HMRC disty cds 80 19 24 98 98 2 89 99 74 18 19 95
HMRZF disty cds 76 15 44 100 97 2 92 99 73 17 44 96
HMRCZF disty cds 77 15 53 92 98 2 92 99 73 18 40 91
HMR pid cds 71 17 8 94 96 3 88 99 66 18 4 95
HMRC pid cds 81 17 23 99 98 2 90 99 75 18 18 98
HMRZF pid cds 80 12 57 99 97 2 94 100 76 16 38 96
HMRCZF pid cds 80 13 54 94 98 1 95 99 76 17 41 96
HMR bino fct 57 18 7 83 96 3 89 100 69 17 6 95
HMRC bino fct 60 19 24 89 98 2 91 100 79 17 25 99
HMRZF bino fct 65 15 27 88 98 2 94 100 80 14 43 99
HMRCZF bino fct 66 19 26 88 98 1 96 100 81 15 49 99
HMR diverg fct 57 17 7 83 96 3 88 99 69 17 6 95
HMRC diverg fct 60 19 24 88 98 2 91 100 78 16 27 99
HMRZF diverg fct 63 16 27 88 97 2 93 100 77 16 42 96
HMRCZF diverg fct 63 18 26 84 98 2 94 100 78 17 44 99
HMR disty fct 58 17 11 83 96 3 88 99 69 17 6 95
HMRC disty fct 59 19 22 88 98 2 89 100 77 17 27 100
HMRZF disty fct 62 16 27 88 97 2 92 99 75 17 44 96
HMRCZF disty fct 61 19 26 83 98 2 92 100 76 19 42 99
HMR pid fct 58 17 11 83 96 3 88 99 69 17 6 95
HMRC pid fct 60 19 24 89 98 2 90 100 77 17 27 99
HMRZF pid fct 65 15 27 88 97 2 94 100 78 16 38 97
HMRCZF pid fct 65 18 26 85 98 1 95 100 79 17 46 99
Table S2 : Accuracy of detection of functional sequences. Data were obtained
with a 20 bp window. 'HMR' : human, mouse and rat; 'HMRC' : human, mouse, rat
and chicken ; 'HMRZF' : human, mouse, rat, zebrafish and fugu ; 'HMRCZF' :
human, mouse, rat, chicken, zebrafish and fugu ; 'bino': binomial score; 'diverg'
score based on dS estimate, 'disty': score based on the distance in years between
species; 'pid': score defined as the average percentage of identity; 'rr': regulatory
region; 'cds': coding sequence; 'fcf: functional sequence (i.e. 'rr' or 'cds'); ppv:
positive predictive value ; 'av' : average ; 'sd' ; standard deviation ; 'min' :




Set Score Seq av sd min max av sd min max av sd min max
HMR bino rr 31 18 10 69 97 3 89 100 37 22 5 82
HMRC bino rr 20 16 4 50 98 1 96 100 34 18 11 74
HMRZF bino rr 25 14 7 50 98 1 95 100 31 20 6 58
HMRCZF bino rr 24 18 1 50 98 2 96 99 27 17 4 51
HMR diverg rr 31 18 10 69 97 3 89 100 37 22 5 82
HMRC diverg rr 21 15 4 50 98 1 96 100 35 18 11 74
HMRZF diverg rr 26 15 8 50 97 2 94 99 36 17 5 54
HMRCZF
u diverg L. 16 1 44 97 2 94 99 23 13 4 41
HMR disty rr 31 18 10 75 97 3 87 100 37 22 5 82
HMRC disty rr 22 16 4 50 98 1 97 100 35 18 12 74
HMRZF disty rr 22 11 6 38 96 3 93 100 34 22 9 76
HMRCZF disty rr 18 15 1 44 97 2 93 99 20 11 4 39
HMR pid rr 31 18 10 75 97 3 87 100 37 22 5 82
HMRC pid rr 21 15 4 50 98 1 95 100 34 18 10 74
HMRZF pid rr 24 15 8 50 97 2 95 99 31 20 2 59
HMRCZF pid rr 26 21 1 63 98 2 95 99 26 15 4 44
HMR bino cds 76 17 6 98 97 2 89 100 74 18 4 99
HMRC bino cds 82 19 24 98 98 3 85 100 76 18 19 96
HMRZF bino cds 82 9 65 97 98 1 95 100 78 12 49 95
HMRCZF bino cds 80 13 56 92 98 2 95 99 74 15 45 91
HMR diverg cds 76 17 6 98 97 2 89 100 74 18 5 99
HMRC diverg cds 82 18 30 98 98 3 85 100 76 17 23 96
HMRZF diverg cds 80 11 57 97 97 2 94 99 76 14 46 95
HMRCZF diverg cds 78 15 52 92 97 2 94 99 71 17 45 90
HMR disty cds 77 17 6 98 97 3 87 100 74 18 4 99
HMRC disty cds 81 18 30 98 98 3 85 100 76 17 24 96
HMRZF disty cds 79 12 55 97 97 2 93 100 74 15 46 95
HMRCZF disty cds 76 16 46 92 97 2 93 99 69 19 33 90
HMR pid cds 77 17 6 98 97 3 87 100 74 18 4 99
HMRC pid cds 82 18 30 98 98 3 85 100 76 17 24 96
HMRZF pid cds 81 9 65 97 97 2 95 99 77 14 42 95
HMRCZF pid cds 78 14 52 92 97 2 94 99 72 16 45 90
HMR bino fct 61 18 10 87 97 2 89 100 76 18 9 101
HMRC bino fct 60 20 24 88 98 3 85 100 79 18 27 103
HMRZF bino fct 66 15 26 89 98 1 95 100 80 12 52 98
HMRCZF
u bino fct 63 19 24 85 98 2 96 99 76 14 50 92
HMR diverg fct 61 18 10 88 97 2 89 100 76 18 9 100
HMRC diverg fct 60 19 24 88 98 3 85 100 78 17 30 103
HMRZF diverg fct 64 16 25 89 97 2 94 100 78 14 46 98
HMRCZF diverg fct 61 19 24 83 97 2 94 99 74 15 50 90
HMR disty fct 61 19 10 88 97 3 87 100 76 18 9 101
HMRC disty fct 60 20 23 87 98 3 85 100 78 17 31 103
HMRZF disty fct 63 16 24 86 97 2 93 100 76 15 46 103
HMRCZF disty fct 59 19 24 82 97 2 93 99 72 18 39 90
HMR pid fct 61 19 10 88 97 3 87 100 76 18 9 101
HMRC pid fct 60 19 24 88 98 3 85 100 78 17 31 103
HMRZF pid fct 66 15 25 89 97 2 95 100 78 14 44 98
HMRCZF pid fct 62 19 24 83 97 2 95 99 75 14 52 90
Table S3 : Accuracy of detection of functional sequences. Data were obtained
with a 40 bp window. 'HMR' : human, mouse and rat; 'HMRC' : human, mouse, rat
and chicken ; 'HMRZF' : human, mouse, rat, zebrafish and fugu ; 'HMRCZF' :
human, mouse, rat, chicken, zebrafish and fugu ; 'bino': binomial score; 'diverg'
score based on dS estimate, 'disty': score based on the distance in years between
species; 'pid': score defined as the average percentage of identity; 'rr': regulatory
region; 'cds': coding sequence; 'fcf: functional sequence (i.e. 'rr' or 'cds'); ppv:
positive predictive value ; 'av' : average ; 'sd' ; standard deviation ; 'min' :




Set Score Seq av sd min max av sd min max av sd min max
HMR bino rr 35 22 4 75 97 3 90 99 38 26 7 81
HMRC bino rr 31 21 3 59 98 1 96 99 36 19 3 59
HMRZF bino rr 30 15 6 50 97 2 94 99 31 20 12 73
HMRCZF bino rr 30 24 4 59 97 2 94 99 26 17 12 53
HMR diverg rr 36 23 4 79 97 3 89 99 38 26 7 81
HMRC diverg rr 29 20 3 59 98 1 95 99 33 16 3 50
HMRZF diverg rr 28 13 6 50 97 2 94 99 30 19 11 73
HMRCZF
L diverg rr 38 32 18 74 98 2 96 99 33 12 20 44
HMR disty rr 36 23 4 79 97 3 89 99 38 26 7 81
HMRC disty rr 27 18 3 50 98 1 95 99 31 16 3 46
HMRZF disty rr 23 11 6 37 96 2 94 99 33 20 13 64
HMRCZF disty rr 38 32 18 74 98 2 96 99 32 13 19 44
HMR pid rr 36 23 4 79 97 3 89 99 38 26 7 81
HMRC pid rr 31 21 6 59 98 1 96 99 35 17 5 55
HMRZF pid rr 28 13 6 50 97 2 94 99 32 21 9 73
HMRCZF pid rr 33 37 6 74 98 1 97 99 28 22 12 53
HMR bino cds 80 16 15 99 97 2 90 99 75 16 12 98
HMRC bino cds 76 20 11 98 97 5 78 99 69 19 10 95
HMRZF bino cds 77 15 37 97 97 3 89 99 73 16 30 94
HMRCZF bino cds 72 18 28 92 97 2 94 99 66 20 22 88
HMR diverg cds 80 16 15 99 97 2 89 99 75 16 12 98
HMRC diverg cds 75 20 11 98 97 5 78 99 68 19 10 95
HMRZF diverg cds 78 15 37 97 97 2 93 99 73 16 27 94
HMRCZF diverg cds 71 17 28 92 96 2 93 99 64 18 24 87
HMR disty cds 80 16 15 99 97 2 89 99 75 16 12 98
HMRC disty cds 75 20 11 98 96 5 78 99 67 19 10 90
HMRZF disty cds 76 15 37 97 97 2 92 99 70 17 26 94
HMRCZF disty cds 71 17 28 92 96 2 93 99 63 19 22 86
HMR pid cds 80 16 15 99 97 2 89 99 75 16 12 98
HMRC pid cds 76 20 11 98 97 5 78 99 69 19 10 95
HMRZF pid cds 78 15 37 97 97 2 93 99 74 17 24 94
HMRCZF pid cds 72 18 28 92 96 2 93 99 64 19 24 88
HMR bino fct 61 18 21 88 97 2 90 99 76 15 20 98
HMRC bino fct 56 20 6 84 97 5 78 100 71 20 10 95
HMRZF bino fct 62 16 22 86 97 3 89 100 74 16 36 101
HMRCZF
L bino fct 56 20 21 85 97 2 94 99 68 19 29 90
HMR diverg fct 61 17 21 88 97 2 89 99 76 15 20 98
HMRC diverg fct 55 20 6 84 97 5 78 100 70 19 10 95
HMRZF diverg fct 63 16 22 87 97 2 93 100 75 16 33 101
HMRCZF diverg fct 55 18 18 78 96 2 93 99 66 17 36 87
HMR disty fct 62 17 21 88 97 2 89 99 76 16 20 98
HMRC disty fct 55 20 6 84 97 5 78 100 69 19 10 95
HMRZF disty fct 60 16 22 86 97 2 92 100 72 17 26 99
HMRCZF disty fct 54 18 18 78 96 2 93 99 66 18 34 86
HMR pid fct 62 17 21 88 97 2 89 99 76 16 20 98
HMRC pid fct 56 20 6 85 97 5 78 99 71 19 10 95
HMRZF pid fct 63 16 22 86 97 2 93 100 75 16 29 101
HMRCZF pid fct 55 18 18 78 96 2 93 99 66 17 36 90
Table S4 : Accuracy of detection of functional sequences. Data were obtained
with a 100 bp window. 'HMR' : human, mouse and rat ; 'HMRC' : human, mouse,
rat and chicken ; 'HMRZF' : human, mouse, rat, zebrafish and fugu ; 'HMRCZF' :
human, mouse, rat, chicken, zebrafish and fugu ; 'bino': binomial score; 'diverg'
score based on dS estimate, "disty': score based on the distance in years between
species; 'pid': score defined as the average percentage of identity; 'rr': regulatory
region; 'cds': coding sequence; 'fct': functional sequence (i.e. 'rr' or 'cds'); ppv:
positive predictive value ; 'av' : average ; 'sd' ; standard deviation ; 'min' :
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A report from HGM200I, the sixth annual International
Human Genome Meeting organized by The Human Genome
Organisation (HUGO), Edinburgh, UK, 19-22 April 2001.
In his opening remarks, the president of HUGO, Lap Chee
Tsui, included a plea to avoid the term 'post-genomic era'.
One does not have to look hard to see why. According to the
Genome Monitoring Table [http://www.ebi.ac.uk/genomes/
mot/] hosted by the European Bioinformatics Institute (EBI)
about 45% of the human genome is available in finished form,
and the rest is available as fragmented 'draft' sequence. Also,
accurate and comprehensive descriptions of the functions and
often even the structures of the 30,000-40,000 predicted
genes are, at the moment, rare. Added to this, the catalog of
variations seen in the human genome is growing but far from
complete. At the same time, the Entrez Genome pages
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Genome]
at the National Center for Biotechnology Information
(NCBI) say that there are currently sequences for 9 finished
or draft eukaryotic, 40 bacterial and 10 archaean genomes,
but a veritable avalanche of new genomes is already on its
way. This new wave of data will extend genomics to new pro¬
tozoan, fungal, plant and animal taxa, including eagerly
awaited vertebrates such as zebrafish, pufferfish, the chimp
and other apes. From several perspectives we are decidedly
in the 'mid-genomic' era.
At this conference a good sampling of activities in the present
'meso-genomic' era was presented and several themes recurred.
We carried out a superficial survey of the abstracts available at
the HGM2001 website [http://hgm2001.hgu.mrc.ac.uk/] and
found certain terms to be better represented than others
(Figure 1). Many abstracts (134 out of the 543 online) dealt
with studies of human variation and particularly of single-
nucleotide polymorphisms (SNPs). Far fewer abstracts con¬
tained references to human diseases or disorders, reflecting
the fact that much work on variation was concerned simply
with the detection ofSNPs and issues around data analysis. In
such 'data-rich times' computational analysis is very much in
evidence. Much ofwhat we know about the function of human
genes is inferred computationally and so, to rectify this,
studies are underway to generate functional data using model
organisms. Comparative genomics is rapidly coming of age
and many studies, particularly those using the draft mouse
genome, demonstrated its utility in sequence annotation.
Fewer studies at this meeting concentrated on what precisely
is transcribed and eventually translated from the genome,
although important initiatives were described. It is also
becoming evident that epigenetic mechanisms can be impor¬
tant in the journey from genotype to phenotype.
The finer details: genomic variation and
complex traits
It is often quoted that all humans are around 99.9% geneti¬
cally identical, but that still leaves millions of sites in the
genome where we differ. The largest public repository for
SNPs, dbSNP [http://www.ncbi.nlm.nih.gov/SNP/] at the
NCBI, now contains more than 1.68 million of these varia¬
tions. At the HUGO conference it became clear that the
search is on for the variations that are important in identify¬
ing predisposition to disease and tracing our evolutionary
history. A key question, which received a lot of attention, is
the extent of linkage disequilibrium (LD) between SNPs. LD
is a measure of the association between alleles; for example
if no recombination has occurred between alleles they are in
complete LD. The greater the distance such associations
span, the more chance we have of finding SNPs that indicate
predisposition to disease. A great deal depends on the
ancient history of human populations. Some previous theo¬
retical work, assuming constant population expansion, has
suggested that LD should extend over only a few kilobases. It
now appears, however, that the history of Northern Euro¬
pean populations involved bottleneck events since migration
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Figure I
A survey of common terms in abstracts submitted to HGM200I. The categories on the horizontal axis were derived from
searches for the presence of the following terms: polymorphism* or SNP*; bioinformatic* or comput*; function* and genom*;
compar* and genom*; disease* or disorder*; proteom* or protein* and structur*; epigenet* or methylat* or heterochrom*;
RNA and splic* or process*. Individual abstracts can appear in more than one category, so little can be concluded from the
absolute heights of columns.
from Africa. Eric Lander (Whitehead Institute, Cambridge,
USA) revealed that this has resulted in LD extending over
some regions of around 120 kb (although great variation in
LD was seen across the genome) and that a map defining
perhaps 30,000 ancestral regions of LD can be constructed
for such populations. In a Nigerian population, by contrast,
LD extended over less than 10 kb and is more consistent
with a simple model of population expansion. The results
suggest that a representative set of only 100,000 SNPs could
be effective for whole-genome association studies of disease
in Northern European populations. Michael Olivier (Stan¬
ford Human Genome Center, USA) found LD extending over
regions of chromosome 21 that were between 2 and 85 kb,
but these regions were disrupted by segments of similar or
larger size that showed no significant LD between SNPs. In
addition, each segment was characterized by a restricted
number of observed haplotypes, with the commonest haplo-
type found in over 50% of all chromosomes. These results
illustrate the need to characterize the pattern of LD in a
region of interest before association studies are undertaken.
They also imply that initial localization of disease loci may be
easier in populations with LD that extends over more than
100 kb (such as Northern European populations), but that
finer mapping of such loci, to specific areas of genes, may be
easier in populations with smaller blocks of LD.
Joseph Terwilliger (Columbia University, New York, USA)
discussed the feasibility of identifying common susceptibility
alleles that exert small effects. Much depends upon the rela¬
tionships between three factors: the marker genotype, the
susceptibility allele and the phenotype of interest. In associ¬
ation studies, we measure the correlation between the
marker genotype and the phenotype. The success of this
enterprise depends on two relationships: between the
marker genotype and the susceptibility allele (measured by
linkage and/or LD), and between the susceptibility allele and
the phenotype. The latter relationship depends in turn on
the capacity to infer the genetic factor from the phenotype
(detectance). With complex traits such as predisposition to
common diseases, however, there may be many different
causal genotypes, making detectance low. In such cases,
linkage and LD mapping may not give significant results. All
this still leaves aside the question of gene-environment
interactions, which can further complicate the observed pat¬
terns of disease.
A model association study was presented by Xavier Estevill
(Duran i Rynals Hospital, Barcelona, Spain), who investi¬
gated susceptibility to panic and phobic disorders. His group
identified an interstitial duplication on chromosome
i5q24-26 that is significantly associated with panic disorder
within families from a small Catalonian village. The duplica¬
tion is estimated to be present in around 7% of the general
population. The association was then replicated in a more
diverse population of patients from elsewhere in Spain and




genes within the duplication. One of these genes was overex-
pressed in transgenic mice and was found to cause an
enhanced panic reaction in behavioral tests. In addition, the
duplication was found in different forms within families,
showed an absence of linkage with other i5q markers and
exhibited mosaicism in patients' cells. It therefore appears to
represent a novel, non-Mendelian disease mechanism. Allen
Roses (GlaxoSmithKline, Triangle Park, USA) discussed suc¬
cesses in association studies based on SNPs. High-density
disequilibrium mapping of SNPs has identified new suscep¬
tibility genes for psoriasis, migraine, diabetes mellitus
(type 2) and Parkinson's disease within previously defined
large linkage regions. He predicted that within the next few
years clinical tests for drug efficacy or hypersensitivity will
emerge using collections of SNPs that are associated with a
given phenotype. The successes in identifying associations
and the emerging LD patterns in the human genome have
renewed optimism among those working on common dis¬
eases that show complex inheritance patterns.
The conference also included talks covering complex traits in
species other than human. Complex genetic traits have been
studied and manipulated in agriculture for thousands of
years. The conventional breeding schemes of 'breeding the
best to the best' have been incredibly successful, to the
extent that most people would not think of eating - or indeed
even recognizing - wild tomatoes. Dani Zamir (Hebrew Uni¬
versity of Jerusalem, Israel) presented a model system for
investigating quantitative trait loci (QTL) in tomato. Zamir
and co-workers produced nearly isogenic lines (NILs) of
tomato but included exotic chromosome segments from wild
breeds of tomato, essentially using a back-cross strategy.
Armed with NILs covering the entire genome, they found
and mapped 23 QTLs for the brix (sugar) content of the fruit.
Extension of the original strategy focused on one of the
strongest QTLs, narrowing it to 484 bp within a gene for an
apoplastic invertase, a key enzyme in sugar metabolism.
Further work demonstrated that lower levels of mRNA from
this gene are found in commercial cultivars than in the wild
tomato. Not only is the tomato a good model for studying
QTLs, it is also of substantial commercial significance:
higher brix levels mean better ketchup.
Michel Goeorges (University of Liege, Belgium) described
the fascinating inheritance pattern of "beautifully propor¬
tioned buttocks" (callipyge), in sheep. A ram with the
desired trait was initially identified; through breeding of this
ram and by using a least exclusion breakpoint mapping
approach (that is, using recombination breakpoints to iden¬
tify a common haplotype between individuals), a single,
apparently autosomal dominant locus was pinpointed on
chromosome 18 with a logarithm of odds (LOD) of 55. Clas¬
sical genetic crosses were carried out and these revealed
imprinting at the locus, with only those offspring that inher¬
ited a paternal callipyge allele expressing the phenotype.
Back-crossing to produce sheep homozygous at the callipyge
locus revealed that only heterozygous animals with a pater¬
nally derived allele expressed the phenotype, a phenomenon
described as polar overdominance. Within the callipyge-
determining locus four genes have been found, all of which
are imprinted. It will be interesting to see the molecular
explanation for this bizarre pattern of inheritance.
The same but different: comparative genomics
The human genome is unfinished and we still lack another
complete vertebrate genome for comparison, but comparative
genomics is already becoming popular. Jean Weissenbach
(National Centre for Scientific Research (CNRS), Paris,
France) described successes in comparisons between the
human and more compact vertebrate genomes using the draft
sequences from the two pufferfish species Fugu rubripes and
Tetraodon nigroviridis. His group found such comparisons to
be a valuable addition to the output of ab initio gene-predic¬
tion programs such as GenScan, for detecting novel exons and
conserved, non-coding regions assumed to be important in
regulation. By comparison, they had found human versus
mouse comparisons to be more sensitive (detecting a larger
number of exons) but also 'noisier' (generating many uninfor-
mative matches). Several studies were presented that exploit
the draft mouse sequence to aid the annotation of the human
genome. Lisa Stubbs (Lawrence Livermore National Labora¬
tory, Livermore, USA) described a large-scale comparison
between human chromosome 19 and 15 syntenic regions of the
mouse genome adding up to 46 Mb of mouse sequence within
35 bacterial artificial chromosome (BAC) contigs. Combining
these comparisons with other annotation methods (ab initio
predictions and identifying matches to expressed sequences)
gave a total of around 1,200 genes for human chromosome 19,
with perhaps 50 genes identified by comparative genomics
that had been missed by other methods. The mouse compar¬
isons also identified many new candidate exons, 5' untrans¬
lated regions (UTRs) and more than 4,000 non-coding
conserved regions. Around 30% of the genes on human chro¬
mosome 19 are members of tandemly duplicated clusters,
including vomeronasal receptors, olfactory receptors and zinc-
finger genes. The regions containing clusters were found to
have diverged considerably between human and mouse,
varying in gene content, number and organization, in contrast
to other regions.
Peter Holland (University of Reading, UK) has investigated
the evolution of vertebrate genomes by studying the
numbers of homeotic-gene clusters in vertebrates and
amphioxus (the living invertebrate that is closest to the ver¬
tebrates). He postulates two episodes of tetraploidy, fol¬
lowed by selective gene loss in early chordate evolution near
the time point at which the vertebrates emerged. Gazing
further back in evolutionary time, Eugene Koonin (NCBI,
Bethesda, USA) described using the combination of analyses
of protein structure and comparative genomics to discover
ancient protein domains originating in the last universal
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common ancestor (LUCA) of all extant life forms. The main
biological functions of the LUCA appear to have revolved
around RNA metabolism and translation, whereas the DNA
processing machinery is a later innovation. Koonin also
offered insights into the way new domains evolved, by dupli¬
cation and accretion, during eukaryotic evolution. Many
eukaiyote-specific domains are the result of explosive bursts
of innovation; for example, exploiting the basic a helix in a
variety of novel configurations such as the coiled coil.
It is clear that comparative genomics has thrown up a variety
of new challenges for bioinformatics. Comparisons between
multiple, long sequences that may only share small regions of
limited homology is, in itself, a non-trivial problem. Burkhard
Morgenstern (Munich Information Center for Protein
Sequences (MIPS), Germany) presented a new version of the
DIALIGN program that performs well in the identification of
small regulatory regions in large non-coding DNA sequences.
But although many conference participants emphasized the
success of combinations of methods in gene prediction, we
still lack software that combines intrinsic sequence properties
(as detected by ab initio methods) with genomic-sequence
comparisons and analyses of similarity to proteins or
expressed sequence tags (ESTs). Tim Hubbard (Sanger
Centre, Hinxton, UK) described how the Ensembl
[http://www.ensembl.org] database, which provides annota¬
tion of the draft human genome, has incorporated compar¬
isons to the draft mouse sequence. Hubbard and colleagues
are now grappling with the prospect of incorporating compar¬
isons between human and several other vertebrate genomes.
In spite of substantial conservation between species, there are
clearly very significant differences in the genes and/or their
regulation between species. One such difference between
species is being investigated by Svante Paabo (Max-Planck-
Institute for Evolutionary Anthropology, Leipzig, Germany)
using comparative genomics. His group focuses on the differ¬
ences between humans and other, closely related species.
Previously, the only well-characterized biochemical differ¬
ence between humans and great apes was the level of hydrox-
ylation of sialic acids (major components of cell surfaces in
animals), which is of major importance for the success of
xenotransplantation. Comparing the relative expression
levels of 20,000 genes in blood, liver and brain between
humans, chimpanzees and rhesus macaques has revealed
that the rate of 'transcriptome' change has been similar
between chimps and humans (using macaques as a standard)
in blood and liver. In stark contrast, the rate of change of
expression patterns in the brain is accelerated approximately
three-fold in humans. A number of the most strikingly differ¬
ent expression patterns are now being followed up.
The wild frontier: from genotype to phenotype
With an established foothold in genomics and large-scale,
public collections ofmicroarray data on gene expression just
around the corner, people have begun to peer over the
horizon at the proteome. Most human genes have not been
characterized functionally, so what we do know about them
mostly comes from computational detection of homology. As
Janet Thornton (University College London, UK) made
clear, protein family members commonly exhibit some simi¬
larity in function, but there is remarkable functional varia¬
tion within many families. By examining enzymes within 167
structural superfamilies from the CATH database
[http://www.biochem.ucl.ac.uk/bsm/cath/CATH.html], which
classifies groups of proteins by class, architecture, topology
or homology, she estimated that only around 90 superfami¬
lies contained members with conserved functions. In vari¬
able superfamilies, members often differed in substrate
specificity. Thus, although structural homology can extend
computational predictions beyond homology at the sequence
level, there will always be many proteins for which no reli¬
able predictions can be made. Thornton also discussed
an analysis of proteins associated with disease garnered
from the Online Mendelian Inheritance in Man (OMIM)
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM]
database. By superimposing disease-associated mutations
onto these protein structures she concluded that there was
no general pattern in the positions of disease-causing muta¬
tions. Some occurred within regions, such as active sites,
that would be predicted to alter function, but many others
appear to relate to interactions with other proteins. It is
widely accepted that a wider sampling of the protein-struc¬
tural universe is needed to enhance our understanding of
protein function and dysfunction. Tim Harris (Structural
Genomix, San Diego, USA) discussed large-scale approaches
to X-ray crystallography which might transform information
obtained from the human sequence into novel three-dimen¬
sional protein structures. Initially, the focus is on structural
families with pharmaceutical significance.
Traditionally, the development of new drugs involves testing
novel compounds in disease models with little knowledge of
the biochemical pathways or physiological systems underly¬
ing the disease. Because disruptions in the abundances and
activities of proteins are the molecular basis of many dis¬
eases, proteomics promises to revolutionize drug discovery
by allowing rational identification of drug targets. But the set
of proteins present within a cell at any one time is the net
outcome of many complex processes, including synthesis,
degradation, modification and processing. Each protein can
then participate in myriad interactions with other molecules
in different places within the cell. In addition, protein abun¬
dances, cellular locations, activities and interactions may
differ across tissues and between normal and disease states.
A number of approaches to investigate this awe-inspiring
complexity were presented. Ian Tomlinson (MRC Labora¬
tory for Molecular Biology, Cambridge, UK) described
recombinant-antibody technologies for use in large-scale
studies of protein localization, quantification and interac¬




that are able to profile the expression ofmost human proteins
in a given tissue within the next 3-10 years. Mark Vidal
(Dana-Faber Cancer Institute, Boston, USA) outlined his
approach to building a protein-interaction map for the
Caenorhabditis elegans proteome. The idea is to amplify and
clone every open reading frame in the genome for use in
extensive yeast two-hybrid system assays. The resulting inter¬
action map is to form part of an envisaged functional atlas for
C. elegans. As Patricia Kuwabara (Sanger Centre, Hinxton,
UK) pointed out, because around three quarters of human
disease genes have C. elegans homologs, the worm could be a
valuable source of functional annotation for the human
genome. She outlined efforts to carry out comprehensive DNA
microarray expression profiling as well as RNA-mediated
interference (RNAi) the latter of which provides a rapid,
sequence-specific method to abolish gene activity.
The mouse continues to be a favorite model organism for
investigating gene function, and in this field investigations
are also increasing in the form of screens and multiple studies
carried out in parallel. Keats Nelms (John Curtin School of
Medical Research, Canberra, Australia) and Sally Cross (MRC
Human Genetics Unit, Edinburgh, UK) described the use of
the mutagen N-ethyl-N-nitrosourea (ENU) for the genera¬
tion of thousands of mice with random point mutations
throughout their genome. All of the mutagenesis screens are
picking up dominant, highly penetrant morphological and
behavioral phenotypes. Each project is also following up spe¬
cific groups of phenotypes: mutants affecting the immune
system in the case of Keats Nelms and mutants affecting eye
development and eye disease with Sally Cross. Whereas
most ENU screens of mice are designed to identify only
dominant mutations, the strategy employed by Nelms and
co-workers generates pedigrees to uncover recessive muta¬
tions and intrinsically provides the basic resources to map
the locus of the mutation by back-crossing. Not surprisingly,
90% of the mutations that have been found are recessive. As
an alternative strategy for uncovering recessive ENU-
induced mutations, Allan Bradley (Sanger Centre, Hinxton,
UK) has been coordinating the development of mouse lines
with Cre-Zox-induced megabase deletions, which, when
crossed with ENU-mutagenized mice would uncover reces¬
sive mutations in a locus-targeted manner. Other innova¬
tions from the Bradley lab include coat-color chromosome
tags and megabase inversions, both of which have the poten¬
tial to speed up the characterization ofmutant mice.
The armored, three-spined stickleback (Gasterosteus
aculeatus) is no stranger to the laboratory, having been well
characterized in terms of morphology, color and behavior.
Now David Kingsley (Stanford University, USA) and col¬
leagues are using these fish to characterize the molecular
genetic changes that are responsible for the morphological
evolution of vertebrates. Geographically isolated populations
of stickleback have undergone substantial adaptive radiation
in lakes left in the wake of retreating glaciers around to,000
years ago. The different species vary in size, shape, behavior,
color and patterns of defensive armor. As most of these
species have undergone parapatric divergence (as a result of
population subdivision and reproductive isolation), isolating
mechanisms are largely behavioral and can be overcome in
the laboratory to produce fully viable Ft and F2 generations.
With cDNA-library resources and a genome-wide linkage
map in place, Kingsley is crossing species pairs and watching
the divergent traits segregate in the offspring. It is immedi¬
ately apparent that many of the segregating morphologies are
caused by genes that have a major effect, rather than by many
genes that have a relatively minor effect. These loci are being
mapped and eventually the molecular basis of the trait will be
uncovered. For one of the armor-patterning traits, it has
already been found that one locus has independently changed
twice to produce the same morphological adaptation.
Wendy Bickmore (MRC Human Genetics Unit, Edinburgh,
UK) opened the workshop on chromosome structure and
epigenetic mechanisms with the observation that it is often
assumed that by combining the genome sequence with infor¬
mation about gene expression and the proteome we will
understand inheritance. This is wrong, she said, because epi¬
genetic processes such as histone modification and DNA
methylation as well as chromatin-remodeling systems can all
be important. A striking example was given by Mark Bailey
(University of Glasgow, UK) who described his studies of the
methyl CpG-binding protein 2 gene (MECP2). Mutations in
this gene cause Rett syndrome, a severe X-linked, neurode-
velopmental disorder that is the commonest cause of severe
cognitive incapacity in the female population. MECP2 is
believed to bind methylated CpG islands and mediate tran¬
scriptional repression. Bailey's work has identified genomic
fragments to which MECP2 binds strongly. Intriguingly,
many of these fragments contain Alu interspersed repeat ele¬
ments, suggesting the possibility that Alu overexpression
could be a cause of Rett syndrome. Not only the pioneering
work going on in epigenetic mechanisms but also many
other studies presented at the meeting showed that even
when we finally have a functionally annotated human
genome there will still be much to learn.
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ABSTRACT
We have compared the accuracy, efficiency and
robustness of three methods of genotyping single
nucleotide polymorphisms on pooled DNAs. We
conclude that (i) the frequencies of the two alleles in
pools should be corrected with a factor for unequal
allelic amplification, which should be estimated
from the mean ratio of a set of heterozygotes (k);
(ii) the repeatability of an assay is more important
than pinpoint accuracy when estimating allele fre¬
quencies, and assays should therefore be optimised
to increase the repeatability; and (iii) the size of a
pool has a relatively small effect on the accuracy of
allele frequency estimation. We therefore recom¬
mend that large pools are genotyped and replicated
a minimum of four times. In addition, we describe
statistical approaches to allow rigorous comparison
of DNA pool results. Finally, we describe an
extension to our ACeDB database that facilitates
management and analysis of the data generated by
association studies.
INTRODUCTION
Single nucleotide polymorphisms (SNPs) are the most
common type of polymorphism in the human genome, with
an approximate frequency of one every kilobase (1). These
biallelic variants are relatively easy to genotype compared
with VNTRs and microsatellites. For these reasons SNPs are
thought to have a promising future in a wide range of human
genetics applications including pharmacogenomics, the study
of population evolution, analysis of forensic samples and the
identification of susceptibility genes involved in complex
diseases. Hence, a large proportion of the effort of genome
centres is now focused on the identification and the mapping
of a large collection of SNPs: to date about 1 260 000 have
been mapped onto the human draft sequence (http://snp.
cshl.org/).
The study of complex common diseases and quantitative
traits is confounded by the effects of disease heterogeneity,
gene-gene and gene-environment interactions. This means
that large numbers of SNPs must be surveyed in large numbers
of individuals in order to detect single gene variants with a
small to moderate effect size (2,3). The use of pooled samples,
comprised of equal amounts of genomic DNA from up to 1000
individuals, has been proposed as a means of reducing the
number of genotyping reactions required. The method used to
genotype SNPs in pooled DNAs must provide accurate
estimates of allele frequencies, and must be time and cost
effective. The spectra of methods currently available for
genotyping SNPs in individual samples [for an extensive
review of SNP genotyping methods see Syvanen (4)] can be
divided into three classes. First, methods such as SSCP or
dHPLC that are based on the physical-chemical properties of
the alleles. Secondly, methods such as TAQMAN™ (Applied
Biosystems); oligo-ligation assay; Invader assay™ (Third
Wave Technologies Inc.); and allele-specific amplification
and padlock probes that are based on hybridisation, amplifi¬
cation or ligation of an allele-specific probe. Thirdly, methods
based on allele-specific extension or minisequencing from a
primer adjacent to the site of the SNP such as SNaPshot™
(Applied Biosystems); primer extension read by dHPLC or
by mass spectrometry; primer extension performed on
microarrays; fluorescence polarisation; bioluminometric
assay coupled with modified primer extension reactions
(BAMPER) and Pyrosequencing™ (Pyrosequencing).
Previous studies have shown that allelic frequencies can be
accurately estimated from pools using primer extension
followed by dHPLC (5); TAQMAN™ and RFLP analysis
(6); allele-specific amplification with real-time PCR (7); SSCP
(8); BAMPER (9) and MassARRAY™ (10). In common with
many other groups, we wish to screen a large candidate region
*To whom correspondence should be addressed. Tel: +44 131 651 1061; Fax: +44 131 651 1059; Email: s.lehellard@ed.ac.uk
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for evidence of genetic association. The preferred strategy is to
assay small numbers of pooled DNA samples with large
numbers of SNPs. Consequently, methods such as Pyro-
sequencing™, TAQMAN™ or BAMPER that use modified
primers are too expensive. Methods based on hybridisation or
on physical-chemical properties are ruled out as each assay
must be optimised. We therefore chose to compare the
robustness, accuracy and cost of three methods based on
minisequencing: SNaPshot™ (Applied Biosystems) and
primer extension followed either by dHPLC, or mass
spectrometry (MassARRAY™ system by Sequenom).
We have also addressed the important issues of how many
DNAs can be pooled, and how many times pool genotypes
should be replicated to optimise the accuracy of allele
frequency estimation.
In addition, we suggest the use of a modified statistical
method that allows rigorous analysis of allele frequencies
estimated from pools. Classical association studies on indi¬
vidual DNA samples use the%2 test to compare the frequencies
of alleles in case and control populations. However, when
pooled DNAs are used, allelic frequencies are estimated rather
than directly counted from individual genotypes, which
introduces extra sources of error. We have therefore modified
the x2 test t0 take these sources of error into account,
diminishing the risks of type I error.
Finally, genotyping large numbers of SNPs on pools or on
individual samples generates a large data set. We have set up
an extension of our ACeDB database (11) to store and manage
information on the pools, individuals and markers and to
record and analyse genotyping results. Furthermore, we have
created in ACeDB a model ('Pop_pool_meta') that allows the
data of several pools or populations of individual samples to
be merged and analysed as a single set. This option allows the
pools or populations to be stratified on the basis of phenotypic
traits, and then analysed independently or together. We have
also developed a "user friendly' web interface for submission
of new data, which is fed automatically into an analysis
pipeline, before being recorded in the database.
MATERIALS AND METHODS
DNA pool set up
All subjects gave written ethical consent to take part in these
studies.
The concentration of the DNAs used to construct pools was
measured using the PicoGreen dsDNA Quantitation Reagent
(Molecular Probes) in a CytoFluor fluorimeter (Applied
Biosystems). The DNAs were diluted to a final concentration
of 8 ng/pl and equal amounts of DNAs were mixed to form the
pools.
Range pools were constructed by mixing appropriate
volumes of homozygote DNA. Five homozygote DNAs for
each genotype were used for pooling. The concentrations
ranged from 50-50% to 85-15%, with 5% increments.
Markers and PCR
SNPs RS643304, RS1402045, RS15020285, RS489009 and
RS508509 were retrieved from the dbSNP database (http://
www.ncbi.nlm.nih.gov/SNP). Primers were designed using
Primer3 programme (http://www-genome.wi.mit.edu/cgi-bin/
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primer/primer3_www.cgi), and synthesised by Genosys
Biotechnologies (Europe) Ltd. Sequences of PCR and
genotyping primers are available upon request.
PCRs were carried out on a PTC225 (MJ Research) using
40 ng total DNA, 10 pmol of each primer, 80 pM dNTPs
(Sigma), 1.5 mM MgCl2 and 1 U Taq (Sigma) in IX PCR
buffer [67 mM Tris-HCl, 16 mM enzyme grade (NH4)2S04,
6.7 mM MgCl2 pH 8.8], The programme used was an
initial denaturation of 94°C for 3 min, followed by 10 cycles
of 94°C for 15 s, touch down annealing from 65 to 55°C for
30 s over 10 cycles (-l°C/cycle) and 72°C for 45 s,
followed by 30 cycles of 94°C for 15 s, 55°C for 30 s and
72°C for 45 s.
PCR clean up
After PCR, the products were checked on a 2% agarose gel.
PCR primers and dNTPs were removed before genotyping:
5 pi of PCR product was incubated with 1 pi of ExoSaplT
(Amersham Pharmacia) for 45 min at 37°C, followed by
20 min at 80°C for enzyme inactivation. For multiplexing of
PCRs, 1 pi of each PCR product was pooled and treated with
1 pi of ExoSaplT.
Primer extension followed by dHPLC
Reactions were carried out as described in Hoogendoorn et al.
(12).
SNaPshot™ reactions
The primers used for the extension reactions were designed
according to the manufacturer's recommendations.
Additionally, we used the mfold server (http://bioinfo.math.
rpi.edu/~mfold/dna/forml.cgi) to assess the secondary struc¬
ture of the PCR product and the accessibility of the SNP, in
order to decide whether to use the forward or the reverse
primer.
Reactions were carried out in a final volume of 10 pi,
containing 2 pi of cleaned up PCR product, 1 pi of
SNaPshot™ multiplex mix (Applied Biosystems), 2 pi of
half term buffer (200 mM Tris-HCl, 5 mM MgCl2 pH 9),
2 pmol of genotyping primer. In multiplex reactions 2 pi of the
cleaned PCR multiplex was used. The cycling programme was
25 cycles of 94°C for 10 s, 50°C for 5 s, 60°C for 30 s. After
cycling, the unincorporated fluorescent ddNTPs were removed
by adding 1 U of shrimp alkaline phosphatase (Amersham
Pharmacia) and incubating for 45 min at 37°C, followed by
20 min at 80°C for enzyme inactivation. An aliquot of 9 pi
formamide was added to 1 pi of SNaPshot™ reactions and
loaded on ABI3700 sequencer (Applied Biosystems). Samples
were run using the POP6 Polymer, with dye set E and analysed
using the Genescan v3.5.2 program. The relative proportion of
each allele was measured by the height of the corresponding
peaks.
Primer extension on MassARRAY™
Reactions were performed at Sequenom GmbH (Hamburg,
Germany; http://www.sequenom.com). Assays were designed
using Sequenom's SpectroDESIGNER™ software (version
1.3.4). Genotypes were performed using MassARRAY™
system and SpectroTYPER™ software.
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Statistical analysis
Correction for unequal allelic amplification and estimation of
frequencies. Let k be the ratio of the two allele peak heights in
heterozygotes. Following Hoogendoorn et al. (5), this factor is
estimated from a number of independent heterozygotes, and
we assume that the estimator k is unbiased with a variance of
ak2, i.e. k ~ (k, 0k2) with ak = SE(k). The error in estimating k
arises from variation in the quality of the DNA from each
heterozygote, and from a pure experimental error attached to
each individual analysis. The estimate of the allele frequency
in the pool is estimated as
p = A/(A + kB),
with p the estimated frequency in pools, and A and B the
observed peak heights corresponding to the two alleles. The
variance of the estimated allele frequency as a function of the
variance of k is, approximately, following a Taylor series
expansion,
var(p due to k) = p2 (1 - p)2 CV2(k)
with p the true frequency in the population, and CV the
coefficient of variation. Furthermore we observed a pool
specific error (e) which contributes to a difference between the
allele frequency estimated from the pools and the estimate of
the allele frequency from a direct count of alleles on individual
genotypes (p),
p = p + s
We assumed that these errors are normally distributed. This
assumption was confirmed for the distribution of the frequen¬
cies for 10 replicates of the five markers we have tested in this
study. Following these assumptions, the variance of the
estimated allele frequency from a pool of N individuals is
var(p) = var(/5) + var(e) + var(p due to k)
= p(l - p)/(2N) + var(e) + p2 (1 - p)2 CN\k)
Comparing freqencies between pools. The standard procedure
to test whether the allele frequencies in two pools are
significantly different from each other is to summarise the
observed counts in a 2X2 table and to perform a %2 test (13).










- d = NControl
a + b = Nam
c + d = Nan2
N
In this notation Ncase is twice the number of case individuals
and, for an equal number of cases (n) and controls (n), N = 2n
+ 2n = 4n. The standard test statistic of independence can be
written as
Ti = (ad - bc)2N/(Ncase X Ncontrol X Nam X Nan2)
Under the null hypothesis of the same population allele
frequencies in cases and controls, for large N and not too
extreme population frequencies, this test is distributed as a %2
with one degree of freedom. If estimated counts are substituted
for the observed ones, this test is then Test
Test = (aede - bece)2N/(Ncase ^ Ncontroi X Nam X Nali2)
with ae, be, ce and de the estimates of a, b, c and d, respectively.
The expected value of Tes, is, approximately,
E(Test) - 1 + var(e)/[2var(/50)],
with p0 the estimate of the allele frequency across the two
pools under the null hypothesis, i.e. p0 = (a + b)/N, and its
variance is obtained from the binomial distribution [var(/30) =
A)0 - PoVNJ- Under the null hypothesis of equal allele
frequencies, the expected value of the test statistic based upon
observed counts is E(T,) = 1. Hence, the test statistic is
inflated by the extra source of errors in estimating the allele
frequencies and its use would lead to an inflated type 1 error
rate. We suggest a simple adjusted test,
Tadj = Tes, X [2var(po)]/[2var(p0) + var(e)],
i.e. a shrunk version of the standard test statistic, with the
estimate of the sampling variance of the allele frequency under
the null hypothesis obtained from the estimated counts (i.e. p0
replacing p0).
A more detailed protocol is available online at our website
(http://www.genetics.med.ed.ac.uk/protocols/).
Data management in ACeDB
Modified models. The 'STS' model was modified to cross-
reference to the allele model for the markers (SNPs or
microsatellites) that are present in the STS. The 'allele' model
was modified to store information on the method used to
genotype the marker (e.g. details of the extension primer and
genotyping method used, and the experimental conditions);
the pools, populations, metapopulations and metapools that
have been typed with the marker and the statistical analysis of
the results obtained.
New models. The 'Individual' model was created to store
individual genotypes and indicate which pool or population,
metapopulation and metapool an individual DNA sample
belongs to.
The new 'Pop_pool' model stores the identities of the DNA
samples that constitute the pool or the population, and
provides links to the markers that have been genotyped on
the pool/population and the genotyping results. It also stores
the results of comparison of allele frequencies with those of
other pools/populations, or metapools/metapopulations, and
information regarding inclusion of the pool/population in a
metapool/metapopulation.
The 'Pop_pool_metapool' model stores data on the set of
pools/populations combined and provides links to the markers
typed on the pools/populations, the statistical description of
the data set obtained, and information on the comparison of
allele frequencies with those of other samples (pools, popu¬
lations, metapopulations and metapools).
265
Appendix



















► ddT ^ rlrlT ^rldT
Extension product for
allele G




A: peak for allele A









Figure 1. Genotyping a SNP with SNaPshot™, primer extension followed by dHPLC or mass spectrometry (MassArray™) analysis. The three methods are
based on the allele specific extension of a genotyping primer adjacent to the SNP site (see below). The region containing the primer is first amplified by PCR.
The statistical description model 'Stat_des' stores the
results of the statistical analysis of data obtained by
genotyping specified markers on a given sample (mean
frequencies of the two alleles, standard deviation, standard
error).
Finally, the statistical comparison model 'Stat_comp' stores
the results of association studies carried out by comparing
allele frequencies in the samples or direct allele counts for a
given marker, using the appropriate statistical test.
Web interface for submission of data and automation of
statistical analysis
CGI/Perl scripts were produced to facilitate the submission of
new data and to perform statistical description and x2 tests.
When entering new data or updating a given object, the tace
program (Morris, J. 1994; http://www.acedb.org/Cornell/
tace.html) is used by the script to retrieve existing information,
e.g. names of the pool and the marker, and information on the
genotyping experimental conditions. The user then selects
parameters from pull-down lists that are either defined in the
script or retrieved from the database (e.g. names of the pool
and the marker), which ensures accurate data entry. Pool
genotyping data are then automatically analysed using a script
that computes descriptive statistics and runs the Shapiro-Wilk
test for goodness-of-fit to normality.
Tests of association based on pools and metapools are
automatically performed using a script that runs the modified
X2 test. The interface also allows classical association studies
to be carried out based on genotypes of individuals. A '.ace'
file storing any new data submitted is generated and read into
the database. All the models and scripts described here are
available at http://www.genetics.med.ed.ac.uk.
RESULTS
Figure 1 gives a brief description of the methods compared in
this study.
Estimating allele frequency in pools: correction for
unequal allele amplification
By definition, heterozygote individuals have an equal number
of copies of the two alleles at any given locus. If genotyping
was equally efficient for the two alleles, then the two amplified
peaks would be the same height. However, in practice unequal
peak heights is the norm. We genotyped individual hetero-
zygotes 6-10 times and recorded the variation in peak height
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Table 1. Unequal allelic amplification
Marker SNaPshot™ dHPLC MassARRAY™
RSI 5020285 0.951 + 0.272 (0.086) 0.416 + 0.272 (0.087) 0.566 (nd)
RS508509 0.268 ± 0.085 (0.027) 0.389 ± 0.016 (0.005) 0.593 (nd)
RSI402045 0.447 ± 0.047 (0.015) 0.911 0.465 (0.147) 0.754 (nd)
RS643304 0.648 ± 0.009 (0.003) 0.748 ± 0.063 (0.020) 0.564 (nd)
RS489009 0.813 ± 0.275 (0.087) 0.569 ± 0.161 (0.051) 0.515 (nd)
Ten heterozygote individuals were genotyped for each of the five markers. The mean ratio of the two allele
peaks across 10 different heterozygotes individuals ± standard deviation between the ratios of the
heterozygotes (and standard error of the mean) is shown, nd, not determined.
ratios between replicates. This indicated that the standard error
of the mean (SEM) ratios were less than one-twentieth of the
mean value (data not shown).
We observed greater variation in peak height ratios between
different heterozygotes (SEM ranging from 0.003 to 0.147;
Table 1). Hoogendoorn et al. (5) reported a SEM of 0.005-
0.06 when comparing the peak height ratios of different
heterozygotes for nine markers genotyped by primer extension
followed by dHPLC. It is possible that the variation observed
between heterozygotes could be due to variable DNA quality.
However, all of the DNAs used for this study were collected,
extracted and stored under the same conditions. The observed
variation is therefore more likely to be caused by factors
specific to the experimental procedures. The maximum
variation (SEM) between the ratios of different heterozygote
individuals was within one-seventh of the mean ratio (Table 1).
A mean ratio of unequal amplification (k) can therefore be
accurately calculated for any given marker genotyped by a
given method.
When allele frequencies are estimated by genotyping a
pooled sample the resultant peak heights must be corrected for
unequal amplification by the factor k. If k is the mean ratio of
the allele A and B peak heights (HA and HB, respectively) in
heterozygote individuals, i.e. k = HA/HB, then the frequency of
the allele A in the pools would be pApoois = HApools/(HApoois +
kHBpoois). If the unequal amplification of alleles is ignored and
the ratios of peak heights are used in a x2 statistic this will
result in a biased test procedure, as the test statistic is not
distributed as a x2 under the null hypothesis of equal allele
frequencies in the pools. To a first order approximation, the
expected value of the test statistic based upon the unadjusted
ratio of peak heights is
E(test statistic) = k/[l + (k - l)p]**2,
where p is the population frequency. This result was validated
by computer simulation. Depending on the true value of k and
the frequency (p), this test is either expected to be smaller or
larger than 1.0 (which is the expected value from a proper x2
test). For example, for p = 0.25 and k = 0.5, the expected value
of the test statistic is -0.65, which will result in a test that is
too conservative.
Hoogendoorn et al. (5) used the mean ratio from eight
heterozygote individuals to determine k. We currently use a
panel of 16 control individuals, which are genotyped for each
marker. We then calculate a mean ratio from the heterozygote
individuals of this panel—we always divide the height of the
smaller allele peak by the height of the bigger allele peak to
keep data homogenous. As long as the SEM of the ratio
between the heterozygotes is less than one-tenth of the mean
value, we use this mean value as k. If the SEM is greater than
one-tenth of k, then either the assay must be optimised or the
number of heterozygote genotypes must be increased appro¬
priately until this criterion is met.
To avoid introducing any extra sources of variation, we
perform all stages of the genotyping procedure simultaneously
on all samples.
Effect of allele frequencies on unequal amplification in
pools
The allele frequencies in pools of cases and controls are both
corrected with the same k factor. This approach is valid only if
unequal amplification is linearly correlated with allele
frequencies. To test this, we constructed two sets of artificial
pools with a range of allele frequencies by mixing appropriate
volumes of two homozygote DNAs for the markers
RS1402045 and RS643304. The ratio of concentrations of
alleles in both sets of pools ranged from 50-50% to 85-15%,
at 5% increments. Each pool was genotyped 5-10 times.
Results (Fig. 2) show that there is a linear correlation between
the allele frequencies and the ratios for all three methods
tested. These data indicate that variation in allele frequency
does not affect the extent of unequal allele amplification, and
that pools with different allele frequencies can be corrected
with the same k factor.
Comparison of accuracy and repeatability of
SNaPshot™, primer extension followed by dHPLC, or
by mass spectrometry (MassARRAY™) methods
Five markers were genotyped on a set of 96 individual DNAs
to obtain the sample allelic frequencies. The 96 DNAs were
then pooled (Pool96), and the pool was genotyped 10 times
with each of the five markers by the three methods. The k
factors were obtained for the three methods and used to correct
the estimate of allele frequencies within the pools. The
estimated allele frequencies were in good agreement with the
results of individual genotyping. This was true for all methods
and markers tested (Table 2). Several parameters are import¬
ant in comparing the efficiency of the different methods. First,
the estimation of frequencies has to be close to the sample
frequencies, as a large discrepancy would introduce a risk of
type I and type II errors. However, as we demonstrate below,
good repeatability (i.e. a smaller SEM) is more important than
pinpoint accuracy. Poor repeatability necessitates a larger
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Figure 2. Test for linearity for the markers RSI402045 and RS643304 across artificial pools with allele frequencies ranging from 50-50% to 85-15% with
5% increments were constructed. Comparison of the three methods: SNaPshot™ (diamonds), dHPLC (triangles) and MassARRAY™ (squares).
Table 2. Comparison of the accuracy of the three methods in estimating allele frequencies in a pool of 96 DNAs (Pool96)
Marker Sample Estimated frequency
frequency
SnaPshot™ dHPLC MassARRAY™
RSI 5020285 0.658 0.666 ± 0.022 (0.007) 0.633 + 0.013 (0.004) 0.727 0.013 (0.004)
RS508509 0.714 0.702 ± 0.135 (0.043) 0.711 + 0.013 (0.004) 0.761 0.009 (0.003)
RSI402045 0.713 0.699 ± 0.047 (0.015) 0.683 ± 0.047 (0.015) 0.724 ■jr 0.009 (0.003)
RS643304 0.657 0.648 ± 0.032 (0.010) 0.656 ± 0.022 (0.007) 0.645 ± 0.013 (0.004)
RS489009 0.528 0.561 ± 0.063 (0.02) 0.501 ± 0.054 (0.017) 0.503 - 0.009 (0.003)
The sample allelic frequencies were obtained from genotyping the 96 individuals (using the SNaPshot™ method). A k correction factor for unequal
amplification was obtained for each of the three methods and used to estimate the frequencies in the Pool96. Ten replicates of Pool96 were genotyped to test
the repeatability of the method, which is expressed here as ± standard deviation (and SEM).
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Table 3. Comparison of cost and throughput of the methods
Cost per sample Throughput/day/machine
dHPLC 157 cents 192
MassARRAY™ 100 cents 40 000
SNaPshot™ 87 cents 7000"
1500b
The calculations include genotyping reagents and primers (on the basis of
100 reactions per primer), plastic consumables and the cost of running the
assay on the detection platform. Salary costs are not included. PCR costs
are not included, as they are the same for the three methods.
"With a 96 capillary system (ABI37000).
bWith a 16 capillary system (ABI3100).
number of replications in order to lower the SEM of the
estimated allele frequencies. The SEMs observed varied from
0.003 to 0.066 for SNaPshot™, 0.003 to 0.017 for primer
extension followed by dHPLC and 0.003 to 0.004 for
MassARRAY™. Thus, from a quantitative point of view, the
three methods tested are all suitable for genotyping pools, with
the MassARRAY™ method performing substantially better
than the other two.
Ease of use and cost considerations
For all of the markers tested, the SNaPshot™ method was
found to be robust and required little optimisation. However,
multiplexing SNP assays was less straightforward, as the
signal strength varied between assays. We circumvented this
problem by multiplexing assays on the basis of signal strength,
or by increasing the amount of genotyping primer for the
weaker assays (14). We currently find that multiplexing four
markers is relatively straightforward, although according to
the manufacturer 10 SNPs can be successfully multiplexed.
In our hands, SNP genotyping using primer extension
followed by dHPLC required extensive optimisation of the
primer extension reaction. Optimisation of the gradient that is
best suited to the elution of each product was also required
and, furthermore, attempts to multiplex reactions were
unsuccessful.
For the MassARRAY™ analysis, sequence files with
information on the marker and localisation of the SNPs to
be detected were provided to Sequenom who designed the
assays using their 'in house' software. Coded samples and
pools were provided, and highly satisfactory results returned
promptly for each SNP assay.
The cost of genotyping pools (Table 3) is highly dependent
on the ability to multiplex reactions and minimise reaction
volume. For these reasons, primer extension followed by
dHPLC or MassARRAY™ is not as cost effective as the
SNaPshot™ method. However, as we demonstrate below, the
MassARRAY™ requires less replicates per pool than the
SNaPshot™, which makes MassARRAY™ as cost effective as
SNaPshof™. Table 3 also provides a comparison of the
throughputs of the different platforms.
Effect of pool size
We wanted to determine whether the number of the samples in
the pool would affect the accuracy of allele frequency
estimation in pooled DNAs. We genotyped 384 individual
Nucleic Acids Research, 2002, Vol. 30 No. 15 e74
DNAs to calculate the sample frequencies for the markers
RS1402045, RS15020285 and RS643304. The same 384
individuals were then included in four pools of 96, two pools
of 192, one pool of 288 and one pool of 384 individuals, and
genotyped using the SNaPshot™ method (six replicates per
pool). The frequencies estimated from the pools were
compared with the sample frequencies (Fig. 3). We found
that for the range tested, pool size had no significant effect on
the accuracy of frequency estimations or on repeatability. This
indicates that pooling larger numbers of samples does not
result in a loss of power. We therefore recommend that larger
pools are typed, minimising the number of genotyping
reactions required.
Statistical comparison of two or more pools genotyped
with a given marker
Estimating the allelic frequencies in pools. As we have
demonstrated above, estimating allele frequencies in pooled
DNAs introduces three potential sources of error: (i) error
caused by sampling a finite number of individuals from a
population (the standard sampling error); (ii) error in estimat¬
ing the adjustment factor k; and (iii) a pool-specific measure¬
ment error. The first source of error is reduced by increasing
the sample size; the second source of error is reduced by using
the appropriate number of heterozygotes to estimate k (see
above); and the third source of error is reduced by genotyping
replicate samples of the pools. When allele frequencies from
two (or more) pools are compared, a minor error in the
estimation of k will induce a covariance between the estimates
from the two pools, because the error in estimating k is the
same for both pools. However, as the same error in estimating
k is made for both pools, and as k is independent of the allelic
frequency, the difference between the estimates of the
frequency in both pools is not affected to a first order
approximation. This was also observed by Hoogendoorn
et al. (5).
Comparing frequencies between pools. We have modified the
standard y} test, which is used in classical case-control
association studies, to take into account the sources of error
discussed above. The effect of a larger variance in allele
frequencies from pools due to the use of estimated rather than
observed counts was investigated using models that simulate
observed and estimated counts. The results are shown in
Tables 4 and 5. Generally, unless the sources of errors are
large, the inflation in the type I error is small. However, if the
pool-specific error is large [e.g. experimental error (oe) >
0.025], then the type I error can be substantially inflated. For
example, for oe = 0.025 the type I error is at least doubled
relative to the type 1 error rate on the observed counts.
Regarding the type II error, power is reduced when using
the adjusted statistical test relative to the power based upon
observed counts (Table 5). For cte > 0.025, the reduction in
power can be substantial. To achieve the same power for
pooling and direct genotyping, the pool sample size must be
increased by a factor of 1/[1 - 2var(e)/var(A)J, with var(A) the
variance of the difference in allele frequencies in the two
groups obtained from observed counts, and var(e) the
experimental pool-specific error. For example, for ae = 0.01
(which corresponds to a standard error of 0.01, as is typically
seen in SNaPshot™ experiments) and oA = 0.03 (which
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0rs1402045 sample frequencies
■ rs1402045 estimated frequencies
0rs6433O4 sample frequencies
■ rs643304 estimated frequencies
Ors15020285 sample frequencies
Drs15020285 estimated frequencies
Number of individuals in the pools
Figure 3. Estimation of allele frequency in different sized pools. Marker RS1402045, RS15020285 and RS643304 were typed on 384 individuals (using the
SNaPshot™ method) to obtain sample allelic frequencies. 384 DNAs were combined in four pools of 96, two pools of 192, one pool of 276 and one pool of
384 individuals. Each pool was genotyped six times (using the SNaPshot™ method) and the frequencies were estimated from the mean frequency corrected
for unequal amplification. The repeatability is expressed as the SEM estimated frequency.
Table 4. Empirical type I errors from 10 000 simulations, for 100 cases
and 100 controls, and p = 0.5




0.10 0.01 0.099 0.113 0.093
0.025 0.098 0.180 0.094
0.05 0.100 0.345 0.102
0.05 0.01 0.051 0.060 0.048
0.025 0.051 0.112 0.053
0.05 0.051 0.264 0.054
0.01 0.01 0.011 0.015 0.011
0.025 0.011 0.039 0.011
0.05 0.011 0.144 0.011
"Nominal type I error.
bSEM of estimated allele frequency.
T i x2 test on observed counts.
Test unadjusted test on estimated counts.
Tadj adjusted test on estimated counts.
corresponds to, for example, 200 case and 200 control
individual populations with frequencies of 0.3 and 0.2,
respectively), the sample size of the pool would have to be
increased by a factor of 1/(1 - 0.0002/0.0009) = 1.3.
To achieve an experimental error of oe = 0.01 or less,
replicate pools must be used. If the estimate of the between-
replicate variation in the estimate of the allele frequency is in
the range of 0.02-0.04 (standard deviation), then to achieve a
SEM of <0.01, approximately 4—16 replicate pools would give
the same power as tests based upon observations, assuming
that there are no errors in determining individual genotypes.
Table 5. Power for a significance level of 0.05 and 100 cases and 100
controls, from 10 000 simulations
<V p(cases) p(controls) T,b Tadj'
0.01 0.50 0.45 0.17 0.16
0.40 0.52 0.48
0.35 0.86 0.83
0.025 0.50 0.45 0.17 0.13
0.40 0.52 0.38
0.35 0.86 0.71
0.05 0.50 0.45 0.17 0.09
0.40 0.52 0.22
0.35 0.86 0.42
aSEM of estimated allele frequency.
bTi x2 test °n observed counts.
Tadj adjusted test on estimated counts.
From the results in Table 2 we can conclude that most standard
deviations are in this range, so that a minimum of four
replicates appears to be appropriate.
Database development
We have previously used an ACeDB database (15) to manage
the construction of a physical map of chromosome
4pl6.1-15.3 (16). Although this database necessitates expert
bio-informatics support, it possesses the flexible architecture
required to adapt it to our current purpose. We were able to
modify existing models and create new ones to allow storage
of all information relevant to pool construction, populations
and genotyping results. The new models facilitate storage of
statistical analysis and of association data based on both pools
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and populations of individual samples. We have also created a
model ('Pop_pool_meta') that allows the genotyping data
obtained for a set of pools or populations to be merged and
analysed as a single data set. The data from different pools can
then be merged and the results analysed as a single group.
Submission and analysis of new genotyping data
Data submission via a web interface. CGI/Perl scripts were
produced to facilitate the submission of new data and to
perform direct statistical analysis. A web page with a graphical
representation of a 96-well plate allows the submission of
individual genotypes for use in classical association studies.
This interface can also be used to enter peak heights obtained
from heterozygote samples, which are used to calculate the
correction factor k. Another form is used to submit the allele
peak heights for the different pool replicates.
Statistical analysis and description ofpool genotypinf• data.
Once entered, peak height ratios are subjected to statistical
analyses (the mean frequencies of the two alleles, standard
deviation and SEM are calculated). The interface also allows
the analysis of a data set produced by combining two or more
pools. A table of results is displayed and a file containing the
new data and their statistical description is automatically
created and read into the database.
Association studies based on pools. The modified yf test is
used to detect differences between the allele frequencies of
selected pools. The results are displayed and stored in a new
file that is then read into the database.
Association studies based on populations. For a specified
marker, allele numbers in each selected population, or group
of populations, are calculated from the genotypes of all
individuals. A classical y2 test's performed on these data to
identify differences between populations. Results are dis¬
played and automatically read into the database.
DISCUSSION
Pool allele frequencies can be estimated with a high degree of
accuracy using SNaPshot™ and primer extension followed by
either dHPLC or MassARRAY™. However, accurate estima¬
tion of allele frequencies requires calculation of a correction
factor for unequal allelic amplification from the peak height
ratios of a small set of heterozygotes. Of the three methods
tested, the MassARRAY™ method gives the best repeat¬
ability, while primer extension followed by dHPLC requires
more optimisation than the other methods and does not allow
easy multiplexing. The number of samples in a pool has a
negligible effect on the accuracy of frequency estimations. We
therefore recommend the use of larger pools (we use pools of
384 individuals) and multiple replicates rather than smaller
pools with fewer replicates. The ideal number of replicates
required is dependent on the reliability of the marker, and the
repeatability of the method. For example, for the majority of
markers four replicates appeared to be sufficient when the
MassARRAY™ method was used.
Choosing a method for genotyping, particularly if this
implies the purchase of expensive equipment, is difficult and
no golden rule can be applied. The deciding factors include the
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number of genes/SNPs to be typed, the need for single
genotyping versus pool genotyping, the level of throughput
required and whether there is a need for SNP detection as well
as genotyping. For example, MassARRAY™ may be the best
choice for a core facility that provides a very high throughput
SNP genotyping service on pools and/or individuals, but a
capillary electrophoresis instrument would provide more
flexibility for a project that requires SNP detection and
medium genotyping throughput.
We have expanded the ACeDB architecture to allow the
storage, management and analysis of genotyping data and
related information. The ACeDB database provides a
graphical, multi-window interface and allows the user to
navigate easily between objects. With the new models one can
now navigate from a marker to the pools tested with the
marker, to the data obtained, and to the results of the
comparison of allele frequencies in that pool with those of
other pools. Additionally, we have developed a web interface
that allows easy and accurate submission of new data and their
automatic examination, via descriptive statistical analysis and
association studies. A useful future development of the
analysis pipeline would be a graphical display of the
association data along the DNA sequence of a genomic
region. This would allow researchers to visualise the strength
of the association in the context of other sequence annotation.
We have modified an existing statistical test to correct for
extra sources of error introduced by the pooling methodology.
Our test controls the type I error well, but at the expense of a
slight decrease of power, which is expected because extra
sources of error increase the random variation of the
difference in allele frequencies between pools, so that a true
difference is more difficult to detect. However, the power of
the pooled sample can be maintained at a level equivalent to
that obtained by individual genotypes by minimising the
experimental error and slightly increasing the sample size.
Genotyping accuracy has not been systematically examined
but recent studies (16; L. Peltonen, personal communication)
have suggested that no genotyping method is 100% accurate,
and that as many as 5% of individual genotypes could be mis¬
called. Such genotyping errors would decrease the power to
detect quantitative trait loci (17) or could have serious effect
on linkage disequilibrium measures (18). Most of the scoring
errors are caused by ambiguities in the allele peaks, sample-to-
sample contamination or mislabelling of DNAs. The use of
pools should reduce all of these sources of error. Hence, the
procedures described above can be used to perform very
accurate association studies, saving valuable time and money
compared with genotyping individual samples. Pooling
studies should therefore be used to perform a fast, cheap and
reliable preliminary screen of a candidate region.
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